{"288d96a77df44759ee1026f9e51867323a1f07fa": [["D iarrhea is one of the most likely reasons young beef calves become sick or die.", [["iarrhea", "DISEASE", 2, 9], ["calves", "ORGANISM", 55, 61], ["beef", "SPECIES", 50, 54], ["calves", "SPECIES", 55, 61], ["beef", "SPECIES", 50, 54], ["D iarrhea", "PROBLEM", 0, 9]]], ["1 Besides its detriment to calf health and well-being, neonatal calf diarrhea is an economic burden to cattle producers due to poor calf performance, death, and the expense of medications and labor to treat sick calves.", [["diarrhea", "DISEASE", 69, 77], ["death", "DISEASE", 150, 155], ["calf", "ORGANISM_SUBDIVISION", 27, 31], ["calf", "ORGANISM_SUBDIVISION", 64, 68], ["cattle", "ORGANISM", 103, 109], ["calf", "ORGANISM_SUBDIVISION", 132, 136], ["calves", "ORGANISM", 212, 218], ["calf", "SPECIES", 27, 31], ["calf", "SPECIES", 64, 68], ["cattle", "SPECIES", 103, 109], ["calf", "SPECIES", 132, 136], ["calves", "SPECIES", 212, 218], ["cattle", "SPECIES", 103, 109], ["neonatal calf diarrhea", "PROBLEM", 55, 77], ["an economic burden", "PROBLEM", 81, 99], ["cattle producers", "TREATMENT", 103, 119], ["poor calf performance", "PROBLEM", 127, 148], ["death", "PROBLEM", 150, 155], ["medications", "TREATMENT", 176, 187], ["labor", "PROBLEM", 192, 197], ["sick calves", "PROBLEM", 207, 218], ["calf", "ANATOMY", 27, 31], ["calf", "ANATOMY", 64, 68], ["diarrhea", "OBSERVATION", 69, 77]]], ["2, 3 In addition, catching and treating young calves puts herd owners and their employees at risk of physical harm, and many producers become disheartened after investing long hours to treat scouring calves during an already exhausting calving season.INVESTIGATING OUTBREAKS OF NEONATAL CALF DIARRHEACattle producers may not discuss neonatal calf diarrhea with a veterinarian until a serious outbreak occurs.", [["diarrhea", "DISEASE", 347, 355], ["calves", "ORGANISM", 46, 52], ["calves", "ORGANISM", 200, 206], ["calf", "ORGANISM_SUBDIVISION", 342, 346], ["calves", "SPECIES", 46, 52], ["calves", "SPECIES", 200, 206], ["calf", "SPECIES", 342, 346], ["scouring calves", "PROBLEM", 191, 206], ["NEONATAL CALF DIARRHEACattle producers", "TREATMENT", 278, 316], ["neonatal calf diarrhea", "PROBLEM", 333, 355], ["CALF", "ANATOMY", 287, 291], ["calf", "ANATOMY", 342, 346], ["diarrhea", "OBSERVATION", 347, 355]]], ["Veterinarians investigating outbreaks of neonatal calf diarrhea must first make recommendations for therapy of affected calves, then take action to protect susceptible and unborn calves from ongoing exposure and illness.", [["calf diarrhea", "DISEASE", 50, 63], ["illness", "DISEASE", 212, 219], ["calf", "ORGANISM_SUBDIVISION", 50, 54], ["calves", "ORGANISM", 120, 126], ["calves", "ORGANISM", 179, 185], ["calf", "SPECIES", 50, 54], ["calves", "SPECIES", 120, 126], ["calves", "SPECIES", 179, 185], ["neonatal calf diarrhea", "PROBLEM", 41, 63], ["therapy of affected calves", "TREATMENT", 100, 126], ["illness", "PROBLEM", 212, 219], ["calf", "ANATOMY", 50, 54]]], ["Finally, attention should focus on determining what future actions might prevent the disease in subsequent calving seasons.", [["the disease", "PROBLEM", 81, 92]]], ["The outbreak investigation sometimes becomes sidetracked in the pursuit of an etiologic agent rather than identifying more useful explanations for the outbreak.", [["The outbreak investigation", "TEST", 0, 26], ["the outbreak", "PROBLEM", 147, 159]]], ["Knowing the etiologic agent may provide an explanation for the proximal cause of a calf's illness or death (although that knowledge rarely explains the outbreak) or provide a solution for treatment, control, or prevention.INVESTIGATING OUTBREAKS OF NEONATAL CALF DIARRHEANeonatal calf diarrhea is a complex, multifactorial, and temporally dynamic disease.", [["illness", "DISEASE", 90, 97], ["death", "DISEASE", 101, 106], ["diarrhea", "DISEASE", 285, 293], ["calf", "ORGANISM_SUBDIVISION", 83, 87], ["calf", "SPECIES", 83, 87], ["calf", "SPECIES", 280, 284], ["a calf's illness", "PROBLEM", 81, 97], ["death", "PROBLEM", 101, 106], ["a solution", "TREATMENT", 173, 183], ["treatment", "TREATMENT", 188, 197], ["NEONATAL CALF DIARRHEANeonatal calf diarrhea", "PROBLEM", 249, 293], ["temporally dynamic disease", "PROBLEM", 328, 354], ["calf", "ANATOMY", 83, 87], ["NEONATAL CALF", "ANATOMY", 249, 262], ["DIARRHEANeonatal calf", "ANATOMY", 263, 284], ["diarrhea", "OBSERVATION", 285, 293], ["temporally", "OBSERVATION_MODIFIER", 328, 338], ["dynamic disease", "OBSERVATION", 339, 354]]], ["[4] [5] [6] Agent, host, and environmental factors collectively explain neonatal calf diarrhea, and these factors interact dynamically over the course of time.", [["diarrhea", "DISEASE", 86, 94], ["[4] [5] [6] Agent", "SIMPLE_CHEMICAL", 0, 17], ["calf", "ORGANISM_SUBDIVISION", 81, 85], ["calf", "SPECIES", 81, 85], ["Agent", "TREATMENT", 12, 17], ["neonatal calf diarrhea", "PROBLEM", 72, 94], ["calf", "ANATOMY", 81, 85], ["diarrhea", "OBSERVATION", 86, 94]]], ["Veterinarians must understand the relationships among these factors within the production system to control the disease or prevent its occurrence.", [["the disease", "PROBLEM", 108, 119]]], ["7AGENT FACTORSNumerous infectious agents have been recovered from calves with neonatal diarrhea.", [["neonatal diarrhea", "DISEASE", 78, 95], ["calves", "ORGANISM", 66, 72], ["calves", "SPECIES", 66, 72], ["neonatal diarrhea", "PROBLEM", 78, 95], ["infectious", "OBSERVATION", 23, 33], ["diarrhea", "OBSERVATION", 87, 95]]], ["4, 5, 7, [8] [9] [10] [11] [12] [13] [14] Common agents of neonatal calf diarrhea include bacteria such as Escherichia coli and Salmonella, viruses such as rotavirus and coronavirus, and protozoa such as cryptosporidia.", [["4, 5, 7, [8] [9] [10] [11] [12] [13] [14", "CHEMICAL", 0, 40], ["calf diarrhea", "DISEASE", 68, 81], ["rotavirus and coronavirus, and protozoa", "DISEASE", 156, 195], ["cryptosporidia", "DISEASE", 204, 218], ["4, 5, 7, [8] [9] [10] [11]", "CHEMICAL", 0, 26], ["5, 7, [8] [9] [10] [11] [12] [13] [14] Common agents", "SIMPLE_CHEMICAL", 3, 55], ["calf", "ORGANISM", 68, 72], ["Escherichia coli", "ORGANISM", 107, 123], ["Salmonella", "ORGANISM", 128, 138], ["rotavirus", "ORGANISM", 156, 165], ["coronavirus", "ORGANISM", 170, 181], ["calf", "SPECIES", 68, 72], ["Escherichia coli", "SPECIES", 107, 123], ["rotavirus and coronavirus", "SPECIES", 156, 181], ["Escherichia coli", "SPECIES", 107, 123], ["neonatal calf diarrhea", "PROBLEM", 59, 81], ["bacteria", "PROBLEM", 90, 98], ["Escherichia coli", "PROBLEM", 107, 123], ["Salmonella", "PROBLEM", 128, 138], ["viruses", "PROBLEM", 140, 147], ["rotavirus", "PROBLEM", 156, 165], ["coronavirus", "PROBLEM", 170, 181], ["protozoa", "PROBLEM", 187, 195], ["cryptosporidia", "PROBLEM", 204, 218], ["calf", "ANATOMY", 68, 72], ["diarrhea", "OBSERVATION", 73, 81], ["Escherichia coli", "OBSERVATION", 107, 123]]], ["Bovine rotavirus, bovine coronavirus, and cryptosporidia are ubiquitous to most cattle populations and can be recovered from calves in herds not experiencing calf diarrhea.", [["Bovine rotavirus", "DISEASE", 0, 16], ["bovine coronavirus, and cryptosporidia", "DISEASE", 18, 56], ["diarrhea", "DISEASE", 163, 171], ["Bovine rotavirus", "ORGANISM", 0, 16], ["bovine coronavirus", "ORGANISM", 18, 36], ["cryptosporidia", "CANCER", 42, 56], ["cattle", "ORGANISM", 80, 86], ["calves", "ORGANISM", 125, 131], ["calf", "ORGANISM_SUBDIVISION", 158, 162], ["Bovine", "SPECIES", 0, 6], ["rotavirus", "SPECIES", 7, 16], ["bovine", "SPECIES", 18, 24], ["coronavirus", "SPECIES", 25, 36], ["cattle", "SPECIES", 80, 86], ["calves", "SPECIES", 125, 131], ["calf", "SPECIES", 158, 162], ["Bovine rotavirus", "SPECIES", 0, 16], ["bovine coronavirus", "SPECIES", 18, 36], ["cattle", "SPECIES", 80, 86], ["Bovine rotavirus", "PROBLEM", 0, 16], ["bovine coronavirus", "PROBLEM", 18, 36], ["cryptosporidia", "PROBLEM", 42, 56], ["calf diarrhea", "PROBLEM", 158, 171], ["rotavirus", "OBSERVATION", 7, 16], ["bovine coronavirus", "OBSERVATION", 18, 36], ["calf", "ANATOMY", 158, 162], ["diarrhea", "OBSERVATION", 163, 171]]], ["7 Further, multiple agents can be recovered from herds experiencing outbreaks of calf diarrhea; suggesting that even during outbreaks more than one agent may be involved.", [["diarrhea", "DISEASE", 86, 94], ["calf", "ORGANISM_SUBDIVISION", 81, 85], ["calf", "SPECIES", 81, 85], ["calf", "SPECIES", 81, 85], ["calf diarrhea", "PROBLEM", 81, 94], ["calf", "ANATOMY", 81, 85], ["diarrhea", "OBSERVATION", 86, 94]]], ["The adult cow herd commonly serves as the reservoir of pathogens from one year to the next.", [["cow", "ORGANISM", 10, 13], ["cow", "SPECIES", 10, 13], ["cow", "SPECIES", 10, 13]]], ["[15] [16] [17] [18] [19] [20]HOST FACTORSCalves obtain passive immunity against common agents of calf diarrhea after absorbing antibodies from colostrum or colostrum supplements shortly after birth.", [["colostrum", "ANATOMY", 143, 152], ["colostrum", "ANATOMY", 156, 165], ["diarrhea", "DISEASE", 102, 110], ["[15] [16] [17] [18] [19] [20]HOST", "SIMPLE_CHEMICAL", 0, 33], ["calf", "ORGANISM", 97, 101], ["diarrhea", "ORGANISM_SUBDIVISION", 102, 110], ["colostrum", "ORGANISM_SUBSTANCE", 143, 152], ["colostrum", "ORGANISM", 156, 165], ["antibodies", "PROTEIN", 127, 137], ["calf", "SPECIES", 97, 101], ["calf", "SPECIES", 97, 101], ["HOST FACTORSCalves", "TEST", 29, 47], ["calf diarrhea", "PROBLEM", 97, 110], ["absorbing antibodies", "PROBLEM", 117, 137], ["colostrum supplements", "TREATMENT", 156, 177], ["calf", "ANATOMY", 97, 101], ["diarrhea", "OBSERVATION", 102, 110]]], ["[21] [22] [23] The quantity of antibodies absorbed is determined by the quality and quantity of colostrum the calf ingests, as well as how soon after birth it is ingested.", [["[21] [22] [23]", "SIMPLE_CHEMICAL", 0, 14], ["colostrum", "ORGANISM_SUBSTANCE", 96, 105], ["calf", "ORGANISM_SUBDIVISION", 110, 114], ["antibodies", "PROTEIN", 31, 41], ["calf", "SPECIES", 110, 114], ["antibodies absorbed", "PROBLEM", 31, 50], ["colostrum", "OBSERVATION", 96, 105], ["calf", "ANATOMY", 110, 114]]], ["In colostrum the presence of maternal antibodies against specific agents requires prior exposure of the dam to antigens of the agent.", [["colostrum", "ANATOMY", 3, 12], ["colostrum", "ORGANISM_SUBSTANCE", 3, 12], ["maternal antibodies", "PROTEIN", 29, 48], ["maternal antibodies", "PROBLEM", 29, 48], ["the agent", "TREATMENT", 123, 132], ["colostrum", "OBSERVATION", 3, 12]]], ["Vaccines are sometimes used to immunize the dam C H A P T E R 114 DAVID R. SMITH Management of Neonatal Diarrhea in Cow-Calf Herds against specific agents, and some commercially available colostrum supplements contain polyclonal or monoclonal antibodies directed against specific agents.", [["colostrum", "ANATOMY", 188, 197], ["Neonatal Diarrhea", "DISEASE", 95, 112], ["colostrum", "ORGANISM", 188, 197], ["monoclonal antibodies", "PROTEIN", 232, 253], ["Cow-Calf Herds", "SPECIES", 116, 130], ["Vaccines", "TREATMENT", 0, 8], ["Neonatal Diarrhea", "PROBLEM", 95, 112], ["Cow-Calf Herds", "TREATMENT", 116, 130], ["specific agents", "TREATMENT", 139, 154], ["colostrum supplements", "TREATMENT", 188, 209], ["polyclonal or monoclonal antibodies", "TREATMENT", 218, 253], ["specific agents", "TREATMENT", 271, 286], ["Calf", "ANATOMY", 120, 124]]], ["Unfortunately, the use of vaccines or colostrum supplements has not always prevented undifferentiated neonatal calf diarrhea.HOST FACTORSCalves typically become ill or die from neonatal diarrhea within 1 to 2 weeks of age.", [["diarrhea", "DISEASE", 116, 124], ["diarrhea", "DISEASE", 186, 194], ["colostrum", "ORGANISM", 38, 47], ["calf", "ORGANISM_SUBDIVISION", 111, 115], ["calf", "SPECIES", 111, 115], ["vaccines", "TREATMENT", 26, 34], ["colostrum supplements", "TREATMENT", 38, 59], ["undifferentiated neonatal calf diarrhea", "PROBLEM", 85, 124], ["neonatal diarrhea", "PROBLEM", 177, 194], ["calf", "ANATOMY", 111, 115], ["diarrhea", "OBSERVATION", 116, 124], ["ill", "OBSERVATION", 161, 164]]], ["4, 8, 10, 24 The narrow range of age within which neonatal calf diarrhea occurs is not explained solely by the incubation period of the agents.", [["diarrhea", "DISEASE", 64, 72], ["calf", "ORGANISM", 59, 63], ["calf", "SPECIES", 59, 63], ["neonatal calf diarrhea", "PROBLEM", 50, 72], ["the agents", "TREATMENT", 132, 142], ["narrow", "OBSERVATION_MODIFIER", 17, 23], ["range", "OBSERVATION_MODIFIER", 24, 29], ["calf", "ANATOMY", 59, 63], ["diarrhea", "OBSERVATION", 64, 72]]], ["Diarrhea is observed in colostrum-deprived and gnotobiotic calves within a few days of pathogen challenge regardless of age.", [["Diarrhea", "DISEASE", 0, 8], ["colostrum", "ORGANISM_SUBDIVISION", 24, 33], ["calves", "ORGANISM", 59, 65], ["calves", "SPECIES", 59, 65], ["Diarrhea", "PROBLEM", 0, 8], ["gnotobiotic calves", "TREATMENT", 47, 65], ["pathogen challenge", "TREATMENT", 87, 105]]], ["[25] [26] [27] Calves may have an age-specific susceptibility to neonatal diarrhea that occurs as lactogenic immunity is waning and before the calf is fully capable of developing an active immune response.", [["diarrhea", "DISEASE", 74, 82], ["[25] [26] [27]", "SIMPLE_CHEMICAL", 0, 14], ["Calves", "ORGANISM", 15, 21], ["calf", "ORGANISM_SUBDIVISION", 143, 147], ["calf", "SPECIES", 143, 147], ["neonatal diarrhea", "PROBLEM", 65, 82], ["calf", "ANATOMY", 143, 147], ["active", "OBSERVATION_MODIFIER", 182, 188], ["immune response", "OBSERVATION", 189, 204]]], ["21 Regardless of the reason for the age-specificity of neonatal calf diarrhea, this period defines the age of susceptibility, as well as the age calves are most likely to become infective and shed the agents in their feces.", [["feces", "ANATOMY", 217, 222], ["diarrhea", "DISEASE", 69, 77], ["calf", "ORGANISM_SUBDIVISION", 64, 68], ["calves", "ORGANISM", 145, 151], ["feces", "ORGANISM_SUBDIVISION", 217, 222], ["calf", "SPECIES", 64, 68], ["calves", "SPECIES", 145, 151], ["neonatal calf diarrhea", "PROBLEM", 55, 77], ["susceptibility", "PROBLEM", 110, 124], ["infective", "PROBLEM", 178, 187], ["calf", "ANATOMY", 64, 68], ["diarrhea", "OBSERVATION", 69, 77], ["most likely", "UNCERTAINTY", 156, 167], ["infective", "OBSERVATION", 178, 187]]], ["[28] [29] [30] [31] [32] Age specificity of susceptibility and infectivity has important implications for controlling transmission of the pathogens of neonatal diarrhea because in some calving systems the number of susceptible and infective calves can change dynamically with time.", [["neonatal diarrhea", "DISEASE", 151, 168], ["[28] [29] [30] [31] [32]", "SIMPLE_CHEMICAL", 0, 24], ["calves", "ORGANISM", 241, 247], ["calves", "SPECIES", 241, 247], ["susceptibility and infectivity", "PROBLEM", 44, 74], ["neonatal diarrhea", "PROBLEM", 151, 168], ["susceptible and infective calves", "PROBLEM", 215, 247], ["infective", "OBSERVATION", 231, 240]]], ["At times the number of potentially infective calves may greatly outnumber the number of susceptible calves, resulting in widespread opportunity for effective contacts.HOST FACTORSThe dam's age also explains a calf's risk for undifferentiated neonatal diarrhea.", [["neonatal diarrhea", "DISEASE", 242, 259], ["calves", "ORGANISM", 45, 51], ["calves", "ORGANISM", 100, 106], ["calf", "ORGANISM_SUBDIVISION", 209, 213], ["calves", "SPECIES", 45, 51], ["calves", "SPECIES", 100, 106], ["calf", "SPECIES", 209, 213], ["potentially infective calves", "PROBLEM", 23, 51], ["a calf's risk", "PROBLEM", 207, 220], ["undifferentiated neonatal diarrhea", "PROBLEM", 225, 259], ["infective", "OBSERVATION", 35, 44], ["calf", "ANATOMY", 209, 213], ["diarrhea", "OBSERVATION", 251, 259]]], ["Calves born to heifers are at higher risk for neonatal diarrhea and have lower maternal antibody levels than calves born to older cows.", [["diarrhea", "DISEASE", 55, 63], ["Calves", "ORGANISM", 0, 6], ["calves", "ORGANISM", 109, 115], ["cows", "ORGANISM", 130, 134], ["Calves", "SPECIES", 0, 6], ["calves", "SPECIES", 109, 115], ["cows", "SPECIES", 130, 134], ["neonatal diarrhea", "PROBLEM", 46, 63], ["lower maternal antibody levels", "PROBLEM", 73, 103], ["diarrhea", "OBSERVATION", 55, 63]]], ["33 Calves born to heifers are probably more susceptible to disease because heifers produce a lower volume and quality of colostrum, may have poor mothering skills, and are more likely to experience dystocia.", [["colostrum", "ANATOMY", 121, 130], ["dystocia", "DISEASE", 198, 206], ["Calves", "ORGANISM", 3, 9], ["heifers", "ORGANISM", 18, 25], ["heifers", "ORGANISM", 75, 82], ["colostrum", "ORGANISM_SUBSTANCE", 121, 130], ["Calves", "SPECIES", 3, 9], ["disease", "PROBLEM", 59, 66], ["dystocia", "PROBLEM", 198, 206], ["lower volume", "OBSERVATION_MODIFIER", 93, 105]]], ["34, 35ENVIRONMENTAL FACTORSThe environment may influence both the level of pathogen exposure and the ability of the calf to resist disease.", [["calf", "ORGANISM_SUBDIVISION", 116, 120], ["calf", "SPECIES", 116, 120], ["35ENVIRONMENTAL FACTORSThe environment", "TREATMENT", 4, 42], ["pathogen exposure", "PROBLEM", 75, 92], ["resist disease", "PROBLEM", 124, 138], ["calf", "ANATOMY", 116, 120]]], ["Exposure to pathogens may occur through direct contact with other cattle or via contact with contaminated environmental surfaces.", [["cattle", "SPECIES", 66, 72], ["cattle", "SPECIES", 66, 72], ["pathogens", "PROBLEM", 12, 21]]], ["Establishing environmental hygiene has long been recognized as important for controlling neonatal calf diarrhea, 36,37 but doing so is often a challenge.", [["diarrhea", "DISEASE", 103, 111], ["calf", "ORGANISM_SUBDIVISION", 98, 102], ["calf", "SPECIES", 98, 102], ["neonatal calf diarrhea", "PROBLEM", 89, 111]]], ["An effective contact is an exposure to pathogens of a dose-load or duration sufficient to cause disease.", [["disease", "PROBLEM", 96, 103]]], ["Crowded conditions increase opportunities for effective contacts with infected animals or contaminated surfaces.", [["Crowded conditions", "PROBLEM", 0, 18], ["increase", "OBSERVATION_MODIFIER", 19, 27]]], ["Ambient temperature (e.g., excessive heat or cold) and moisture (e.g., mud or snow) are important stressors that impair the ability of the calf to resist disease and may influence pathogen numbers, as well as opportunities for oral ingestion.TEMPORAL FACTORSHost susceptibility, pathogen exposure, and pathogen transmission occur dynamically over time within the calving season.", [["oral", "ANATOMY", 227, 231], ["calf", "ORGANISM_SUBDIVISION", 139, 143], ["oral", "ORGANISM_SUBDIVISION", 227, 231], ["calf", "SPECIES", 139, 143], ["Ambient temperature", "PROBLEM", 0, 19], ["excessive heat or cold)", "PROBLEM", 27, 50], ["disease", "PROBLEM", 154, 161], ["oral ingestion", "PROBLEM", 227, 241], ["TEMPORAL FACTORSHost susceptibility", "PROBLEM", 242, 277], ["pathogen exposure", "PROBLEM", 279, 296], ["calf", "ANATOMY", 139, 143], ["susceptibility", "OBSERVATION", 263, 277], ["pathogen exposure", "OBSERVATION", 279, 296]]], ["7 Although the adult cow-herd likely serves as the reservoir of neonatal diarrhea pathogens from year to year, 15-20 the average dose-load of pathogen exposure to calves is likely to increase over time within a calving season because calves infected earlier serve as pathogen multipliers and become the primary source of exposure to younger susceptible calves.", [["diarrhea", "DISEASE", 73, 81], ["cow", "ORGANISM", 21, 24], ["calves", "ORGANISM", 163, 169], ["calves", "ORGANISM", 234, 240], ["calves", "ORGANISM", 353, 359], ["cow", "SPECIES", 21, 24], ["calves", "SPECIES", 163, 169], ["calves", "SPECIES", 234, 240], ["calves", "SPECIES", 353, 359], ["cow", "SPECIES", 21, 24], ["calves", "SPECIES", 234, 240], ["neonatal diarrhea pathogens", "PROBLEM", 64, 91], ["pathogen exposure", "PROBLEM", 142, 159], ["calves infected", "PROBLEM", 234, 249], ["likely to", "UNCERTAINTY", 173, 182], ["increase", "OBSERVATION_MODIFIER", 183, 191]]], ["This multiplier effect can result in high calf infectivity and widespread environmental contamination with pathogens.", [["calf", "ORGANISM_SUBDIVISION", 42, 46], ["calf", "SPECIES", 42, 46], ["high calf infectivity", "PROBLEM", 37, 58], ["pathogens", "PROBLEM", 107, 116], ["high calf infectivity", "OBSERVATION", 37, 58], ["widespread", "OBSERVATION_MODIFIER", 63, 73], ["environmental contamination", "OBSERVATION", 74, 101]]], ["38 Each calf serves as growth media for pathogen production, amplifying the dose-load of pathogen it received.", [["calf", "ORGANISM", 8, 12], ["calf", "SPECIES", 8, 12], ["pathogen production", "PROBLEM", 40, 59], ["pathogen", "TREATMENT", 89, 97], ["calf", "ANATOMY", 8, 12]]], ["[27] [28] [29] Therefore calves born later in the calving season may receive larger doseloads of pathogens and, in turn, may become relatively more infective by growing even greater numbers of agents.", [["calves", "ORGANISM", 25, 31], ["calves", "SPECIES", 25, 31], ["pathogens", "PROBLEM", 97, 106], ["pathogens", "OBSERVATION", 97, 106]]], ["Eventually the dose-load of pathogens overwhelms the calf's ability to resist disease.", [["calf", "ORGANISM_SUBDIVISION", 53, 57], ["calf", "SPECIES", 53, 57], ["pathogens", "PROBLEM", 28, 37], ["disease", "PROBLEM", 78, 85], ["calf", "ANATOMY", 53, 57]]], ["These factors alone or in combination may explain observations that calves born later in the calving season are at greater risk for disease or death (Smith and colleagues, unpublished).", [["death", "DISEASE", 143, 148], ["calves", "ORGANISM", 68, 74], ["calves", "SPECIES", 68, 74], ["disease", "PROBLEM", 132, 139], ["death", "PROBLEM", 143, 148]]], ["24BIOCONTAINMENT OF NEONATAL CALF DIARRHEABiosecurity is the sum of actions taken to prevent introducing a disease agent into a population (pen, herd, region), whereas biocontainment describes the actions taken to control a pathogen already present in the population.", [["NEONATAL CALF DIARRHEABiosecurity", "TREATMENT", 20, 53], ["a disease agent", "TREATMENT", 105, 120], ["a pathogen", "PROBLEM", 222, 232], ["NEONATAL CALF", "ANATOMY", 20, 33], ["DIARRHEABiosecurity", "OBSERVATION", 34, 53]]], ["39 In theory outbreaks of undifferentiated neonatal calf diarrhea could be prevented by eliminating the pathogens, decreasing calf susceptibility, or altering the production system to reduce opportunities for pathogen exposure and transmission.", [["calf diarrhea", "DISEASE", 52, 65], ["calf", "ORGANISM", 52, 56], ["calf", "ORGANISM_SUBDIVISION", 126, 130], ["calf", "SPECIES", 52, 56], ["calf", "SPECIES", 126, 130], ["undifferentiated neonatal calf diarrhea", "PROBLEM", 26, 65], ["the pathogens", "PROBLEM", 100, 113], ["decreasing calf susceptibility", "PROBLEM", 115, 145], ["pathogen exposure", "PROBLEM", 209, 226], ["outbreaks", "OBSERVATION_MODIFIER", 13, 22], ["undifferentiated", "OBSERVATION_MODIFIER", 26, 42], ["neonatal calf diarrhea", "OBSERVATION", 43, 65], ["pathogens", "OBSERVATION", 104, 113]]], ["However, the endemic nature of the common pathogens of neonatal calf diarrhea makes it unlikely that cattle populations could be made biosecure from these agents.", [["diarrhea", "DISEASE", 69, 77], ["calf", "ORGANISM_SUBDIVISION", 64, 68], ["cattle", "ORGANISM", 101, 107], ["calf", "SPECIES", 64, 68], ["cattle", "SPECIES", 101, 107], ["cattle", "SPECIES", 101, 107], ["neonatal calf diarrhea", "PROBLEM", 55, 77], ["cattle populations", "PROBLEM", 101, 119], ["these agents", "TREATMENT", 149, 161], ["endemic", "OBSERVATION_MODIFIER", 13, 20], ["common", "OBSERVATION_MODIFIER", 35, 41], ["calf", "ANATOMY", 64, 68], ["diarrhea", "OBSERVATION", 69, 77]]], ["Maternal immunity is clearly important to calf susceptibility to enteric agents, 6,40 but lactogenic immunity wanes with time 21 and managers of extensive beef cattle systems have limited practical opportunities to improve rates of passive antibody transfer.", [["calf", "ORGANISM_SUBDIVISION", 42, 46], ["calf", "SPECIES", 42, 46], ["beef", "SPECIES", 155, 159], ["cattle", "SPECIES", 160, 166], ["enteric agents", "TREATMENT", 65, 79], ["lactogenic immunity wanes", "TREATMENT", 90, 115], ["extensive beef cattle systems", "TREATMENT", 145, 174], ["passive antibody transfer", "TREATMENT", 232, 257]]], ["In addition, vaccines are not available against all pathogens of calf diarrhea, they may not induce sufficient crossprotection, 32 and pathogens may evade the protection afforded by vaccination by evolving away from vaccine strains.", [["diarrhea", "DISEASE", 70, 78], ["calf", "ORGANISM", 65, 69], ["calf", "SPECIES", 65, 69], ["vaccines", "TREATMENT", 13, 21], ["calf diarrhea", "PROBLEM", 65, 78], ["pathogens", "PROBLEM", 135, 144], ["vaccination", "TREATMENT", 182, 193], ["vaccine strains", "PROBLEM", 216, 231], ["calf", "ANATOMY", 65, 69], ["diarrhea", "OBSERVATION", 70, 78]]], ["41 For these reasons, a biocontainment approach to control neonatal calf diarrhea seems prudent and logical.", [["diarrhea", "DISEASE", 73, 81], ["calf", "ORGANISM_SUBDIVISION", 68, 72], ["calf", "SPECIES", 68, 72], ["a biocontainment approach", "TREATMENT", 22, 47], ["neonatal calf diarrhea", "PROBLEM", 59, 81], ["calf", "ANATOMY", 68, 72], ["diarrhea", "OBSERVATION", 73, 81]]], ["39, 42SANDHILLS CALVING SYSTEM FOR PREVENTING NEONATAL DIARRHEAEffective contacts with pathogens can be prevented by physically separating animals, reducing the level of exposure (e.g., through the use of sanitation or dilution over space), or minimizing contact time.", [["NEONATAL DIARRHEAEffective contacts", "PROBLEM", 46, 81], ["pathogens", "PROBLEM", 87, 96]]], ["These principles have been successfully applied in calf hutch systems to control neonatal diseases in dairy calves.", [["neonatal diseases", "DISEASE", 81, 98], ["calf", "ORGANISM_SUBDIVISION", 51, 55], ["calves", "ORGANISM_SUBDIVISION", 108, 114], ["calf", "SPECIES", 51, 55], ["calves", "SPECIES", 108, 114], ["calf hutch systems", "TREATMENT", 51, 69], ["neonatal diseases in dairy calves", "PROBLEM", 81, 114], ["calf", "ANATOMY", 51, 55], ["neonatal diseases", "OBSERVATION", 81, 98], ["dairy calves", "OBSERVATION", 102, 114]]], ["43 Various biocontainment systems for beef herds have been developed to prevent neonatal calf diarrhea.", [["diarrhea", "DISEASE", 94, 102], ["calf", "ORGANISM_SUBDIVISION", 89, 93], ["beef", "SPECIES", 38, 42], ["calf", "SPECIES", 89, 93], ["beef", "SPECIES", 38, 42], ["Various biocontainment systems", "TREATMENT", 3, 33], ["beef herds", "TREATMENT", 38, 48], ["neonatal calf diarrhea", "PROBLEM", 80, 102], ["calf", "ANATOMY", 89, 93], ["diarrhea", "OBSERVATION", 94, 102]]], ["[44] [45] [46] Each of these are strategies to manage cattle in a system that prevents calves from having effective contacts with pathogens by reducing opportunities for exposure and transmission.", [["cattle", "ORGANISM", 54, 60], ["calves", "ORGANISM", 87, 93], ["cattle", "SPECIES", 54, 60], ["calves", "SPECIES", 87, 93], ["cattle", "SPECIES", 54, 60], ["calves", "SPECIES", 87, 93]]], ["The management actions defined as the Sandhills Calving System prevent effective contacts among beef calves by (1) segregating calves by age to prevent direct and indirect transmission of pathogens from older to younger calves and (2) moving pregnant cows to clean calving pastures to minimize pathogen dose-load in the environment and contact time between calves and the larger portion of the cow herd.", [["calves", "ORGANISM_SUBDIVISION", 101, 107], ["calves", "ORGANISM", 127, 133], ["calves", "ORGANISM", 220, 226], ["cows", "ORGANISM", 251, 255], ["calves", "ORGANISM", 357, 363], ["cow", "ORGANISM", 394, 397], ["herd", "ORGANISM_SUBDIVISION", 398, 402], ["beef", "SPECIES", 96, 100], ["calves", "SPECIES", 101, 107], ["calves", "SPECIES", 127, 133], ["calves", "SPECIES", 220, 226], ["calves", "SPECIES", 357, 363], ["cow", "SPECIES", 394, 397], ["beef", "SPECIES", 96, 100], ["cow", "SPECIES", 394, 397], ["The management actions", "TREATMENT", 0, 22], ["the Sandhills Calving System", "TREATMENT", 34, 62], ["pathogens", "PROBLEM", 188, 197], ["clean calving pastures", "TREATMENT", 259, 281], ["pathogen dose", "TREATMENT", 294, 307]]], ["These more ideal conditions are that cows are calving on ground that has been previously unoccupied by cattle (for at least some months), and older, infective calves are not present.SANDHILLS CALVING SYSTEM FOR PREVENTING NEONATAL DIARRHEAThe Sandhills Calving System uses larger, contiguous pastures for calving, rather than high-animal-density calving lots.", [["cows", "ORGANISM", 37, 41], ["cattle", "ORGANISM", 103, 109], ["calves", "ORGANISM", 159, 165], ["cows", "SPECIES", 37, 41], ["cattle", "SPECIES", 103, 109], ["calves", "SPECIES", 159, 165], ["cattle", "SPECIES", 103, 109], ["infective calves", "PROBLEM", 149, 165], ["NEONATAL DIARRHEAThe Sandhills Calving System", "TREATMENT", 222, 267], ["calving", "TREATMENT", 305, 312], ["infective calves", "OBSERVATION", 149, 165], ["larger", "OBSERVATION_MODIFIER", 273, 279], ["density", "OBSERVATION", 338, 345]]], ["Cows are turned into the first calving pasture (Pasture 1) as soon as the first calves are born.", [["Cows", "ORGANISM", 0, 4], ["calves", "ORGANISM", 80, 86], ["Cows", "SPECIES", 0, 4], ["calves", "SPECIES", 80, 86]]], ["After 2 weeks the cows that have not yet calved are moved to Pasture 2.", [["cows", "ORGANISM", 18, 22], ["cows", "SPECIES", 18, 22]]], ["Existing cow-calf pairs remain in Pasture 1.", [["cow", "ORGANISM", 9, 12], ["calf", "ORGANISM", 13, 17], ["cow", "SPECIES", 9, 12], ["calf", "SPECIES", 13, 17], ["calf", "ANATOMY", 13, 17], ["Pasture", "OBSERVATION", 34, 41]]], ["After a week of calving in Pasture 2, cows that have not calved are moved to Pasture 3 and cow-calf pairs born in Pasture 2 remain in Pasture 2.", [["cows", "ORGANISM", 38, 42], ["cow", "ORGANISM", 91, 94], ["calf", "ORGANISM", 95, 99], ["cows", "SPECIES", 38, 42], ["cow", "SPECIES", 91, 94], ["calf", "SPECIES", 95, 99], ["calf", "ANATOMY", 95, 99]]], ["Each subsequent week cows that have not yet calved are moved to a new pasture and pairs remain in their pasture of birth.", [["cows", "ORGANISM", 21, 25], ["cows", "SPECIES", 21, 25]]], ["The result is cow-calf pairs distributed over multiple pastures, each containing calves within 1 week of age of each other.", [["cow", "ORGANISM", 14, 17], ["calf", "ORGANISM", 18, 22], ["calves", "ORGANISM_SUBDIVISION", 81, 87], ["cow", "SPECIES", 14, 17], ["calf", "SPECIES", 18, 22], ["calves", "SPECIES", 81, 87], ["cow-calf pairs", "PROBLEM", 14, 28], ["calf", "ANATOMY", 18, 22], ["multiple", "OBSERVATION_MODIFIER", 46, 54], ["pastures", "OBSERVATION", 55, 63]]], ["Cow-calf pairs from different pastures may be commingled after the youngest calf is 4 weeks of age and all calves are considered low risk for neonatal diarrhea.SANDHILLS CALVING SYSTEM FOR PREVENTING NEONATAL DIARRHEAIt can be difficult to manage many cattle groups in intensive grass management systems; therefore the Sandhills Calving System in these herds is modified to reduce the number of groups.", [["diarrhea", "DISEASE", 151, 159], ["calf", "ORGANISM", 4, 8], ["calf", "ORGANISM_SUBDIVISION", 76, 80], ["calves", "ORGANISM", 107, 113], ["calf", "SPECIES", 4, 8], ["calf", "SPECIES", 76, 80], ["calves", "SPECIES", 107, 113], ["cattle", "SPECIES", 252, 258], ["Cow-calf pairs", "PROBLEM", 0, 14], ["different pastures", "PROBLEM", 20, 38], ["neonatal diarrhea", "PROBLEM", 142, 159], ["NEONATAL DIARRHEAIt", "PROBLEM", 200, 219], ["intensive grass management systems", "TREATMENT", 269, 303], ["the Sandhills Calving System", "TREATMENT", 315, 343], ["calf", "ANATOMY", 4, 8], ["different", "OBSERVATION_MODIFIER", 20, 29], ["pastures", "OBSERVATION", 30, 38], ["calf", "ANATOMY", 76, 80], ["low risk", "OBSERVATION_MODIFIER", 129, 137], ["diarrhea", "OBSERVATION", 151, 159]]], ["Cattle are moved to different pastures throughout the calving season as appropriate for forage utilization; however, every 10 days, or whenever 100 calves are born, the herd is divided by sorting cows that had not calved from the cow-calf pairs of the preceding group.", [["Cattle", "ORGANISM", 0, 6], ["calves", "ORGANISM", 148, 154], ["calf", "ORGANISM_SUBDIVISION", 234, 238], ["calves", "SPECIES", 148, 154], ["cow", "SPECIES", 230, 233], ["calf", "SPECIES", 234, 238], ["calf", "ANATOMY", 234, 238]]], ["In this manner, fewer cattle groups are required, although the number of calves within any pasture group never exceeds 100, and all calves within a group are within 10 days of age of each other.SANDHILLS CALVING SYSTEM FOR PREVENTING NEONATAL DIARRHEAThe Sandhills Calving System prevents effective contacts by using clean calving pastures, preventing direct contact between younger calves and older calves and preventing later-born calves from being exposed to an accumulation of pathogens in the environment.", [["cattle", "ORGANISM", 22, 28], ["calves", "ORGANISM", 73, 79], ["calves", "ORGANISM", 132, 138], ["calves", "ORGANISM", 383, 389], ["calves", "ORGANISM_SUBDIVISION", 400, 406], ["calves", "ORGANISM", 433, 439], ["calves", "SPECIES", 73, 79], ["calves", "SPECIES", 132, 138], ["calves", "SPECIES", 383, 389], ["calves", "SPECIES", 400, 406], ["calves", "SPECIES", 433, 439], ["cattle", "SPECIES", 22, 28], ["NEONATAL DIARRHEAThe Sandhills Calving System", "TREATMENT", 234, 279], ["clean calving pastures", "TREATMENT", 317, 339], ["pathogens", "OBSERVATION", 481, 490]]], ["Key components of the systems are age segregation of calves and the frequent movement of gravid cows to clean calving pastures.", [["calves", "ORGANISM", 53, 59], ["cows", "ORGANISM_SUBDIVISION", 96, 100], ["calves", "SPECIES", 53, 59], ["age segregation of calves", "PROBLEM", 34, 59], ["gravid cows", "PROBLEM", 89, 100]]], ["Age segregation prevents the serial passage of pathogens from older calves to younger calves.", [["calves", "ORGANISM_SUBDIVISION", 68, 74], ["calves", "ORGANISM", 86, 92], ["calves", "SPECIES", 68, 74], ["calves", "SPECIES", 86, 92], ["Age segregation", "PROBLEM", 0, 15], ["the serial passage of pathogens", "PROBLEM", 25, 56], ["passage", "OBSERVATION_MODIFIER", 36, 43]]], ["The routine movement (every 7-10 days) of gravid cows to new calving pastures prevents the buildup of pathogens in the calving environment over the course of the calving season and prevents exposure of the latest born calves to an overwhelming dose-load of pathogens.SANDHILLS CALVING SYSTEM FOR PREVENTING NEONATAL DIARRHEADevelopment of a ranch-specific plan for implementing the Sandhills Calving System must take place well in advance of the calving season, in some circumstances in consultation with a range specialist.", [["cows", "ORGANISM", 49, 53], ["calves", "ORGANISM", 218, 224], ["cows", "SPECIES", 49, 53], ["calves", "SPECIES", 218, 224], ["gravid cows", "PROBLEM", 42, 53], ["new calving pastures", "TREATMENT", 57, 77], ["pathogens", "PROBLEM", 257, 266], ["the Sandhills Calving System", "TREATMENT", 378, 406], ["pathogens", "OBSERVATION", 102, 111]]], ["Available pastures must be identified and their use coordinated with the calving schedule.", [["the calving schedule", "TREATMENT", 69, 89]]], ["The size of the pastures should be matched to the number of calves expected to be born in a given week.", [["calves", "ORGANISM", 60, 66], ["calves", "SPECIES", 60, 66], ["size", "OBSERVATION_MODIFIER", 4, 8], ["pastures", "OBSERVATION", 16, 24]]], ["Use of the pastures must not be damaging to later grazing.SANDHILLS CALVING SYSTEM FOR PREVENTING NEONATAL DIARRHEAThe Sandhills Calving System may offer additional benefits to labor management.", [["NEONATAL DIARRHEAThe Sandhills Calving System", "TREATMENT", 98, 143], ["labor management", "TREATMENT", 177, 193]]], ["For example, there may be some efficiency because cattle movement could be scheduled once a week as labor is available.", [["cattle", "ORGANISM", 50, 56], ["cattle", "SPECIES", 50, 56], ["some efficiency", "PROBLEM", 26, 41], ["may be", "UNCERTAINTY", 19, 25], ["some", "OBSERVATION_MODIFIER", 26, 30], ["efficiency", "OBSERVATION", 31, 41]]], ["Moving cows without calves to a new pasture is often easier than sorting and moving individual cow-calf pairs.", [["calves", "ORGANISM", 20, 26], ["cow", "ORGANISM_SUBDIVISION", 95, 98], ["calf", "ORGANISM_SUBDIVISION", 99, 103], ["cows", "SPECIES", 7, 11], ["calves", "SPECIES", 20, 26], ["cow", "SPECIES", 95, 98], ["calf", "SPECIES", 99, 103], ["calf pairs", "ANATOMY", 99, 109]]], ["Also, the workload is partitioned between pasture groups such that cows at risk for dystocia are together in one pasture while calves at risk for diarrhea are in another.", [["dystocia", "DISEASE", 84, 92], ["diarrhea", "DISEASE", 146, 154], ["cows", "ORGANISM", 67, 71], ["calves", "ORGANISM", 127, 133], ["cows", "SPECIES", 67, 71], ["calves", "SPECIES", 127, 133], ["dystocia", "PROBLEM", 84, 92], ["diarrhea", "PROBLEM", 146, 154]]], ["Information from pregnancy examination, when available, enables sorting cows into early and later calving groups.", [["pregnancy examination", "TEST", 17, 38]]], ["Cows expected to calve later in the season can be maintained elsewhere and added to the calving pasture as appropriate, thereby reducing the number of cattle moving through the initial series of pastures.SANDHILLS CALVING SYSTEM FOR PREVENTING NEONATAL DIARRHEARanchers using the Sandhills Calving System have observed meaningful and sustained reductions in morbidity and mortality caused by neonatal calf diarrhea and greatly reduced use of medications.", [["diarrhea", "DISEASE", 406, 414], ["calf", "ORGANISM_SUBDIVISION", 401, 405], ["Cows", "SPECIES", 0, 4], ["calf", "SPECIES", 401, 405], ["cattle", "SPECIES", 151, 157], ["the calving pasture", "TREATMENT", 84, 103], ["the Sandhills Calving System", "TREATMENT", 276, 304], ["sustained reductions in morbidity", "PROBLEM", 334, 367], ["neonatal calf diarrhea", "PROBLEM", 392, 414], ["medications", "TREATMENT", 442, 453], ["reductions", "OBSERVATION_MODIFIER", 344, 354], ["morbidity", "OBSERVATION", 358, 367], ["calf", "ANATOMY", 401, 405], ["diarrhea", "OBSERVATION", 406, 414]]], ["47 Although the system was tested and initially adopted in ranches typical of the Nebraska Sandhills, it has been useful elsewhere because the principles on which it is based are widely applicable.CONCLUSIONSUnderstanding the multifactorial, temporally dynamic nature of neonatal calf diarrhea in cattle populations is the basis for developing strategies for control and prevention.", [["diarrhea", "DISEASE", 285, 293], ["calf", "ORGANISM_SUBDIVISION", 280, 284], ["calf", "SPECIES", 280, 284], ["cattle", "SPECIES", 297, 303], ["cattle", "SPECIES", 297, 303], ["neonatal calf diarrhea", "PROBLEM", 271, 293], ["cattle populations", "TREATMENT", 297, 315], ["temporally", "OBSERVATION_MODIFIER", 242, 252], ["dynamic", "OBSERVATION_MODIFIER", 253, 260], ["calf", "ANATOMY", 280, 284], ["diarrhea", "OBSERVATION", 285, 293]]], ["The common pathogens of neonatal calf diarrhea are endemic to most cattle herds, and it is unlikely that cattle populations could be made biosecure from these agents.", [["calf diarrhea", "DISEASE", 33, 46], ["calf", "ORGANISM_SUBDIVISION", 33, 37], ["cattle", "ORGANISM", 105, 111], ["calf", "SPECIES", 33, 37], ["cattle", "SPECIES", 67, 73], ["cattle", "SPECIES", 105, 111], ["cattle", "SPECIES", 67, 73], ["cattle", "SPECIES", 105, 111], ["neonatal calf diarrhea", "PROBLEM", 24, 46], ["cattle populations", "PROBLEM", 105, 123], ["these agents", "TREATMENT", 153, 165], ["common", "OBSERVATION_MODIFIER", 4, 10], ["pathogens", "OBSERVATION_MODIFIER", 11, 20], ["neonatal", "OBSERVATION_MODIFIER", 24, 32], ["calf", "ANATOMY", 33, 37], ["diarrhea", "OBSERVATION", 38, 46], ["unlikely", "UNCERTAINTY", 91, 99]]], ["Managers of extensive beef cattle systems have few opportunities to improve rates of passive transfer, and vaccines are not always protective.", [["cattle", "SPECIES", 27, 33], ["cattle", "SPECIES", 27, 33], ["extensive beef cattle systems", "TREATMENT", 12, 41], ["passive transfer", "TREATMENT", 85, 101], ["vaccines", "TREATMENT", 107, 115]]], ["Lactogenic immunity wanes, making calves age susceptible and age infective.", [["calves", "ORGANISM", 34, 40], ["calves", "SPECIES", 34, 40], ["age infective", "PROBLEM", 61, 74]]], ["Each calf serves as growth media for pathogen production, amplifying the dose-load of pathogen it received and resulting in high calf infectivity and widespread environmental contamination over time in a calving season.", [["calf", "ORGANISM", 5, 9], ["calf", "ORGANISM_SUBDIVISION", 129, 133], ["calf", "SPECIES", 5, 9], ["calf", "SPECIES", 129, 133], ["pathogen production", "PROBLEM", 37, 56], ["pathogen", "PROBLEM", 86, 94], ["high calf infectivity", "PROBLEM", 124, 145], ["calf", "ANATOMY", 5, 9], ["high calf infectivity", "OBSERVATION", 124, 145], ["widespread", "OBSERVATION_MODIFIER", 150, 160], ["environmental contamination", "OBSERVATION", 161, 188]]], ["For these reasons it is logical to apply biocontainment strategies to prevent effective transmission of the pathogens causing neonatal diarrhea.", [["neonatal diarrhea", "DISEASE", 126, 143], ["biocontainment strategies", "TREATMENT", 41, 66], ["the pathogens", "PROBLEM", 104, 117], ["neonatal diarrhea", "PROBLEM", 126, 143], ["diarrhea", "OBSERVATION", 135, 143]]], ["Cattle management systems based on an understanding of infectious disease dynamics have successfully reduced sickness and death caused by neonatal calf diarrhea.", [["sickness", "DISEASE", 109, 117], ["death", "DISEASE", 122, 127], ["diarrhea", "DISEASE", 152, 160], ["calf", "ORGANISM_SUBDIVISION", 147, 151], ["calf", "SPECIES", 147, 151], ["Cattle management systems", "TREATMENT", 0, 25], ["infectious disease dynamics", "PROBLEM", 55, 82], ["successfully reduced sickness", "PROBLEM", 88, 117], ["death", "PROBLEM", 122, 127], ["neonatal calf diarrhea", "PROBLEM", 138, 160], ["infectious", "OBSERVATION", 55, 65], ["reduced", "OBSERVATION_MODIFIER", 101, 108], ["sickness", "OBSERVATION", 109, 117], ["calf", "ANATOMY", 147, 151], ["diarrhea", "OBSERVATION", 152, 160]]]], "PMC7387312": [["Checklist with 10 parameters which can be considered for the management of cancer immunotherapy during COVID-19 outbreakPneumonitis is a rare but serious side effect of the immune checkpoint inhibitors (ICIs), involving 2.7% of the patients treated with anti-programmed cell death 1 (PD-1) monotherapy and 6.6% of the patients receiving the combination of anti-PD-1 and anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4).1 Early diagnosis and proper management are required to obtain a complete recovery and avoid an unfavorable outcome.2 Pneumonitis-related deaths were reported in 0.2%\u20132.3% of patients enrolled in clinical trials, with a higher incidence in patients with non-small cell lung cancer.1", [["cancer", "ANATOMY", 75, 81], ["cell", "ANATOMY", 270, 274], ["non-small cell lung cancer", "ANATOMY", 671, 697], ["cancer", "DISEASE", 75, 81], ["outbreakPneumonitis", "DISEASE", 112, 131], ["Pneumonitis", "DISEASE", 535, 546], ["deaths", "DISEASE", 555, 561], ["non-small cell lung cancer", "DISEASE", 671, 697], ["cancer", "CANCER", 75, 81], ["patients", "ORGANISM", 232, 240], ["anti-programmed cell death 1", "GENE_OR_GENE_PRODUCT", 254, 282], ["PD-1", "GENE_OR_GENE_PRODUCT", 284, 288], ["patients", "ORGANISM", 318, 326], ["anti-PD-1", "GENE_OR_GENE_PRODUCT", 356, 365], ["anti-cytotoxic T-lymphocyte antigen 4", "GENE_OR_GENE_PRODUCT", 370, 407], ["CTLA-4", "GENE_OR_GENE_PRODUCT", 409, 415], ["patients", "ORGANISM", 592, 600], ["patients", "ORGANISM", 657, 665], ["non-small cell lung cancer", "CANCER", 671, 697], ["anti-PD", "PROTEIN", 356, 363], ["CTLA", "PROTEIN", 409, 413], ["patients", "SPECIES", 232, 240], ["patients", "SPECIES", 318, 326], ["patients", "SPECIES", 592, 600], ["patients", "SPECIES", 657, 665], ["COVID-19 outbreakPneumonitis", "SPECIES", 103, 131], ["cancer immunotherapy", "TREATMENT", 75, 95], ["COVID", "TEST", 103, 108], ["the immune checkpoint inhibitors", "TREATMENT", 169, 201], ["anti-programmed cell death", "TREATMENT", 254, 280], ["PD", "TEST", 284, 286], ["monotherapy", "TREATMENT", 290, 301], ["anti-PD", "TEST", 356, 363], ["anti-cytotoxic T-lymphocyte antigen", "TREATMENT", 370, 405], ["CTLA", "TEST", 409, 413], ["an unfavorable outcome", "PROBLEM", 510, 532], ["Pneumonitis", "PROBLEM", 535, 546], ["related deaths", "PROBLEM", 547, 561], ["non-small cell lung cancer", "PROBLEM", 671, 697], ["cancer", "OBSERVATION", 75, 81], ["Pneumonitis", "OBSERVATION", 535, 546], ["non-small cell", "OBSERVATION", 671, 685], ["lung", "ANATOMY", 686, 690], ["cancer", "OBSERVATION", 691, 697]]]], "9ae28cb90a9024b7ab5ec9ce47d0cef8ef4e4a39": [["Authors' statementQin Xiang Ng conceived the original idea for the manuscript while Kuan Tsee Chee supervised the study.", [["the study", "TEST", 110, 119]]], ["All authors are responsible for the content and writing of the paper.TO THE EDITOR:We read with great interest the recent report by Ferrando et al., which described three patients who presented to the Emergency Department with similar presentations of agitation, disorganization, paranoid ideation and auditory hallucinations.", [["agitation", "DISEASE", 252, 261], ["paranoid ideation", "DISEASE", 280, 297], ["auditory hallucinations", "DISEASE", 302, 325], ["patients", "ORGANISM", 171, 179], ["patients", "SPECIES", 171, 179], ["agitation", "PROBLEM", 252, 261], ["disorganization", "PROBLEM", 263, 278], ["paranoid ideation", "PROBLEM", 280, 297], ["auditory hallucinations", "PROBLEM", 302, 325], ["paranoid ideation", "OBSERVATION", 280, 297], ["auditory hallucinations", "OBSERVATION", 302, 325]]], ["1 They were all tested for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) albeit the method of testing was not specified, and found to be positive for the Coronavirus Disease 2019 (COVID-19).TO THE EDITOR:We have some thoughts on the observed association and hope this would generate greater discourse on the subject.TO THE EDITOR:First, possible infective origins of mental illness were probably first hypothesized in 1845 by French neurologist Jean Esquirol, and the theory later refined by Swiss psychiatrist Eugen Bleuler in the 19th century.", [["acute respiratory syndrome coronavirus", "DISEASE", 38, 76], ["mental illness", "DISEASE", 386, 400], ["severe acute respiratory syndrome coronavirus", "SPECIES", 31, 76], ["SARS-CoV-2", "SPECIES", 80, 90], ["the severe acute respiratory syndrome coronavirus", "PROBLEM", 27, 76], ["SARS", "TEST", 80, 84], ["CoV", "TEST", 85, 88], ["the method of testing", "TEST", 99, 120], ["the Coronavirus Disease", "PROBLEM", 169, 192], ["COVID", "TEST", 199, 204], ["mental illness", "PROBLEM", 386, 400], ["severe", "OBSERVATION_MODIFIER", 31, 37], ["acute", "OBSERVATION_MODIFIER", 38, 43], ["respiratory syndrome", "OBSERVATION", 44, 64], ["Coronavirus", "OBSERVATION", 173, 184], ["infective", "OBSERVATION", 365, 374]]], ["2 Given the systemic effects of SARS-CoV-2, which are wellreviewed in literature, it is certainly plausible that the coronavirus could, directly or indirectly, affect the brain and the central nervous system.", [["brain", "ANATOMY", 171, 176], ["central nervous system", "ANATOMY", 185, 207], ["SARS", "DISEASE", 32, 36], ["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 32, 42], ["coronavirus", "ORGANISM", 117, 128], ["brain", "ORGAN", 171, 176], ["central nervous system", "ANATOMICAL_SYSTEM", 185, 207], ["SARS-CoV", "SPECIES", 32, 40], ["SARS", "PROBLEM", 32, 36], ["CoV", "TEST", 37, 40], ["the coronavirus", "PROBLEM", 113, 128], ["coronavirus", "OBSERVATION", 117, 128], ["brain", "ANATOMY", 171, 176], ["central", "ANATOMY_MODIFIER", 185, 192], ["nervous system", "ANATOMY", 193, 207]]], ["However, in this case, we are mindful that the observed association in this report could also be fortuitous as this is a small sample of three individual cases, and in terms of epidemiological evidence, the onset of first-episode psychosis (FEP) in the 30s is not uncommon.", [["first-episode psychosis", "DISEASE", 216, 239], ["FEP", "DISEASE", 241, 244], ["psychosis", "PROBLEM", 230, 239], ["FEP", "TEST", 241, 244], ["small", "OBSERVATION_MODIFIER", 121, 126], ["not uncommon", "UNCERTAINTY", 260, 272]]], ["In a study of 555 individuals with FEP, the median age of onset was found to be 27.3 years (interquartile range 21.2, 36.5).", [["FEP", "DISEASE", 35, 38], ["a study", "TEST", 3, 10], ["FEP", "TEST", 35, 38]]], ["3 Second, the authors appropriately mentioned the possibility of a stress-related trigger from the COVID-19 pandemic in psychiatrically vulnerable individuals.", [["individuals", "ORGANISM", 147, 158], ["a stress-related trigger", "PROBLEM", 65, 89], ["the COVID", "TEST", 95, 104]]], ["We recognise that all three of the patients presented had a prior psychiatric diagnosis: patient 1 and patient 2 both had a prior diagnosis of panic disorder while patient 3 had opioid use disorder, on methadone maintenance.", [["psychiatric", "DISEASE", 66, 77], ["panic disorder", "DISEASE", 143, 157], ["disorder", "DISEASE", 189, 197], ["methadone", "CHEMICAL", 202, 211], ["methadone", "CHEMICAL", 202, 211], ["patients", "ORGANISM", 35, 43], ["patient", "ORGANISM", 89, 96], ["patient", "ORGANISM", 103, 110], ["patient", "ORGANISM", 164, 171], ["methadone", "SIMPLE_CHEMICAL", 202, 211], ["patients", "SPECIES", 35, 43], ["patient", "SPECIES", 89, 96], ["patient", "SPECIES", 103, 110], ["patient", "SPECIES", 164, 171], ["panic disorder", "PROBLEM", 143, 157], ["opioid use disorder", "PROBLEM", 178, 197], ["methadone maintenance", "TREATMENT", 202, 223]]], ["Anxiety is the mother of psychopathology in predisposing, precipitating, and perpetuating symptoms.", [["Anxiety", "DISEASE", 0, 7], ["psychopathology", "DISEASE", 25, 40], ["Anxiety", "PROBLEM", 0, 7], ["psychopathology", "PROBLEM", 25, 40], ["perpetuating symptoms", "PROBLEM", 77, 98]]], ["All three patients also appeared to respond to clonazepam, lorazepam and low doses of quetiapine, which all exert anxiolytic effects.TO THE EDITOR:In terms of their physical symptoms (or the lack thereof) and stable hemodynamics, there was no evidence of an excessive immunologic response.", [["clonazepam", "CHEMICAL", 47, 57], ["lorazepam", "CHEMICAL", 59, 68], ["quetiapine", "CHEMICAL", 86, 96], ["clonazepam", "CHEMICAL", 47, 57], ["lorazepam", "CHEMICAL", 59, 68], ["quetiapine", "CHEMICAL", 86, 96], ["patients", "ORGANISM", 10, 18], ["clonazepam", "SIMPLE_CHEMICAL", 47, 57], ["lorazepam", "SIMPLE_CHEMICAL", 59, 68], ["quetiapine", "SIMPLE_CHEMICAL", 86, 96], ["patients", "SPECIES", 10, 18], ["clonazepam", "TREATMENT", 47, 57], ["lorazepam", "TREATMENT", 59, 68], ["quetiapine", "TREATMENT", 86, 96], ["their physical symptoms", "PROBLEM", 159, 182], ["an excessive immunologic response", "PROBLEM", 255, 288], ["no evidence of", "UNCERTAINTY", 240, 254], ["excessive", "OBSERVATION_MODIFIER", 258, 267], ["immunologic response", "OBSERVATION", 268, 288]]], ["Interestingly, Esquirol himself was also of the view that some mental illnesses may be caused by emotional disturbances rather than by organic brain damage.", [["brain", "ANATOMY", 143, 148], ["Esquirol", "CHEMICAL", 15, 23], ["brain damage", "DISEASE", 143, 155], ["Esquirol", "SIMPLE_CHEMICAL", 15, 23], ["brain", "ORGAN", 143, 148], ["some mental illnesses", "PROBLEM", 58, 79], ["emotional disturbances", "PROBLEM", 97, 119], ["organic brain damage", "PROBLEM", 135, 155]]], ["2 If we accept the prevailing biopsychosocial model of mental illness, psychosis is likely to have multiple causes, including genetic, neurobiological, psychological and environmental factors.", [["mental illness", "DISEASE", 55, 69], ["psychosis", "DISEASE", 71, 80], ["mental illness", "PROBLEM", 55, 69], ["psychosis", "PROBLEM", 71, 80]]], ["Psychiatric manifestations may be the indirect (\"reactive\" stress) result of this pandemic rather than the direct pathophysiological effects of the virus.TO THE EDITOR:Third, the classification of acute-onset psychotic disorders is rather inexact, and although the authors reported that the patients did not verbalise preoccupation with COVID-19, this may be difficult to elicit from the patients when they are in an acute agitated and psychotic state.TO THE EDITOR:Fourth, clinically, the elevations in C-reactive protein (0.6 to 1.9 mg/dL) were relatively minor and could well be within normal variations.", [["psychotic disorders", "DISEASE", 209, 228], ["psychotic", "DISEASE", 436, 445], ["COVID-19", "CHEMICAL", 337, 345], ["patients", "ORGANISM", 291, 299], ["patients", "ORGANISM", 388, 396], ["C-reactive protein", "GENE_OR_GENE_PRODUCT", 504, 522], ["C-reactive protein", "PROTEIN", 504, 522], ["patients", "SPECIES", 291, 299], ["patients", "SPECIES", 388, 396], ["Psychiatric manifestations", "PROBLEM", 0, 26], ["the indirect (\"reactive\" stress", "PROBLEM", 34, 65], ["this pandemic", "PROBLEM", 77, 90], ["the virus", "PROBLEM", 144, 153], ["acute-onset psychotic disorders", "PROBLEM", 197, 228], ["an acute agitated and psychotic state", "PROBLEM", 414, 451], ["the elevations in C-reactive protein", "PROBLEM", 486, 522], ["acute", "OBSERVATION_MODIFIER", 197, 202], ["psychotic disorders", "OBSERVATION", 209, 228], ["acute", "OBSERVATION_MODIFIER", 417, 422], ["elevations", "OBSERVATION_MODIFIER", 490, 500], ["normal variations", "OBSERVATION", 589, 606]]], ["'Normal' C-reactive protein (CRP) levels have not been rigorously studied or defined and the levels are known to vary with population, age and ethnicity.", [["Normal' C-reactive protein", "GENE_OR_GENE_PRODUCT", 1, 27], ["CRP", "GENE_OR_GENE_PRODUCT", 29, 32], ["C-reactive protein", "PROTEIN", 9, 27], ["CRP", "PROTEIN", 29, 32], ["' C-reactive protein (CRP) levels", "TEST", 7, 40], ["the levels", "TEST", 89, 99]]], ["4, 5 To play devil's advocate, we know that struggling against restraints, physical agitation or other common events could all result in an elevated CRP.", [["agitation", "DISEASE", 84, 93], ["CRP", "GENE_OR_GENE_PRODUCT", 149, 152], ["CRP", "PROTEIN", 149, 152], ["restraints", "TREATMENT", 63, 73], ["physical agitation", "PROBLEM", 75, 93], ["other common events", "PROBLEM", 97, 116], ["an elevated CRP", "PROBLEM", 137, 152], ["elevated", "OBSERVATION_MODIFIER", 140, 148], ["CRP", "OBSERVATION", 149, 152]]], ["Due to the highly variable causality, a single CRP value at admission lacks clinical utility and is difficult to interpret in isolation.TO THE EDITOR:Last but not least, it would be of value to follow up these patients and their symptoms longitudinally.", [["CRP", "GENE_OR_GENE_PRODUCT", 47, 50], ["patients", "ORGANISM", 210, 218], ["CRP", "PROTEIN", 47, 50], ["patients", "SPECIES", 210, 218], ["a single CRP value", "TEST", 38, 56], ["their symptoms", "PROBLEM", 223, 237]]], ["Outcomes of patients with FEP are known to be heterogeneous, ranging from complete recovery to recurrent and resistant psychotic symptoms.", [["FEP", "DISEASE", 26, 29], ["psychotic symptoms", "DISEASE", 119, 137], ["patients", "ORGANISM", 12, 20], ["patients", "SPECIES", 12, 20], ["FEP", "TEST", 26, 29], ["heterogeneous", "PROBLEM", 46, 59], ["recurrent and resistant psychotic symptoms", "PROBLEM", 95, 137], ["heterogeneous", "OBSERVATION", 46, 59], ["resistant", "OBSERVATION_MODIFIER", 109, 118]]], ["This may give us new insights beyond that of a 'snapshot' picture or cross-sectional mental state examination.", [["cross-sectional mental state examination", "TEST", 69, 109]]], ["The SARS-CoV-2 is undoubtedly a novel virus and there is much to be learnt from it -and it does surprise us sometimes.", [["SARS", "DISEASE", 4, 8], ["SARS-CoV-2", "ORGANISM", 4, 14], ["SARS-CoV", "SPECIES", 4, 12], ["The SARS", "TEST", 0, 8], ["a novel virus", "PROBLEM", 30, 43], ["virus", "OBSERVATION", 38, 43]]]], "b24befee3b9ada142a275ad13f567b65d837a16c": [["IntroductionThe ongoing coronavirus disease pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has quickly become a global health crisis, with over 2 million confirmed cases in the US and 7.4 million worldwide as of June 11, 2020 (1).", [["coronavirus disease pandemic", "DISEASE", 24, 52], ["acute respiratory syndrome coronavirus", "DISEASE", 71, 109], ["coronavirus", "ORGANISM", 24, 35], ["severe acute respiratory syndrome coronavirus 2", "ORGANISM", 64, 111], ["SARS-CoV-2", "ORGANISM", 113, 123], ["severe acute respiratory syndrome coronavirus", "SPECIES", 64, 109], ["SARS-CoV-2", "SPECIES", 113, 123], ["The ongoing coronavirus disease pandemic", "PROBLEM", 12, 52], ["severe acute respiratory syndrome coronavirus", "PROBLEM", 64, 109], ["a global health crisis", "PROBLEM", 145, 167], ["coronavirus disease", "OBSERVATION", 24, 43], ["severe", "OBSERVATION_MODIFIER", 64, 70], ["acute", "OBSERVATION_MODIFIER", 71, 76], ["respiratory syndrome", "OBSERVATION", 77, 97], ["global", "OBSERVATION_MODIFIER", 147, 153], ["health crisis", "OBSERVATION", 154, 167]]], ["Due to limited diagnostic capacity in many countries and high rates of asymptomatic individuals (2, 3) , these numbers are considered to be underestimates of the true prevalence of infection (4, 5) .IntroductionWastewater surveillance offers a complementary approach to clinical disease surveillance (6, 7) as it aggregates health information at the population level.", [["infection", "DISEASE", 181, 190], ["limited diagnostic capacity", "PROBLEM", 7, 34], ["asymptomatic individuals", "PROBLEM", 71, 95], ["infection", "PROBLEM", 181, 190], ["clinical disease surveillance", "TEST", 270, 299], ["infection", "OBSERVATION", 181, 190]]], ["In addition, wastewater surveillance provides an unbiased sample of the infected population, including asymptomatic and pre-symptomatic individuals, those who are symptomatic butIntroductionhave not yet been clinically confirmed, and individuals who may have the disease but do not seek healthcare.", [["wastewater surveillance", "TEST", 13, 36], ["the infected population", "PROBLEM", 68, 91], ["asymptomatic and pre-symptomatic individuals", "PROBLEM", 103, 147], ["symptomatic", "PROBLEM", 163, 174], ["the disease", "PROBLEM", 259, 270], ["infected", "OBSERVATION_MODIFIER", 72, 80], ["population", "OBSERVATION", 81, 91]]], ["Early work has shown that wastewater surveillance could detect SARS-CoV-2 before it became widespread in a population (8) , and that viral levels in wastewater largely paralleled local increases in clinical cases of COVID-19 in France (9), Spain (10), Turkey (11) , and Israel (12) .", [["SARS", "DISEASE", 63, 67], ["COVID-19", "CHEMICAL", 216, 224], ["SARS-CoV-2", "ORGANISM", 63, 73], ["SARS-CoV", "SPECIES", 63, 71], ["wastewater surveillance", "TEST", 26, 49], ["SARS", "PROBLEM", 63, 67], ["CoV", "TEST", 68, 71], ["viral levels", "PROBLEM", 133, 145], ["COVID", "TEST", 216, 221], ["widespread", "OBSERVATION_MODIFIER", 91, 101], ["local", "OBSERVATION_MODIFIER", 179, 184], ["increases", "OBSERVATION_MODIFIER", 185, 194]]], ["These studies highlight the potential of wastewater surveillance to provide early warning of emerging outbreaks -as well as the need for improved modeling and quantitation to understand the relationship between viral concentrations in wastewater and active infections in the population.IntroductionThe Massachusetts wastewater treatment facility where we obtained samples has two major influent streams, which we will refer to as the \"northern\" and \"southern\" influents.IntroductionTogether the two catchments represent approximately 2.25 million sewered individuals in Middlesex, Norfolk, and Suffolk counties, primarily in urban and suburban neighborhoods.", [["infections", "DISEASE", 257, 267], ["These studies", "TEST", 0, 13], ["viral concentrations", "PROBLEM", 211, 231], ["active infections in the population", "PROBLEM", 250, 285], ["active", "OBSERVATION_MODIFIER", 250, 256], ["infections", "OBSERVATION", 257, 267]]], ["We previously reported the detection of SARS-CoV-2 in wastewater from this facility, and showed that viral titers were significantly higher than would be expected based on clinical cases alone (13) .", [["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 40, 50], ["SARS-CoV", "SPECIES", 40, 48], ["SARS", "PROBLEM", 40, 44], ["CoV", "TEST", 45, 48], ["viral titers", "PROBLEM", 101, 113], ["viral titers", "OBSERVATION", 101, 113]]], ["Here, we use longitudinal sampling from January to mid May 2020 (116 samples in total) at the same wastewater treatment facility to identify the virus's first appearance and spread, to infer viral shedding dynamics early in the course of infection, and to investigate the relationship between .", [["infection", "DISEASE", 238, 247], ["longitudinal sampling", "TEST", 13, 34], ["the virus", "PROBLEM", 141, 150], ["infection", "PROBLEM", 238, 247], ["infection", "OBSERVATION", 238, 247]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.15.20117747 doi: medRxiv preprint wastewater SARS-CoV-2 titers at different spatial scales, clinically reported COVID-19 cases, and statewide public health interventions.Results and DiscussionWe first quantified SARS-CoV-2 titers in 116 longitudinal wastewater samples from the wastewater treatment facility's northern and southern influents, from January to May 2020.", [["samples", "ANATOMY", 570, 577], ["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["medRxiv", "TREATMENT", 326, 333], ["CoV", "TEST", 359, 362], ["COVID", "TEST", 421, 426], ["SARS", "TEST", 521, 525], ["CoV", "TEST", 526, 529], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["Samples from March 3 to May 20 were processed a second time in late May, in a single batch for each catchment, to complement initial quantification, which had been performed in chronological groups as samples were received (see Methods).CoV-2 in the population.Viral titers in wastewater followed a trend similar to new clinical cases over the sampled time period ( Figure 1A ).", [["samples", "ANATOMY", 201, 208], ["CoV-2", "GENE_OR_GENE_PRODUCT", 237, 242], ["Viral", "ORGANISM", 261, 266], ["Samples", "TEST", 0, 7], ["CoV", "TEST", 237, 240], ["Viral titers", "TEST", 261, 273]]], ["SARS-CoV-2 was not detected in either influent stream in January or February samples, and was first detected on March 3 (northern influent) andCoV-2 in the population.March 10 (southern influent), at a concentration of \u226415 copies per ml of wastewater ( Figure 1A and Figure S1 ).", [["samples", "ANATOMY", 77, 84], ["SARS", "DISEASE", 0, 4], ["SARS-CoV-2", "ORGANISM", 0, 10], ["CoV-2", "GENE_OR_GENE_PRODUCT", 143, 148], ["SARS-CoV", "TEST", 0, 8], ["CoV", "TEST", 143, 146]]], ["Only two clinically confirmed COVID-19 cases had been .", [["COVID", "TEST", 30, 35]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["15.20117747 doi: medRxiv preprint Wastewater data correlates best with clinically confirmed new cases, with a temporal offset.(which was not certified by peer review)Since SARS-CoV-2 was first detected in wastewater when only two cases were clinically confirmed, we hypothesized that the wastewater signal included a significant undiagnosed, COVID-19 positive population.", [["SARS-CoV-2", "ORGANISM", 172, 182], ["a temporal offset", "PROBLEM", 108, 125], ["the wastewater signal", "PROBLEM", 284, 305], ["a significant undiagnosed", "PROBLEM", 315, 340], ["COVID", "TEST", 342, 347], ["temporal offset", "OBSERVATION", 110, 125], ["significant", "OBSERVATION_MODIFIER", 317, 328], ["undiagnosed", "OBSERVATION", 329, 340]]], ["This difference between wastewater and clinical data could be due to underdiagnosis of asymptomatic or mildly symptomatic cases, limitations in clinical testing capacity, or a time delay between viral shedding and the onset of respiratory and other symptoms.(which was not certified by peer review)We tested the correlation of viral titers with new clinical cases and cumulative cases, allowing for a variable time lag (Figure 1C/D and Figure S2 ).", [["respiratory", "ANATOMY", 227, 238], ["clinical data", "TEST", 39, 52], ["asymptomatic or mildly symptomatic cases", "PROBLEM", 87, 127], ["clinical testing capacity", "TEST", 144, 169], ["a time delay", "PROBLEM", 174, 186], ["viral shedding", "PROBLEM", 195, 209], ["respiratory and other symptoms", "PROBLEM", 227, 257], ["viral titers", "TEST", 327, 339], ["mildly", "OBSERVATION_MODIFIER", 103, 109], ["symptomatic", "OBSERVATION_MODIFIER", 110, 121], ["respiratory", "ANATOMY", 227, 238]]], ["Higher correlations were seen when comparing new clinical cases back-dated by 4-10 days than for shorter or longer temporal offsets, and the maximum agreement between the two time series was observed for a time offset of 4 days (Pearson's r = 0.92, p = 4.17e-15, Figure 1C /D).", [["Pearson's r", "TEST", 229, 240], ["p", "TEST", 249, 250]]], ["This time lag between the wastewater signal and clinically reported cases is consistent with the typical 4-5 day incubation period from SARS-CoV-2 infection to symptom onset (14) (15) (16) .", [["SARS-CoV-2 infection", "DISEASE", 136, 156], ["CoV-2", "SPECIES", 141, 146], ["SARS-CoV-2", "SPECIES", 136, 146], ["the wastewater signal", "TEST", 22, 43], ["SARS", "PROBLEM", 136, 140], ["CoV-2 infection", "PROBLEM", 141, 156], ["symptom onset", "PROBLEM", 160, 173], ["consistent with", "UNCERTAINTY", 77, 92]]], ["Moreover, a short time lag in an exponentially growing process explains large differences in the total number of cases (e.g. 2 cases as of March 3, compared to 108 cases as of March 12) .", [["a short time lag", "PROBLEM", 10, 26], ["large", "OBSERVATION_MODIFIER", 72, 77], ["differences", "OBSERVATION_MODIFIER", 78, 89]]], ["Thus, wastewater surveillance could potentially be used to predict trends in new COVID-19 cases.An inferred viral shedding function suggests an early burst of high viral shedding.The high correlation between wastewater viral titers and daily reports of new clinically confirmed COVID-19 cases ( Figure 1D ) -combined with the time lag between the wastewater signal and clinical data -suggests that newly infected individuals contribute significant viral loads to the wastewater and that most of this shedding occurs early in infection, prior to the individual seeking healthcare and being tested.", [["infection", "DISEASE", 525, 534], ["individuals", "ORGANISM", 413, 424], ["new COVID", "TEST", 77, 86], ["An inferred viral shedding function", "PROBLEM", 96, 131], ["high viral shedding", "PROBLEM", 159, 178], ["wastewater viral titers", "TEST", 208, 231], ["COVID", "TEST", 278, 283], ["the wastewater signal", "TEST", 343, 364], ["clinical data", "TEST", 369, 382], ["newly infected individuals", "PROBLEM", 398, 424], ["significant viral loads", "PROBLEM", 436, 459], ["infection", "PROBLEM", 525, 534], ["viral shedding", "OBSERVATION", 108, 122], ["early", "OBSERVATION_MODIFIER", 144, 149], ["burst", "OBSERVATION_MODIFIER", 150, 155], ["high viral shedding", "OBSERVATION", 159, 178], ["viral loads", "OBSERVATION", 448, 459], ["infection", "OBSERVATION", 525, 534]]], ["As a result, viral dynamics in wastewater could shed light on early shedding, which would be challenging to capture clinically if it precedes patient presentation to the clinic.An inferred viral shedding function suggests an early burst of high viral shedding..", [["patient", "ORGANISM", 142, 149], ["patient", "SPECIES", 142, 149], ["viral dynamics", "PROBLEM", 13, 27], ["An inferred viral shedding function", "PROBLEM", 177, 212], ["high viral shedding", "PROBLEM", 240, 259], ["viral shedding", "OBSERVATION", 189, 203], ["early", "OBSERVATION_MODIFIER", 225, 230], ["burst", "OBSERVATION_MODIFIER", 231, 236], ["high", "OBSERVATION_MODIFIER", 240, 244], ["viral shedding", "OBSERVATION", 245, 259]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)An inferred viral shedding function suggests an early burst of high viral shedding.The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.15.20117747 doi: medRxiv preprint 6 We attempted to infer average individual viral shedding dynamics by comparing our longitudinal wastewater data with daily reports of new clinical cases.", [["CC", "CHEMICAL", 0, 2], ["ND", "PROBLEM", 9, 11], ["An inferred viral shedding function", "PROBLEM", 202, 237], ["high viral shedding", "PROBLEM", 265, 284], ["med", "ANATOMY", 105, 108], ["viral shedding", "OBSERVATION", 214, 228], ["early", "OBSERVATION_MODIFIER", 250, 255], ["burst", "OBSERVATION_MODIFIER", 256, 261], ["high viral shedding", "OBSERVATION", 265, 284]]], ["We modeled the wastewater data W(t) as a convolution of new clinical cases I(t) and a function s(t) describing viral shedding (whether from fecal, urine, or other unknown sources) into wastewater by each infected individual.", [["fecal", "ANATOMY", 140, 145], ["urine", "ANATOMY", 147, 152], ["fecal", "ORGANISM_SUBSTANCE", 140, 145], ["urine", "ORGANISM_SUBSTANCE", 147, 152], ["viral shedding", "PROBLEM", 111, 125], ["fecal, urine", "TEST", 140, 152]]], ["To obtain I(t), clinical data was back-dated to account for the time lag with wastewater data.", [["clinical data", "TEST", 16, 29]]], ["We optimized the parameters of the shedding function to minimize the error between the convolutional model's prediction and the observed wastewater titers.An inferred viral shedding function suggests an early burst of high viral shedding.Modeling revealed a short burst of viral shedding lasting 3-4 days.", [["the error", "PROBLEM", 65, 74], ["An inferred viral shedding function", "PROBLEM", 155, 190], ["high viral shedding", "PROBLEM", 218, 237], ["a short burst of viral shedding", "PROBLEM", 256, 287], ["wastewater titers", "OBSERVATION", 137, 154], ["viral shedding", "OBSERVATION", 167, 181], ["early", "OBSERVATION_MODIFIER", 203, 208], ["burst", "OBSERVATION_MODIFIER", 209, 214], ["high viral shedding", "OBSERVATION", 218, 237], ["short burst", "OBSERVATION_MODIFIER", 258, 269], ["viral", "OBSERVATION", 273, 278]]], ["This short burst of shedding was also seen after modeling each catchment individually ( Figure S5-6 ).", [["This short burst of shedding", "PROBLEM", 0, 28], ["short", "OBSERVATION_MODIFIER", 5, 10], ["burst", "OBSERVATION_MODIFIER", 11, 16], ["shedding", "OBSERVATION", 20, 28]]], ["Using a 4-day time lag, which gave the best correlation between wastewater and clinical data ( Figure 1C -D), we found that the individual shedding function peaked around day 2 and spanned approximately 3-4 days ( Figure 1E ).", [["clinical data", "TEST", 79, 92], ["the individual shedding function", "PROBLEM", 124, 156]]], ["Peak shedding was an order of magnitude greater than the highest clinically reported abundance of SARS-CoV-2 in stool, and generally several orders of magnitude greater than typical values, which are measured after symptom onset and clinical testing The inferred viral shedding function allows us to estimate the viral titers in wastewater based on reported clinical cases.", [["stool", "ANATOMY", 112, 117], ["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 98, 108], ["stool", "ORGANISM_SUBSTANCE", 112, 117], ["SARS-CoV", "SPECIES", 98, 106], ["Peak shedding", "PROBLEM", 0, 13], ["SARS", "PROBLEM", 98, 102], ["CoV", "TEST", 103, 106], ["symptom onset", "PROBLEM", 215, 228], ["clinical testing", "TEST", 233, 249], ["The inferred viral shedding function", "PROBLEM", 250, 286], ["the viral titers", "TEST", 309, 325], ["SARS", "OBSERVATION", 98, 102], ["viral", "OBSERVATION", 263, 268]]], ["Figure 1F shows new clinical cases, back-dated by 4 days, convolved with the inferred shedding function to generate estimated viral titers in wastewater.", [["new clinical cases", "PROBLEM", 16, 34], ["new", "OBSERVATION_MODIFIER", 16, 19]]], ["These data fit well with observed viral titers.", [["observed viral titers", "PROBLEM", 25, 46]]], ["For example, if only half of cases are reported, then the total amount of shedding per individual would be inferred to be twice the actual value, even though the fit to the model would be equally good.An inferred viral shedding function suggests an early burst of high viral shedding..", [["An inferred viral shedding function", "PROBLEM", 201, 236], ["high viral shedding", "PROBLEM", 264, 283], ["viral shedding", "OBSERVATION", 213, 227], ["early", "OBSERVATION_MODIFIER", 249, 254], ["burst", "OBSERVATION_MODIFIER", 255, 260], ["high", "OBSERVATION_MODIFIER", 264, 268], ["viral shedding", "OBSERVATION", 269, 283]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)An inferred viral shedding function suggests an early burst of high viral shedding.The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.", [["CC", "CHEMICAL", 0, 2], ["ND", "PROBLEM", 9, 11], ["An inferred viral shedding function", "PROBLEM", 202, 237], ["high viral shedding", "PROBLEM", 265, 284], ["med", "ANATOMY", 105, 108], ["viral shedding", "OBSERVATION", 214, 228], ["early", "OBSERVATION_MODIFIER", 250, 255], ["burst", "OBSERVATION_MODIFIER", 256, 261], ["high viral shedding", "OBSERVATION", 265, 284]]], ["15.20117747 doi: medRxiv preprint Together, our data suggest that SARS-CoV-2 levels in wastewater may be largely driven by a burst of shedding that occurs early in infection -likely before the onset of respiratory symptoms commonly used as testing criteria.", [["respiratory", "ANATOMY", 202, 213], ["SARS", "DISEASE", 66, 70], ["infection", "DISEASE", 164, 173], ["respiratory symptoms", "DISEASE", 202, 222], ["SARS-CoV-2", "ORGANISM", 66, 76], ["our data", "TEST", 44, 52], ["SARS", "TEST", 66, 70], ["CoV", "TEST", 71, 74], ["infection", "PROBLEM", 164, 173], ["respiratory symptoms", "PROBLEM", 202, 222], ["testing criteria", "TEST", 240, 256], ["infection", "OBSERVATION", 164, 173]]], ["Although the early peak of viral shedding in our model does not directly reflect patients' reported clinical courses, it is consistent with reports of abdominal pain, nausea, and diarrhea preceding onset of respiratory symptoms in COVID-19 patients (19) (20) (21) , suggesting that individuals may shed SARS-CoV-2 virus early in this process.", [["abdominal", "ANATOMY", 151, 160], ["respiratory", "ANATOMY", 207, 218], ["abdominal pain", "DISEASE", 151, 165], ["nausea", "DISEASE", 167, 173], ["diarrhea", "DISEASE", 179, 187], ["respiratory symptoms", "DISEASE", 207, 227], ["SARS", "DISEASE", 303, 307], ["patients", "ORGANISM", 81, 89], ["abdominal", "ORGANISM_SUBDIVISION", 151, 160], ["patients", "ORGANISM", 240, 248], ["individuals", "ORGANISM", 282, 293], ["SARS-CoV-2 virus", "ORGANISM", 303, 319], ["patients", "SPECIES", 81, 89], ["patients", "SPECIES", 240, 248], ["SARS-CoV-2 virus", "SPECIES", 303, 319], ["viral shedding", "PROBLEM", 27, 41], ["abdominal pain", "PROBLEM", 151, 165], ["nausea", "PROBLEM", 167, 173], ["diarrhea", "PROBLEM", 179, 187], ["respiratory symptoms", "PROBLEM", 207, 227], ["COVID", "TEST", 231, 236], ["SARS", "PROBLEM", 303, 307], ["CoV-2 virus", "PROBLEM", 308, 319], ["early", "OBSERVATION_MODIFIER", 13, 18], ["peak", "OBSERVATION_MODIFIER", 19, 23], ["viral shedding", "OBSERVATION", 27, 41], ["consistent with", "UNCERTAINTY", 124, 139], ["abdominal", "ANATOMY", 151, 160], ["pain", "OBSERVATION", 161, 165], ["respiratory", "ANATOMY", 207, 218]]], ["Our data is also consistent with recent findings in patients' oropharyngeal swab samples (peak shedding at 0.7 days before onset of respiratory symptoms, Ref.", [["oropharyngeal swab samples", "ANATOMY", 62, 88], ["respiratory", "ANATOMY", 132, 143], ["respiratory symptoms", "DISEASE", 132, 152], ["patients", "ORGANISM", 52, 60], ["oropharyngeal swab samples", "ORGANISM_SUBSTANCE", 62, 88], ["patients", "SPECIES", 52, 60], ["Our data", "TEST", 0, 8], ["patients' oropharyngeal swab samples", "TEST", 52, 88], ["respiratory symptoms", "PROBLEM", 132, 152], ["consistent with", "UNCERTAINTY", 17, 32], ["respiratory", "ANATOMY", 132, 143]]], ["We hypothesize that viral shedding is characterized by an early burst, inferred by our model, followed by a period of prolonged low-level shedding as reported in the literature (17, 18, 24) .", [["viral shedding", "PROBLEM", 20, 34], ["prolonged low-level shedding", "PROBLEM", 118, 146], ["viral", "OBSERVATION", 20, 25], ["early", "OBSERVATION_MODIFIER", 58, 63], ["burst", "OBSERVATION_MODIFIER", 64, 69], ["prolonged", "OBSERVATION_MODIFIER", 118, 127], ["low", "OBSERVATION_MODIFIER", 128, 131]]], ["In several clinical studies, the earliest stool samples collected have been months is unlikely to interfere with the sensitivity of wastewater surveillance to detect new infections above the background of previous cases.", [["stool samples", "ANATOMY", 42, 55], ["infections", "DISEASE", 170, 180], ["stool samples", "ORGANISM_SUBSTANCE", 42, 55], ["several clinical studies", "TEST", 3, 27], ["the earliest stool samples", "TEST", 29, 55], ["wastewater surveillance", "TEST", 132, 155], ["new infections", "PROBLEM", 166, 180], ["new", "OBSERVATION_MODIFIER", 166, 169], ["infections", "OBSERVATION", 170, 180]]], ["Our model, which suggests peak viral shedding at levels up to 1.1 x 10^12 viral copies per day, also helps to explain our previously reported findings, that SARS-CoV-2 levels in wastewater are significantly higher than would be expected based on clinical case numbers and observations of viral shedding in patient stool (13) .Wastewater SARS-CoV-2 titers in the context of behavior and interventionsSARS-CoV-2 levels in wastewater began to increase exponentially after March 15, coinciding with a peak in reports to the US Centers for Disease Control and Prevention of \"influenza-like illnesses\" (ILI) in Massachusetts that were not caused by influenza .", [["SARS", "DISEASE", 157, 161], ["SARS", "DISEASE", 399, 403], ["influenza-like illnesses", "DISEASE", 570, 594], ["ILI", "DISEASE", 597, 600], ["influenza", "DISEASE", 643, 652], ["SARS-CoV-2", "ORGANISM", 157, 167], ["patient", "ORGANISM", 306, 313], ["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 399, 409], ["patient", "SPECIES", 306, 313], ["Our model", "TEST", 0, 9], ["peak viral shedding", "PROBLEM", 26, 45], ["SARS-CoV-2 levels", "TEST", 157, 174], ["viral shedding in patient stool", "PROBLEM", 288, 319], ["Wastewater SARS", "TEST", 326, 341], ["CoV", "TEST", 342, 345], ["interventions", "TREATMENT", 386, 399], ["SARS", "TEST", 399, 403], ["CoV-2 levels", "TEST", 404, 416], ["Disease Control", "TREATMENT", 535, 550], ["\"influenza", "PROBLEM", 569, 579], ["illnesses", "PROBLEM", 585, 594], ["influenza", "PROBLEM", 643, 652], ["peak", "OBSERVATION_MODIFIER", 26, 30], ["viral", "OBSERVATION", 31, 36], ["viral", "OBSERVATION_MODIFIER", 288, 293], ["increase", "OBSERVATION_MODIFIER", 440, 448], ["influenza", "OBSERVATION", 570, 579], ["not caused", "UNCERTAINTY", 629, 639], ["influenza", "OBSERVATION", 643, 652]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.", [["CC", "CHEMICAL", 0, 2], ["ND", "PROBLEM", 9, 11], ["med", "ANATOMY", 105, 108]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)Wastewater SARS-CoV-2 titers in the context of behavior and interventionsThe copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.15.20117747 doi: medRxiv preprint shoppers -might have contributed to the sharp rise in viral titers in wastewater ( Figure 1A ) that began in the following days.Wastewater SARS-CoV-2 titers in the context of behavior and interventionsWastewater viral titers at the neighborhood level correlate better with demographic variables than with population size.Wastewater SARS-CoV-2 titers in the context of behavior and interventionsWhatever the cause of the additional infection cycles after the public began to stay at home in mid-March, was the exponential rise in viral titers uniformly distributed across the catchments we sampled?", [["CC", "CHEMICAL", 0, 2], ["infection", "DISEASE", 848, 857], ["ND", "PROBLEM", 9, 11], ["Wastewater SARS", "TEST", 202, 217], ["CoV", "TEST", 218, 221], ["interventions", "TREATMENT", 262, 275], ["medRxiv preprint shoppers", "TREATMENT", 400, 425], ["the sharp rise in viral titers", "PROBLEM", 453, 483], ["Wastewater SARS", "TEST", 545, 560], ["CoV", "TEST", 561, 564], ["interventions", "TREATMENT", 605, 618], ["Wastewater viral titers", "TEST", 618, 641], ["Wastewater SARS", "TEST", 738, 753], ["CoV", "TEST", 754, 757], ["interventions", "TREATMENT", 798, 811], ["the additional infection cycles", "PROBLEM", 833, 864], ["viral titers", "PROBLEM", 946, 958], ["med", "ANATOMY", 105, 108], ["sharp", "OBSERVATION_MODIFIER", 457, 462], ["rise", "OBSERVATION_MODIFIER", 463, 467], ["viral titers", "OBSERVATION", 471, 483], ["size", "OBSERVATION_MODIFIER", 733, 737], ["infection", "OBSERVATION", 848, 857], ["exponential", "OBSERVATION_MODIFIER", 926, 937], ["rise", "OBSERVATION_MODIFIER", 938, 942], ["viral titers", "OBSERVATION", 946, 958]]], ["The wastewater treatment facility's northern and southern influents showed similar SARS-CoV-2 levels and dynamics ( Figure 1B ) -suggesting that disease incidence (new cases) and/or prevalence (total cases) were similar in both catchments.", [["SARS", "DISEASE", 83, 87], ["The wastewater treatment facility", "TREATMENT", 0, 33], ["southern influents", "TEST", 49, 67], ["similar SARS", "TEST", 75, 87], ["CoV", "TEST", 88, 91], ["disease incidence", "PROBLEM", 145, 162]]], ["We hypothesized that similar viral levels in the two influents were due to a relatively uniform spatial distribution of disease burden across both catchments, which represent similar population sizes.", [["similar viral levels", "PROBLEM", 21, 41], ["disease burden", "PROBLEM", 120, 134], ["similar", "OBSERVATION_MODIFIER", 21, 28], ["viral levels", "OBSERVATION", 29, 41], ["relatively", "OBSERVATION_MODIFIER", 77, 87], ["uniform", "OBSERVATION_MODIFIER", 88, 95], ["spatial", "OBSERVATION_MODIFIER", 96, 103], ["distribution", "OBSERVATION_MODIFIER", 104, 116], ["disease", "OBSERVATION", 120, 127], ["both catchments", "OBSERVATION", 142, 157], ["similar", "OBSERVATION_MODIFIER", 175, 182], ["population", "OBSERVATION_MODIFIER", 183, 193], ["sizes", "OBSERVATION_MODIFIER", 194, 199]]], ["An equal distribution of disease incidence across the catchment would mean that the likelihood of seeing a positive SARS-CoV-2 signal should increase with the size of the catchment according to Poisson statistics ( Figure S8 ).", [["SARS", "DISEASE", 116, 120], ["disease incidence", "PROBLEM", 25, 42], ["a positive SARS", "PROBLEM", 105, 120], ["equal", "OBSERVATION_MODIFIER", 3, 8], ["distribution", "OBSERVATION_MODIFIER", 9, 21], ["disease", "OBSERVATION", 25, 32], ["size", "OBSERVATION_MODIFIER", 159, 163]]], ["Thus, comparing presence/absence of disease to a binomial (Poisson) model of infection would enable more accurate estimates of disease incidence, and would allow us to calibrate the observed viral titers to the true number of underlying cases.Wastewater SARS-CoV-2 titers in the context of behavior and interventionsTo test this approach to calibrating viral titers to the number of cases, we sampled 11 urban neighborhoods within the wastewater treatment facility's catchment (see Methods), representing populations ranging from ~4,000 to ~40,000 individuals.", [["infection", "DISEASE", 77, 86], ["disease", "PROBLEM", 36, 43], ["a binomial (Poisson) model of infection", "PROBLEM", 47, 86], ["disease incidence", "PROBLEM", 127, 144], ["the observed viral titers", "PROBLEM", 178, 203], ["Wastewater SARS", "TEST", 243, 258], ["CoV", "TEST", 259, 262], ["interventions", "TREATMENT", 303, 316], ["disease", "OBSERVATION", 36, 43], ["infection", "OBSERVATION", 77, 86]]], ["The observed viral titers deviated strongly from that expected under a Poisson process ( Fig. 3A and Figure S8B ).", [["The observed viral titers", "PROBLEM", 0, 25], ["viral titers", "OBSERVATION", 13, 25]]], ["Many small catchments were found to be positive while larger catchments were negative, suggesting significant heterogeneity in disease levels between different neighborhoods.", [["Many small catchments", "PROBLEM", 0, 21], ["significant heterogeneity in disease levels", "PROBLEM", 98, 141], ["small", "OBSERVATION_MODIFIER", 5, 10], ["catchments", "OBSERVATION", 11, 21], ["suggesting", "UNCERTAINTY", 87, 97], ["significant", "OBSERVATION_MODIFIER", 98, 109], ["heterogeneity", "OBSERVATION", 110, 123], ["disease", "OBSERVATION", 127, 134]]], ["It should be noted that while some neighborhood catchments did not have detectable viral titers in sewage at the time they were sampled, new clinical cases were reported during the week of sampling.Wastewater SARS-CoV-2 titers in the context of behavior and interventionsTo understand which factors were associated with this microgeographic heterogeneity, we investigated 38 different demographic variables.", [["detectable viral titers", "PROBLEM", 72, 95], ["Wastewater SARS", "TEST", 198, 213], ["CoV", "TEST", 214, 217], ["interventions", "TREATMENT", 258, 271], ["this microgeographic heterogeneity", "PROBLEM", 320, 354]]], ["We found that viral levels in .", [["viral levels", "TEST", 14, 26], ["viral levels", "OBSERVATION", 14, 26]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.15.20117747 doi: medRxiv preprint wastewater did not correlate strongly with population size, as would be expected under the null model of equal incidence ( Figure 3B ).", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["medRxiv preprint wastewater", "TREATMENT", 326, 353], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108], ["size", "OBSERVATION_MODIFIER", 397, 401]]], ["Instead, wastewater titers correlated most strongly with average household healthcare spending and household income (left panel in Figure 3B ; and Figure 3C ).", [["left panel", "TEST", 117, 127]]], ["The associations between wastewater titers and demographic variables were broadly the same as those from clinical observations.", [["wastewater titers", "TREATMENT", 25, 42], ["demographic variables", "TEST", 47, 68]]], ["An analysis of new clinical case reports for the neighborhoods containing the catchments during the week of sampling showed that new clinical cases correlated with household income, household size, age, healthcare spending, and race/ ethnicity (middle panel in Figure 3B and Figure S9 ; and Figure 3D ).", [["An analysis", "TEST", 0, 11], ["middle panel", "TEST", 245, 257], ["new", "OBSERVATION_MODIFIER", 15, 18]]], ["Similar trends were also found for cumulative clinical case rates (right panel in Figure 3B and Figure S9 ; and Figure 3E ).", [["right panel", "TEST", 67, 78]]], ["Thus, wastewater surveillance at the neighborhood level reflects heterogeneity in disease incidence and prevalence in specific sub-populations, and is consistent with previous reports that the COVID-19 pandemic is disproportionately affecting neighborhoods with more socioeconomically disadvantaged populations (37) (38) (39) .", [["COVID-19", "ORGANISM", 193, 201], ["wastewater surveillance", "TEST", 6, 29], ["heterogeneity in disease incidence", "PROBLEM", 65, 99], ["the COVID", "TEST", 189, 198], ["heterogeneity", "OBSERVATION_MODIFIER", 65, 78], ["disease", "OBSERVATION", 82, 89], ["consistent with", "UNCERTAINTY", 151, 166]]], ["As a next step, we are continuing our neighborhood-level sampling to investigate viral loads in different communities.Uncertainties and future directions of wastewater surveillanceAlthough wastewater viral titers should be relatively unbiased, relatively high day-to-day variation in our data suggests that they are noisy even when disease incidence is high.Uncertainties and future directions of wastewater surveillanceOn the other hand, clinical data may be less noisy but more prone to systematic bias due to constraints such as limited clinical testing capacity.", [["hand", "ORGANISM_SUBDIVISION", 433, 437], ["viral loads", "PROBLEM", 81, 92], ["wastewater surveillance", "TEST", 157, 180], ["wastewater viral titers", "PROBLEM", 189, 212], ["our data", "TEST", 284, 292], ["disease incidence", "PROBLEM", 332, 349], ["wastewater surveillanceOn", "TREATMENT", 397, 422], ["clinical data", "TEST", 439, 452], ["limited clinical testing capacity", "TEST", 532, 565], ["viral loads", "OBSERVATION", 81, 92]]], ["Together, these independent data streams from clinical-and wastewater-based surveillance can provide a more complete picture of viral dynamics, and a new opportunity to explore the relationship between COVID-19 dynamics and concomitant public health interventions and behavioral changes.", [["COVID", "TEST", 202, 207], ["concomitant public health interventions", "TREATMENT", 224, 263], ["behavioral changes", "PROBLEM", 268, 286]]], ["In this study, we infer a viral shedding function that can help to connect these two data streams in a quantitative fashion to allow for more accurate epidemiological modeling -and ultimately, more informed decision-making about how and when to intervene.Uncertainties and future directions of wastewater surveillance.", [["this study", "TEST", 3, 13], ["a viral shedding function", "PROBLEM", 24, 49], ["wastewater surveillance", "TEST", 294, 317]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.15.20117747 doi: medRxiv preprint Several knowledge gaps introduce uncertainty to our modelling approaches.", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["medRxiv", "TREATMENT", 326, 333], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["First, viral titers in wastewater are highly dependent on individual shedding rates, viral stability in wastewater, and flow rates (dilution) of the influent.", [["viral titers", "TEST", 7, 19], ["viral stability in wastewater", "PROBLEM", 85, 114], ["flow rates", "TEST", 120, 130], ["the influent", "PROBLEM", 145, 157], ["viral titers", "OBSERVATION", 7, 19], ["viral stability", "OBSERVATION", 85, 100], ["influent", "OBSERVATION_MODIFIER", 149, 157]]], ["While we have noted that normalization with the human fecal indicator PMMoV (see Methods) helps reduce noise in our datasets that is due to sampling time and flow, significant uncertainties remain regarding the consistency of viral shedding among COVID-19 patients (17, 24) .", [["human", "ORGANISM", 48, 53], ["patients", "ORGANISM", 256, 264], ["human", "SPECIES", 48, 53], ["patients", "SPECIES", 256, 264], ["human", "SPECIES", 48, 53], ["noise", "PROBLEM", 103, 108]]], ["Second, the viral shedding profile inferred by our modelling approach relies on reported clinical new cases per day over the course of the pandemic, and is thus subject to the limitations of clinical testing capacity ( Figure 2 ).", [["the viral shedding profile", "PROBLEM", 8, 34], ["clinical testing capacity", "TEST", 191, 216], ["viral", "OBSERVATION", 12, 17]]], ["This early lack of testing is especially evident given that SARS-CoV-2 was detectable in wastewater when there were only 2 confirmed cases in the catchment ( Figure 1A ).", [["SARS", "DISEASE", 60, 64], ["SARS-CoV-2", "ORGANISM", 60, 70], ["testing", "TEST", 19, 26], ["SARS-CoV", "TEST", 60, 68]]], ["Close examination of the trends of influenza like illnesses likely not attributable to influenza, as captured by ILI Net (26) Results showed that PMMoV is detectable and relatively stable between daily samples, with a standard deviation of 1.789 Ct value in the 108 tested samples ( Figure S7 ).", [["samples", "ANATOMY", 273, 280], ["influenza", "DISEASE", 35, 44], ["influenza", "DISEASE", 87, 96], ["PMMoV", "CHEMICAL", 146, 151], ["PMMoV", "SIMPLE_CHEMICAL", 146, 151], ["Close examination", "TEST", 0, 17], ["influenza like illnesses", "PROBLEM", 35, 59], ["influenza", "PROBLEM", 87, 96], ["PMMoV", "TEST", 146, 151], ["a standard deviation", "TEST", 216, 236], ["Ct value", "TEST", 246, 254], ["influenza", "OBSERVATION", 35, 44], ["influenza", "OBSERVATION", 87, 96], ["stable", "OBSERVATION_MODIFIER", 181, 187]]], ["To adjust the SARS-CoV-2 viral titers for each sample, we first calculated the deviation of its PMMoV copies from the median of PMMoV copies in all 108 samples, i.e., deviation factor = 10^( * (sample Ct -median Ct)), where is the slope of the standard curve and equals to -0.2991 (amplification efficiency is 99.11% for this primer set) based on our test.", [["samples", "ANATOMY", 152, 159], ["SARS-CoV-2", "ORGANISM", 14, 24], ["PMMoV copies", "DNA", 96, 108], ["PMMoV copies", "DNA", 128, 140], ["the SARS", "TEST", 10, 18], ["CoV", "TEST", 19, 22], ["viral titers", "TEST", 25, 37], ["deviation factor", "TEST", 167, 183], ["sample Ct -median Ct", "TEST", 194, 214], ["the standard curve", "TEST", 240, 258], ["our test", "TEST", 347, 355]]], ["We then divided the SARS-CoV-2 viral titers by this deviation.", [["SARS", "DISEASE", 20, 24], ["SARS-CoV-2", "ORGANISM", 20, 30], ["SARS-CoV", "SPECIES", 20, 28], ["the SARS", "TEST", 16, 24], ["CoV", "TEST", 25, 28]]], ["Thus, this data supports that PMMoV is a good internal reference for standardizing detection of RNA virus in sewage samples, and we use it to correct for sampling fluctuations and experimental batch effects.(which was not certified by peer review)We processed 108 longitudinal raw wastewater samples from northern and southern influents using this method ('Method I'), in batches as they were received in the lab, from January 8 to May 5, 2020 ( Figure S1 ).", [["samples", "ANATOMY", 116, 123], ["samples", "ANATOMY", 292, 299], ["PMMoV", "CHEMICAL", 30, 35], ["PMMoV", "SIMPLE_CHEMICAL", 30, 35], ["standardizing detection", "TEST", 69, 92], ["RNA virus", "PROBLEM", 96, 105], ["sampling fluctuations", "TEST", 154, 175], ["experimental batch effects", "TREATMENT", 180, 206], ["this method ('Method I'", "TREATMENT", 343, 366]]], ["As expected, we observed less experimental variation using Method II (single batch) than Method I (6 batches).", [["Method II (single batch)", "TREATMENT", 59, 83], ["Method I (6 batches", "TREATMENT", 89, 108]]], ["For example, with Method I we noted a sharp drop-off of viral titers between March 26 and April 1 ( Figure S1 , Figure S10) , which was not supported by the reprocessed single-batch data ( Figure 1A, Figure 2 , Figure S10 ).", [["a sharp drop", "PROBLEM", 36, 48], ["viral titers", "PROBLEM", 56, 68], ["viral titers", "OBSERVATION", 56, 68]]], ["Therefore, a scaling factor of 1.7 was applied to the southern influent data, generated with Method II, in order to average the two signals for several analyses ( Figure 1A , 1C-F), and key findings are reproduced using the northern and southern influent data sets separately ( Figure S3-S6) .", [["S6", "PROTEIN", 288, 290], ["a scaling factor", "TEST", 11, 27], ["Method II", "TREATMENT", 93, 102], ["several analyses", "TEST", 144, 160]]], ["Our results suggest that batch effects are difficult to eliminate, even with optimized methods and internal references, and that standardization strategies Figure 1A .", [["batch effects", "PROBLEM", 25, 38]]], ["LOWESS smoothing was done with statsmodels.nonparametric.smoothers_lowess.lowess in python 3.6.5 and statsmodels 0.9.0.", [["statsmodels", "TEST", 31, 42], ["statsmodels", "TEST", 101, 112]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.15.20117747 doi: medRxiv preprint wastewater data to daily new clinical cases than to cumulative cases ( Figure 1C and Figure S2 ).", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["Moreover, cumulative cases are monotonically increasing, and do not reflect the trend of wastewater viral titers over the time, and thus we decided to do further analysis with daily new clinical cases.", [["wastewater viral titers", "PROBLEM", 89, 112], ["further analysis", "TEST", 154, 170], ["monotonically", "OBSERVATION_MODIFIER", 31, 44], ["increasing", "OBSERVATION_MODIFIER", 45, 55]]], ["Correlation analysis was done in R (3.5.0).(which was not certified by peer review)Influenza-like illness data was downloaded from CDC FluView Portal, and includes data reported to ILINet (25, 26) .", [["Influenza-like illness", "DISEASE", 83, 105], ["Influenza", "SPECIES", 83, 92], ["Correlation analysis", "TEST", 0, 20], ["Influenza", "PROBLEM", 83, 92], ["illness data", "TEST", 98, 110], ["Portal", "ANATOMY", 143, 149]]], ["Data on hospitalizations, reported deaths, number of tests administered, and daily positive test rates in Massachusetts were downloaded from Mass.gov (46).", [["deaths", "DISEASE", 35, 41], ["tests", "TEST", 53, 58], ["daily positive test rates", "TEST", 77, 102], ["Mass", "PROBLEM", 141, 145], ["Mass", "OBSERVATION", 141, 145]]], ["Public transit and cellular mobility data were downloaded from Massachusetts Bay Transportation Authority (30) and Citymapper (31), respectively.Social media data analysisFor analysis of emotional content, we used the dictionaries from LIWC2015 (47), which are optimized to capture social and psychological states within written text.", [["cellular", "ANATOMY", 19, 27], ["cellular", "CELL", 19, 27], ["Public transit", "TEST", 0, 14], ["cellular mobility data", "TEST", 19, 41], ["emotional content", "PROBLEM", 187, 204], ["cellular mobility", "OBSERVATION", 19, 36]]], ["For analysis, we focused specifically on health, anxiety, and death-related texts.", [["anxiety", "DISEASE", 49, 56], ["death", "DISEASE", 62, 67], ["analysis", "TEST", 4, 12], ["anxiety", "PROBLEM", 49, 56]]], ["For analysis, the available text fields from the Facebook posts were pre-processed, and psychometrics were calculated using the prevalence of words in the LIWC2015 dictionaries within the corpus of posts for a given day.", [["corpus", "ANATOMY", 188, 194], ["analysis", "TEST", 4, 12]]], ["Counts of words related to anxiety, death, and health were retained for analysis.", [["anxiety", "DISEASE", 27, 34], ["death", "DISEASE", 36, 41], ["anxiety", "PROBLEM", 27, 34], ["death", "PROBLEM", 36, 41], ["analysis", "TEST", 72, 80]]], ["The prevalence of posts about anxiety, death, and health by day was calculated by summing the counts of word matches and dividing by the number of posts in that day.Social media data analysisEstimation of viral shedding function.", [["anxiety", "DISEASE", 30, 37], ["death", "DISEASE", 39, 44], ["anxiety", "PROBLEM", 30, 37], ["death", "PROBLEM", 39, 44], ["viral shedding function", "PROBLEM", 205, 228]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.15.20117747 doi: medRxiv preprint infected individual s(t).", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["medRxiv", "TREATMENT", 326, 333], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["We hypothesized that the viral shedding function could be fit by a beta distribution with parameters \u03b1, \u03b2, and scaling factor c.", [["beta", "GENE_OR_GENE_PRODUCT", 67, 71], ["\u03b1", "GENE_OR_GENE_PRODUCT", 101, 102], ["\u03b2", "GENE_OR_GENE_PRODUCT", 104, 105], ["\u03b1", "PROTEIN", 101, 102], ["\u03b2", "PROTEIN", 104, 105], ["scaling factor", "PROTEIN", 111, 125], ["the viral shedding function", "PROBLEM", 21, 48]]], ["Since the beta distribution is defined on the range [0, 1], we sampled the probability density function for points 1/30 apart as a proxy for viral shedding over 30 days.", [["beta", "GENE_OR_GENE_PRODUCT", 10, 14], ["viral shedding", "PROBLEM", 141, 155], ["beta distribution", "OBSERVATION_MODIFIER", 10, 27], ["density", "OBSERVATION", 87, 94]]], ["We also hypothesized that there is some time lag in the clinical counts, which we represent as parameter \u03c4.", [["some time lag", "PROBLEM", 35, 48], ["the clinical counts", "TEST", 52, 71]]], ["Based on the results of the correlation analysis, we back-dated the clinical cases by \u03c4 = 4 days to get the new cases per day function I(t).", [["the correlation analysis", "TEST", 24, 48]]], ["We used the numpy.convolve function to calculate the convolution of the beta distribution s(t) and the number of new cases per day I(t).", [["beta", "GENE_OR_GENE_PRODUCT", 72, 76]]], ["We used the scipy.optimize.minimize function to find parameters \u03b1, \u03b2, c of the beta distribution that minimized the score Figure 1E .(which was not certified by peer review)To investigate the relationship between the shape of the shedding function and the clinical time lag \u03c4, we conducted the optimization for \u03c4 ranging from 0-10 days and report the optimal shedding function for each \u03c4.", [["beta", "GENE_OR_GENE_PRODUCT", 79, 83], ["scipy", "DNA", 12, 17], ["\u03b1", "PROTEIN", 64, 65], ["\u03b2", "PROTEIN", 67, 68], ["the scipy.optimize", "TREATMENT", 8, 26]]], ["We did this analysis for northern and southern influent data separately, as well as the average wastewater data.", [["this analysis", "TEST", 7, 20]]], ["We also modeled the shedding function as a gamma distribution over [0, 30] and had similar results as with the beta distribution.", [["beta", "GENE_OR_GENE_PRODUCT", 111, 115]]], ["All shedding estimation work was done with python 3.6.5, numpy 1.14.", [["All shedding estimation work", "TEST", 0, 28]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["15.20117747 doi: medRxiv preprint For the simulation, we investigated population sizes of 100 -40,000 people in step sizes of 100 people.", [["people", "ORGANISM", 102, 108], ["people", "ORGANISM", 130, 136], ["people", "SPECIES", 102, 108], ["people", "SPECIES", 130, 136], ["the simulation", "TEST", 38, 52], ["population sizes", "TEST", 70, 86], ["sizes", "OBSERVATION_MODIFIER", 81, 86]]], ["We assumed each new case sheds 0.8 n.", [["new", "OBSERVATION_MODIFIER", 16, 19]]], ["The total viral titers for the catchment would be (Cn).", [["The total viral titers", "TEST", 0, 22]]], ["We ran 100 trials of the simulation and plotted the simulated viral titers in Figure S8A .", [["the simulation", "TREATMENT", 21, 35], ["the simulated viral titers", "TREATMENT", 48, 74], ["viral titers", "OBSERVATION", 62, 74]]], ["To calculate the probability of detection at each population size, we counted the number of trials where simulated viral titers are greater than 0.", [["simulated viral titers", "TEST", 105, 127], ["size", "OBSERVATION_MODIFIER", 61, 65]]], ["We plotted the simulation detection probability, theoretical detection probability 1-P(k=0), and observed detections in Figure S8B .", [["the simulation detection probability", "TEST", 11, 47], ["theoretical detection probability", "TEST", 49, 82], ["k", "TEST", 87, 88]]], ["Next, resident size was estimated for each building.", [["size", "OBSERVATION_MODIFIER", 15, 19]]], ["Finally, we calculated the population-weighted average of demographic information for each catchment.(which was not certified by peer review)Spearman rank correlation was calculated between sewage titers or clinical case rate and each of 38 demographic variables. p-values were adjusted using the Benjamini .", [["p-values", "TEST", 264, 272], ["the Benjamini", "TREATMENT", 293, 306]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["15.20117747 doi: medRxiv preprint Hochberg method with false discovery rate of 0.1.", [["false discovery rate", "TEST", 55, 75]]], ["We report all demographic variables that are significant for sewage titers and a selection of additional variables in Figure 3B .(which was not certified by peer review)All 38 demographic variables are reported in Figure S9 .", [["sewage titers", "PROBLEM", 61, 74]]], ["Correlation analysis and multiple hypothesis correction were done with python 3.6.5, numpy 1.14.3, pandas 0.23.0, scipy 1.1.0, and statsmodels 0.9.0. .", [["Correlation analysis", "TEST", 0, 20], ["multiple hypothesis correction", "TEST", 25, 55], ["python", "TEST", 71, 77], ["numpy", "TEST", 85, 90], ["pandas", "TEST", 99, 105], ["scipy", "TEST", 114, 119], ["statsmodels", "TEST", 131, 142]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.15.20117747 doi: medRxiv preprint .", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["medRxiv preprint", "TREATMENT", 326, 342], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.15.20117747 doi: medRxiv preprint 369, m1443 (2020).(which was not certified by peer review).", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020.Centers for Disease Control and Prevention.", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["Disease Control", "TREATMENT", 286, 301], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108], ["Disease", "OBSERVATION", 286, 293]]], ["U.S. Outpatient Influenza-like IllnessSurveillance Network (ILINet). https://wwwn.cdc.gov/ILINet/ (2020).Centers for Disease Control and Prevention.", [["Influenza-like Illness", "DISEASE", 16, 38], ["Influenza", "PROBLEM", 16, 25], ["Disease Control", "TREATMENT", 117, 132], ["Disease", "OBSERVATION", 117, 124]]], ["U.S. Outpatient Influenza-like Illness.", [["Influenza-like Illness", "DISEASE", 16, 38], ["Influenza", "PROBLEM", 16, 25], ["Illness", "PROBLEM", 31, 38]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.15.20117747 doi: medRxiv preprint 991-993 (2020).Centers for Disease Control and Prevention.", [["CC", "CHEMICAL", 0, 2], ["ND", "PROBLEM", 9, 11], ["Disease Control", "TREATMENT", 578, 593], ["med", "ANATOMY", 105, 108], ["med", "ANATOMY", 313, 316], ["Disease", "OBSERVATION", 578, 585]]], ["Research Use Only 2019-Novel Coronavirus (2019-nCoV) Real-time RT-PCR Primers and Probes.https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html (2020).Centers for Disease Control and Prevention.", [["PCR Primers", "TEST", 66, 77], ["Disease Control", "TREATMENT", 186, 201], ["Disease", "OBSERVATION", 186, 193]]], ["Research Use Only 2019-Novel Coronavirus (2019-nCoV) Real-time RT-PCR Primers and Probes..", [["Real-time RT-PCR Primers", "DNA", 53, 77], ["Coronavirus", "TEST", 29, 40], ["PCR Primers", "TEST", 66, 77], ["Probes", "TEST", 82, 88]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. .", [["CC", "CHEMICAL", 0, 2], ["ND", "PROBLEM", 9, 11], ["med", "ANATOMY", 105, 108]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020.", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["Red solid line is the linear regression fitting.", [["Red solid line", "TREATMENT", 0, 14], ["the linear regression fitting", "PROBLEM", 18, 47], ["solid line", "OBSERVATION", 4, 14], ["linear", "OBSERVATION_MODIFIER", 22, 28], ["regression", "OBSERVATION_MODIFIER", 29, 39]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. .", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. .", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. .", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020.", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["The optimal shedding function is sharply peaked for all time lags.", [["sharply", "OBSERVATION_MODIFIER", 33, 40]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. for reference, with linear regression fit (18) .", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["Inset shows shedding on a log scale.(which was not certified by peer review).", [["a log scale", "TREATMENT", 24, 35]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. for reference, with linear regression fit (18) .", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["Inset shows shedding on a log scale.(which was not certified by peer review).", [["a log scale", "TREATMENT", 24, 35]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020.", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020.", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]], ["CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)(which was not certified by peer review)The copyright holder for this preprint this version posted June 23, 2020. . https://doi.org/10.1101/2020.06.15.20117747 doi: medRxiv preprint", [["CC", "CHEMICAL", 0, 2], ["CC", "TEST", 0, 2], ["ND", "PROBLEM", 9, 11], ["medRxiv", "TREATMENT", 367, 374], ["NC", "ANATOMY", 6, 8], ["med", "ANATOMY", 105, 108]]]], "PMC7537065": [["A 69\u2010year\u2010old woman with a 2\u2010day history of fever, dry cough, sore throat, fatigue and diarrhoea was admitted in the Infectious Disease Unit in University Hospital of Ioannina in Greece after being confirmed positive for SARS\u2010CoV\u20102.", [["fever", "DISEASE", 44, 49], ["dry cough", "DISEASE", 51, 60], ["sore throat", "DISEASE", 62, 73], ["fatigue", "DISEASE", 75, 82], ["diarrhoea", "DISEASE", 87, 96], ["Infectious Disease", "DISEASE", 117, 135], ["SARS", "DISEASE", 221, 225], ["woman", "ORGANISM", 14, 19], ["woman", "SPECIES", 14, 19], ["SARS\u2010CoV", "SPECIES", 221, 229], ["fever", "PROBLEM", 44, 49], ["dry cough", "PROBLEM", 51, 60], ["sore throat", "PROBLEM", 62, 73], ["fatigue", "PROBLEM", 75, 82], ["diarrhoea", "PROBLEM", 87, 96], ["SARS", "PROBLEM", 221, 225], ["fever", "OBSERVATION", 44, 49], ["cough", "OBSERVATION", 55, 60], ["sore throat", "ANATOMY", 62, 73], ["diarrhoea", "OBSERVATION", 87, 96]]], ["Previous medical history was unremarkable.", [["unremarkable", "OBSERVATION", 29, 41]]], ["On physical examination, temperature was 38.5\u00b0C, blood pressure 135/80 mmHg, pulse rate 99 b.p.m., respiratory rate 20/min and oxygen saturation 85% while the patient was breathing ambient air.", [["blood", "ANATOMY", 49, 54], ["respiratory", "ANATOMY", 99, 110], ["oxygen", "CHEMICAL", 127, 133], ["oxygen", "CHEMICAL", 127, 133], ["blood", "ORGANISM_SUBSTANCE", 49, 54], ["oxygen", "SIMPLE_CHEMICAL", 127, 133], ["patient", "ORGANISM", 159, 166], ["patient", "SPECIES", 159, 166], ["physical examination", "TEST", 3, 23], ["temperature", "TEST", 25, 36], ["C", "TEST", 46, 47], ["blood pressure", "TEST", 49, 63], ["pulse rate", "TEST", 77, 87], ["respiratory rate", "TEST", 99, 115], ["oxygen saturation", "TEST", 127, 144], ["breathing ambient air", "PROBLEM", 171, 192]]], ["Bilateral crackles were evident on auscultation; chest X\u2010ray showed basilar streaky opacities in both lungs.", [["chest", "ANATOMY", 49, 54], ["basilar", "ANATOMY", 68, 75], ["lungs", "ANATOMY", 102, 107], ["lungs", "ORGAN", 102, 107], ["Bilateral crackles", "PROBLEM", 0, 18], ["auscultation", "TEST", 35, 47], ["chest X\u2010ray", "TEST", 49, 60], ["basilar streaky opacities in both lungs", "PROBLEM", 68, 107], ["crackles", "OBSERVATION", 10, 18], ["chest", "ANATOMY", 49, 54], ["basilar", "ANATOMY_MODIFIER", 68, 75], ["streaky", "OBSERVATION_MODIFIER", 76, 83], ["opacities", "OBSERVATION", 84, 93], ["both", "ANATOMY_MODIFIER", 97, 101], ["lungs", "ANATOMY", 102, 107]]], ["The patient was supplied with oxygen at a flow rate of 10 L/min with a Venturi face mask (FiO2 = 50%) and treated with ceftriaxone (2 g once a day (q.d.)), azithromycin (500 mg q.d.) and hydroxychloroquine (400 mg twice a day (b.i.d.) for the first day and 200 mg b.i.d. afterwards), as proposed by Hellenic National Public Health Organisation.", [["oxygen", "CHEMICAL", 30, 36], ["ceftriaxone", "CHEMICAL", 119, 130], ["azithromycin", "CHEMICAL", 156, 168], ["hydroxychloroquine", "CHEMICAL", 187, 205], ["oxygen", "CHEMICAL", 30, 36], ["ceftriaxone", "CHEMICAL", 119, 130], ["azithromycin", "CHEMICAL", 156, 168], ["hydroxychloroquine", "CHEMICAL", 187, 205], ["patient", "ORGANISM", 4, 11], ["oxygen", "SIMPLE_CHEMICAL", 30, 36], ["ceftriaxone", "SIMPLE_CHEMICAL", 119, 130], ["azithromycin", "SIMPLE_CHEMICAL", 156, 168], ["hydroxychloroquine", "SIMPLE_CHEMICAL", 187, 205], ["patient", "SPECIES", 4, 11], ["oxygen", "TREATMENT", 30, 36], ["a flow rate", "TREATMENT", 40, 51], ["a Venturi face mask", "TREATMENT", 69, 88], ["FiO2", "TREATMENT", 90, 94], ["ceftriaxone", "TREATMENT", 119, 130], ["azithromycin", "TREATMENT", 156, 168], ["hydroxychloroquine", "TREATMENT", 187, 205]]]], "34774777c2473775892c82dc02cd789daa81c386": [["Many analyses have verified the contribution of developed countries' national health care systems to their countries' greenhouse gas (GHG) emissions to be between 3% and 10%.", [["GHG", "CHEMICAL", 134, 137]]], ["The UK National Health Service was estimated to contribute 4.6% of national GHGs in 2015, 2, 3 whereas an analysis of 36 generally first-world countries as well as India and China found that the health care sector was responsible for an average of 5.5% of each nation's overall emissions in 2014.", [["national GHGs", "TEST", 67, 80], ["an analysis", "TEST", 103, 114]]], ["6 Thus, a decrease in US health care GHG emissions would result in a significant decrease in overall US GHG emissions.", [["a decrease in US health care GHG emissions", "PROBLEM", 8, 50], ["a significant decrease", "PROBLEM", 67, 89], ["decrease", "OBSERVATION_MODIFIER", 10, 18], ["significant", "OBSERVATION_MODIFIER", 69, 80], ["decrease", "OBSERVATION_MODIFIER", 81, 89], ["GHG emissions", "OBSERVATION", 104, 117]]]], "PMC7542873": [["Materials and MethodsStudy area.\u2014The study was carried out in Houhe National Nature Reserve(30\u00b02\u203245\u2033\u22128\u203240\u2033N, 110\u00b029\u203225\u2033\u221240\u203245\u2033E), which encompasses 10,340 ha along the middle reachesof the Yangtze River valley of China (Fig. 1).", [["30\u00b02\u203245\u2033\u22128\u203240\u2033N, 110\u00b029\u203225\u2033\u221240\u203245\u2033E", "CHEMICAL", 92, 127], ["The study", "TEST", 33, 42], ["middle", "ANATOMY_MODIFIER", 168, 174]]], ["Thisreserve is in the transitional belt between the middle and northern subtropical zones and ischaracterized by 4 distinct seasons, including a cold winter and a hot, humid summer.Elevations range from 560 m to about 2,252 m above sea level.", [["transitional belt", "OBSERVATION", 22, 39], ["middle", "ANATOMY_MODIFIER", 52, 58], ["northern", "ANATOMY_MODIFIER", 63, 71], ["subtropical", "ANATOMY_MODIFIER", 72, 83], ["zones", "ANATOMY_MODIFIER", 84, 89], ["4 distinct", "OBSERVATION_MODIFIER", 113, 123]]], ["The mean annual temperature is11.5\u00b0C and there are 211 frost-free days per year.", [["The mean annual temperature", "TEST", 0, 27]]], ["The average annual precipitation is 1,814mm.Materials and MethodsThe primary types of natural forest within the reserve are coniferous forest (includingPinus tabulaeformis, Pinus henryi, and Cryptomerialanceolata), broad-leaved forest (including Sycopsis sinensis, Davidiainvolucrata, and Cercidiphyllum japonicum), and bamboo forest.Based on human activity, habitats within the reserve can be categorized as primary(unlogged) forest (PF), selectively logged forest (SLF), logged forest (LF), broad-leavedforest plantation (BFP), coniferous forest plantation (CFP), and farmland (FL).", [["Pinus tabulaeformis", "ORGANISM", 152, 171], ["Pinus henryi", "ORGANISM", 173, 185], ["Sycopsis sinensis", "ORGANISM", 246, 263], ["Davidiainvolucrata", "ORGANISM", 265, 283], ["Cercidiphyllum japonicum", "ORGANISM", 289, 313], ["human", "ORGANISM", 343, 348], ["Pinus tabulaeformis", "SPECIES", 152, 171], ["Pinus henryi", "SPECIES", 173, 185], ["Sycopsis sinensis", "SPECIES", 246, 263], ["Cercidiphyllum japonicum", "SPECIES", 289, 313], ["human", "SPECIES", 343, 348], ["Pinus tabulaeformis", "SPECIES", 152, 171], ["Pinus henryi", "SPECIES", 173, 185], ["Sycopsis sinensis", "SPECIES", 246, 263], ["Cercidiphyllum japonicum", "SPECIES", 289, 313], ["human", "SPECIES", 343, 348], ["Methods", "TREATMENT", 58, 65], ["natural forest", "TREATMENT", 86, 100], ["coniferous forest", "TREATMENT", 124, 141], ["Pinus tabulaeformis", "PROBLEM", 152, 171], ["Pinus henryi", "PROBLEM", 173, 185], ["Sycopsis sinensis", "TREATMENT", 246, 263], ["Davidiainvolucrata", "TREATMENT", 265, 283], ["Cercidiphyllum japonicum)", "TREATMENT", 289, 314], ["bamboo forest", "TREATMENT", 320, 333], ["selectively logged forest (SLF)", "TREATMENT", 440, 471], ["logged forest (LF)", "TREATMENT", 473, 491], ["broad-leavedforest plantation (BFP", "TREATMENT", 493, 527], ["coniferous forest plantation", "TREATMENT", 530, 558], ["average", "OBSERVATION_MODIFIER", 4, 11], ["annual", "OBSERVATION_MODIFIER", 12, 18], ["precipitation", "OBSERVATION_MODIFIER", 19, 32], ["natural forest", "OBSERVATION", 86, 100], ["coniferous forest", "OBSERVATION", 124, 141], ["Pinus henryi", "OBSERVATION", 173, 185]]], ["In alluncultivated habitats, the main fruiting plants are members of the families Rosaceae,Lardizabalaceae, Lauraceae, Actinidiaceae, Moraceae, and Cornaceae, which mature betweenAugust and November.", [["Lardizabalaceae", "GENE_OR_GENE_PRODUCT", 91, 106], ["Lauraceae", "GENE_OR_GENE_PRODUCT", 108, 117], ["Actinidiaceae", "GENE_OR_GENE_PRODUCT", 119, 132], ["Moraceae", "GENE_OR_GENE_PRODUCT", 134, 142], ["Cornaceae", "GENE_OR_GENE_PRODUCT", 148, 157], ["main", "OBSERVATION_MODIFIER", 33, 37], ["fruiting plants", "OBSERVATION", 38, 53], ["Lauraceae", "ANATOMY", 108, 117]]], ["Outside these months fruits are scarce (Song and Liu 1999; Wang et al. 1997),although some species (e.g., Elaeagnus henryi, Cerasus dielsiana, Fragariaorientalis, and Hove nia dulcis) mature during December throughJuly.Materials and MethodsMost logging in Houhe National Nature Reserve occurred before 1998.", [["fruits", "ANATOMY", 21, 27], ["fruits", "ORGANISM_SUBDIVISION", 21, 27], ["Elaeagnus henryi", "ORGANISM", 106, 122], ["Cerasus dielsiana", "ORGANISM", 124, 141], ["Fragariaorientalis", "ORGANISM", 143, 161], ["Hove nia dulcis", "ORGANISM", 167, 182], ["Elaeagnus henryi", "SPECIES", 106, 122], ["Cerasus dielsiana", "SPECIES", 124, 141], ["nia dulcis", "SPECIES", 172, 182], ["Elaeagnus henryi", "SPECIES", 106, 122], ["Cerasus dielsiana", "SPECIES", 124, 141], ["Hove nia dulcis", "SPECIES", 167, 182], ["some species", "PROBLEM", 86, 98]]], ["In LF, all commerciallyvaluable trees with a diameter at breast height (dbh) of 10\u201320 cm were harvested forconstruction or firewood.", [["breast", "ANATOMY", 57, 63], ["breast", "ORGANISM_SUBDIVISION", 57, 63], ["LF", "ANATOMY_MODIFIER", 3, 5], ["all", "OBSERVATION_MODIFIER", 7, 10], ["commerciallyvaluable trees", "OBSERVATION", 11, 37], ["diameter", "OBSERVATION_MODIFIER", 45, 53], ["breast", "ANATOMY", 57, 63]]], ["In contrast, in SFL, approximately 1 tree (with a dbh > 20 cm)per 100 m2 was taken for use by local residents.", [["a dbh", "TREATMENT", 48, 53], ["SFL", "ANATOMY", 16, 19], ["tree", "OBSERVATION_MODIFIER", 37, 41]]], ["The logging methods employeddestroyed more than 50% of the trees with a dbh > 5 cm.", [["The logging methods", "TREATMENT", 0, 19], ["5 cm", "OBSERVATION_MODIFIER", 78, 82]]], ["After logging, a mosaic ofvegetation types remained that was dominated by pioneer tree species, shrubs, vines,climbers, and herbs.", [["a mosaic ofvegetation types", "PROBLEM", 15, 42], ["tree species", "OBSERVATION", 82, 94], ["herbs", "ANATOMY", 124, 129]]], ["BFPs and CFPs were established between 1998 and 2001.", [["BFPs", "SIMPLE_CHEMICAL", 0, 4], ["CFPs", "SIMPLE_CHEMICAL", 9, 13], ["BFPs", "TEST", 0, 4], ["CFPs", "TEST", 9, 13]]], ["More than 99% ofvegetation in CFP and more than 90% of vegetation in BFP consisted of introduced species,with the rest of the vegetation comprised of vines, climbers, and herbs.Materials and MethodsApproximately 87 species of mammals have been reported from the study area.", [["mammals", "ORGANISM", 226, 233], ["CFP", "TEST", 30, 33], ["vegetation in BFP", "PROBLEM", 55, 72], ["introduced species", "PROBLEM", 86, 104], ["the study area", "TEST", 258, 272], ["vegetation", "OBSERVATION", 55, 65], ["vegetation", "OBSERVATION", 126, 136]]], ["The potentialprey of civets includes 2 species of hares, 11 species of insectivores, 5 species ofsquirrels, and 21 other species of rodents (Song and Liu1999).", [["civets", "TREATMENT", 21, 27]]], ["In addition to the masked palm civet, 20 species of carnivores have beenreported, including black bear (Ursus thibetanus), hog badger(Arctonyx collaris), yellow-throated marten (Martesfiavigula), Chinese ferret-badger (Melogale moschata), Siberianweasel (Mustela sibirica), yellow-bellied weasel (M.kathiah), and leopard cat (Prionailurus bengalensis).Particularly relevant to this study are reports of 2 other species of civets, the smallIndian civet (Viverricula indica) and the large Indian civet(Viverra zibetha\u2014Song and Liu1999).", [["palm", "ORGANISM_SUBDIVISION", 26, 30], ["carnivores", "ORGANISM", 52, 62], ["Ursus thibetanus", "ORGANISM", 104, 120], ["hog badger", "ORGANISM", 123, 133], ["Arctonyx collaris", "ORGANISM", 134, 151], ["Martesfiavigula", "ORGANISM", 178, 193], ["ferret", "ORGANISM", 204, 210], ["badger", "ORGANISM", 211, 217], ["Melogale moschata", "ORGANISM", 219, 236], ["Siberianweasel", "ORGANISM", 239, 253], ["Mustela sibirica", "ORGANISM", 255, 271], ["M.kathiah", "ORGANISM", 297, 306], ["cat", "ORGANISM", 321, 324], ["Prionailurus bengalensis", "ORGANISM", 326, 350], ["Viverricula indica", "ORGANISM", 453, 471], ["Ursus thibetanus", "SPECIES", 104, 120], ["hog", "SPECIES", 123, 126], ["badger", "SPECIES", 127, 133], ["Arctonyx collaris", "SPECIES", 134, 151], ["yellow-throated marten", "SPECIES", 154, 176], ["Chinese", "SPECIES", 196, 203], ["ferret-badger", "SPECIES", 204, 217], ["Melogale moschata", "SPECIES", 219, 236], ["Siberianweasel", "SPECIES", 239, 253], ["Mustela sibirica", "SPECIES", 255, 271], ["cat", "SPECIES", 321, 324], ["Prionailurus bengalensis", "SPECIES", 326, 350], ["Viverricula indica", "SPECIES", 453, 471], ["Ursus thibetanus", "SPECIES", 104, 120], ["hog badger", "SPECIES", 123, 133], ["Arctonyx collaris", "SPECIES", 134, 151], ["yellow-throated marten", "SPECIES", 154, 176], ["Chinese ferret-badger", "SPECIES", 196, 217], ["Melogale moschata", "SPECIES", 219, 236], ["Mustela sibirica", "SPECIES", 255, 271], ["yellow-bellied weasel", "SPECIES", 274, 295], ["leopard cat", "SPECIES", 313, 324], ["Prionailurus bengalensis", "SPECIES", 326, 350], ["Viverricula indica", "SPECIES", 453, 471], ["the masked palm civet", "TEST", 15, 36], ["20 species of carnivores", "PROBLEM", 38, 62], ["yellow-throated marten (Martesfiavigula)", "PROBLEM", 154, 194], ["leopard cat (Prionailurus bengalensis", "TREATMENT", 313, 350], ["this study", "TEST", 377, 387], ["large", "OBSERVATION_MODIFIER", 481, 486]]], ["However, more recent studies (Thomas et al.2004, Y. Zhou et al., in litt.), however, failed to detect the latter 2 species,suggesting that they are either very uncommon or extinct in the study area.", [["the latter 2 species", "PROBLEM", 102, 122], ["extinct", "OBSERVATION", 172, 179]]], ["As a result, allforaging by civets can reasonably be attributed to P. larvata.Materials and MethodsSample collection and identification.\u2014The diet of the masked palm civetwas studied by collecting feces and inspecting fresh foraging sites during July-November2004 and April 2005-May 2006.", [["feces", "ANATOMY", 196, 201], ["P. larvata", "ORGANISM", 67, 77], ["palm", "ORGANISM_SUBDIVISION", 160, 164], ["feces", "ORGANISM_SUBDIVISION", 196, 201], ["P. larvata", "SPECIES", 67, 77], ["P. larvata", "SPECIES", 67, 77], ["palm civetwas", "SPECIES", 160, 173], ["MethodsSample collection", "TEST", 92, 116], ["the masked palm civetwas", "TREATMENT", 149, 173], ["fresh foraging", "OBSERVATION", 217, 231]]], ["Twenty transects measuring 2.1\u20133.0 km in length(X\u0304= 2.7 km \u00b1 0.4 SE, range 2.1\u20133.0 km, total length =54.3 km) and 4 m in width were established in the 6 forest types (X\u0304\u0304 = 5.8transects per forest type \u00b1 4.8 SE;Fig.1).", [["Twenty transects", "TEST", 0, 16], ["length", "TEST", 41, 47], ["X\u0304", "TEST", 48, 50], ["km", "TEST", 56, 58], ["SE", "TEST", 65, 67], ["range", "TEST", 69, 74], ["km", "TEST", 83, 85], ["total length", "TEST", 87, 99], ["width", "TEST", 121, 126], ["X\u0304\u0304", "TEST", 167, 170], ["forest type", "TEST", 190, 201], ["Fig", "TEST", 211, 214]]], ["Each transect was systematically searched for feces every 2 weeks following themethods of Martinoli et al. (2001) and Joshi et al. (1995).", [["feces", "ANATOMY", 46, 51], ["feces", "ORGANISM_SUBSTANCE", 46, 51]]], ["During the 1st visit to eachtransect, all feces were removed to make sure that only fresh fecal samples were collectedduring later visits.", [["feces", "ANATOMY", 42, 47], ["fecal samples", "ANATOMY", 90, 103], ["feces", "ORGANISM_SUBSTANCE", 42, 47], ["fecal samples", "ORGANISM_SUBSTANCE", 90, 103], ["all feces", "PROBLEM", 38, 47], ["fresh fecal samples", "TEST", 84, 103]]], ["The location and date of collection were recorded for each fecalsample.", [["collection", "PROBLEM", 25, 35], ["collection", "OBSERVATION", 25, 35]]], ["Samples were air-dried for a minimum of 4 weeks and then stored in air-tight bagsuntil analysis.Materials and MethodsSamples were identified as belonging to P. larvata based on the appearance(e.g., color, shape, and size), texture, and smell of feces; other evidence of civets (e.g.,tracks, feeding signs, active dens, or daybeds) associated with feces; the opinion of localtrappers (Wang 1999); and the presence of civet hairsin the fecal samples (ingested during grooming\u2014Gatti et al.2006; Juarez and Marinho 2002; Manfredi et al. 2004).", [["Samples", "ANATOMY", 0, 7], ["feces", "ANATOMY", 245, 250], ["fecal samples", "ANATOMY", 434, 447], ["P. larvata", "ORGANISM", 157, 167], ["feces", "ORGANISM_SUBDIVISION", 245, 250], ["feces", "ORGANISM_SUBDIVISION", 347, 352], ["fecal samples", "ORGANISM_SUBSTANCE", 434, 447], ["P. larvata", "SPECIES", 157, 167], ["P. larvata", "SPECIES", 157, 167], ["Samples", "TEST", 0, 7], ["MethodsSamples", "TREATMENT", 110, 124], ["smell of feces", "PROBLEM", 236, 250], ["civets (e.g.", "PROBLEM", 270, 282], ["feeding signs", "PROBLEM", 291, 304], ["active dens", "PROBLEM", 306, 317], ["civet hairsin the fecal samples", "PROBLEM", 416, 447], ["air-dried", "OBSERVATION", 13, 22], ["shape", "OBSERVATION_MODIFIER", 205, 210], ["size", "OBSERVATION_MODIFIER", 216, 220], ["texture", "OBSERVATION_MODIFIER", 223, 230], ["fecal", "ANATOMY", 434, 439]]], ["Civet scats were readilydistinguished from those of bears because of their smaller dimensions (scat diameter forcivets = 5\u201320 mm versus > 40 mm for bears).", [["scat diameter forcivets", "TEST", 95, 118], ["smaller", "OBSERVATION_MODIFIER", 75, 82], ["diameter", "OBSERVATION_MODIFIER", 100, 108]]], ["The feces of mustelids were easily identifiedbecause of their characteristic odor and formation.", [["feces", "ANATOMY", 4, 9], ["mustelids", "ANATOMY", 13, 22], ["feces", "ORGANISM_SUBSTANCE", 4, 9], ["The feces of mustelids", "TEST", 0, 22], ["their characteristic odor", "PROBLEM", 56, 81], ["feces", "OBSERVATION_MODIFIER", 4, 9], ["characteristic", "OBSERVATION_MODIFIER", 62, 76], ["odor", "OBSERVATION", 77, 81]]], ["The feces of masked palm civets weredistinguished from those of leopard cats and the 2 other civets reported to occur in thestudy area by their characteristic shape and odor, as determined by comparison with a scatreference collection made from zoo specimens (J\u00e2como et al.2004).", [["feces", "ANATOMY", 4, 9], ["specimens", "ANATOMY", 249, 258], ["feces", "ORGANISM_SUBSTANCE", 4, 9], ["palm", "ORGANISM_SUBDIVISION", 20, 24], ["cats", "ORGANISM", 72, 76], ["cats", "SPECIES", 72, 76], ["masked palm civets", "PROBLEM", 13, 31], ["leopard cats", "TREATMENT", 64, 76], ["the 2 other civets", "TREATMENT", 81, 99], ["a scatreference collection", "PROBLEM", 208, 234], ["zoo specimens", "TEST", 245, 258], ["shape", "OBSERVATION_MODIFIER", 159, 164], ["odor", "OBSERVATION", 169, 173]]], ["Although we used multiple ways to identify fecal samples, 237 of 2,149 fecescollected during our study could not be assigned to species and were therefore excluded fromdietary analyses.", [["fecal samples", "ANATOMY", 43, 56], ["fecal samples", "MULTI-TISSUE_STRUCTURE", 43, 56], ["fecal samples", "TEST", 43, 56], ["our study", "TEST", 93, 102]]], ["Collectively, these procedures suggest that the probability ofmisidentification of civet feces was low.Materials and MethodsDiet determination and calculations of biomass.\u2014Diet analyses were carriedout according to the method of Kruuk and Parish(1981).", [["feces", "ORGANISM_SUBSTANCE", 89, 94], ["these procedures", "TEST", 14, 30], ["the probability ofmisidentification of civet feces", "TEST", 44, 94], ["calculations of biomass", "TREATMENT", 147, 170]]], ["Fecal samples were dissolved in distilled water and examined under adissecting microscope.", [["Fecal samples", "ANATOMY", 0, 13], ["Fecal samples", "ORGANISM_SUBSTANCE", 0, 13], ["Fecal samples", "TEST", 0, 13]]], ["The number of individual prey items was estimated based on the numberof paired or unique anatomical elements detected such as crania, mandibles, toothrows,wings, elytra, fruit cuticles, and seeds.", [["crania", "ANATOMY", 126, 132], ["mandibles", "ANATOMY", 134, 143], ["toothrows", "ANATOMY", 145, 154], ["wings", "ANATOMY", 155, 160], ["fruit cuticles", "ANATOMY", 170, 184], ["seeds", "ANATOMY", 190, 195], ["mandibles", "TISSUE", 134, 143], ["crania, mandibles", "PROBLEM", 126, 143], ["elytra", "TREATMENT", 162, 168], ["mandibles", "ANATOMY", 134, 143], ["fruit cuticles", "OBSERVATION", 170, 184]]], ["Undigested remains of vertebrates were identifiedby comparison with reference collections of specimens from the study area (Marassi and Biancardi 2002).", [["specimens", "ANATOMY", 93, 102], ["reference collections of specimens", "TEST", 68, 102], ["the study area", "TEST", 108, 122]]], ["Fruit consumption wasdetermined based on the remains of undigested seeds and fruit cuticles.", [["Fruit", "ANATOMY", 0, 5], ["seeds", "ANATOMY", 67, 72], ["fruit cuticles", "ANATOMY", 77, 91], ["seeds", "ORGANISM_SUBDIVISION", 67, 72], ["fruit cuticles", "TISSUE", 77, 91], ["undigested seeds", "PROBLEM", 56, 72], ["undigested seeds", "OBSERVATION", 56, 72], ["fruit cuticles", "OBSERVATION", 77, 91]]], ["A referencecollection was used to identify seeds recovered from the samples (Genovesi et al. 1996).", [["samples", "ANATOMY", 68, 75], ["A referencecollection", "TREATMENT", 0, 21]]], ["Identification of invertebrates was carried outaccording to Zhang et al. (2005).Materials and MethodsThe biomasses of the different foods consumed by P. larvata weredetermined from the fresh mass of each food item.", [["P. larvata", "ORGANISM", 150, 160], ["P. larvata", "SPECIES", 150, 160], ["P. larvata", "SPECIES", 150, 160], ["Methods", "TREATMENT", 94, 101], ["biomasses", "OBSERVATION_MODIFIER", 105, 114], ["fresh", "OBSERVATION_MODIFIER", 185, 190], ["mass", "OBSERVATION", 191, 195]]], ["For each species of fruit consumed, weestimated biomass by 1st estimating the number of individual fruits consumed.", [["fruit", "ANATOMY", 20, 25], ["fruits", "ANATOMY", 99, 105], ["fruits", "ORGANISM_SUBDIVISION", 99, 105], ["fruit consumed", "OBSERVATION", 20, 34]]], ["This was doneby determining the mean number of seeds in fruits of each species collected directly fromparent plants.", [["fruits", "ANATOMY", 56, 62], ["fruits", "ORGANISM_SUBDIVISION", 56, 62], ["each species", "PROBLEM", 66, 78]]], ["These values were used to determine the number of fruits represented in eachfecal sample, after which we estimated biomass of fruit consumed based on field measurementsof masses of fruits (Silva et al. 2005).", [["fruits", "ANATOMY", 50, 56], ["eachfecal sample", "ANATOMY", 72, 88], ["fruit", "ANATOMY", 126, 131], ["fruits", "ANATOMY", 181, 187], ["fruits", "ORGANISM_SUBDIVISION", 50, 56], ["fruits", "ORGANISM_SUBDIVISION", 181, 187], ["These values", "TEST", 0, 12], ["biomass", "OBSERVATION_MODIFIER", 115, 122]]], ["Forunidentified seeds, we calculated biomass of fruit based on the mean masses of theidentified fruits in the diet.", [["fruit", "ANATOMY", 48, 53], ["fruits", "ANATOMY", 96, 102], ["fruits", "ORGANISM_SUBDIVISION", 96, 102], ["Forunidentified seeds", "PROBLEM", 0, 21], ["seeds", "OBSERVATION_MODIFIER", 16, 21], ["biomass", "OBSERVATION_MODIFIER", 37, 44]]], ["The biomasses consumed from 2 prey items (ferret-badgers andpheasants) were assigned based on a feeding trial (Revillaand Palomares 2002) conducted with 3 civets captured from the study population.", [["biomasses", "ANATOMY", 4, 13], ["ferret", "ORGANISM", 42, 48], ["ferret", "SPECIES", 42, 48], ["The biomasses", "TREATMENT", 0, 13], ["a feeding trial (Revillaand Palomares", "TREATMENT", 94, 131]]], ["For other identified vertebrate prey, we assumed that they were fullyconsumed by civets and biomass was estimated using mean body masses for these species.", [["body masses", "ANATOMY", 125, 136], ["body", "ORGANISM_SUBDIVISION", 125, 129], ["mean body masses", "PROBLEM", 120, 136], ["these species", "PROBLEM", 141, 154], ["vertebrate prey", "OBSERVATION", 21, 36]]], ["Forunidentified animal prey, we assigned the mean mass of the different species identified fromthe same taxonomic group.", [["the mean mass", "PROBLEM", 41, 54], ["the different species", "PROBLEM", 58, 79], ["mass", "OBSERVATION", 50, 54], ["taxonomic group", "OBSERVATION", 104, 119]]], ["Based on the results of feeding trials, the fresh biomasses ofleaves and cortexes were assigned values of twice their dry mass in feces.Materials and MethodsIn addition to collecting fecal samples, we used the remains of recently consumed prey tocharacterize the diet of the study population.", [["biomasses", "ANATOMY", 50, 59], ["cortexes", "ANATOMY", 73, 81], ["feces", "ANATOMY", 130, 135], ["fecal samples", "ANATOMY", 183, 196], ["feces", "ORGANISM_SUBDIVISION", 130, 135], ["fecal samples", "ORGANISM_SUBSTANCE", 183, 196], ["feeding trials", "TREATMENT", 24, 38], ["the fresh biomasses ofleaves", "TREATMENT", 40, 68], ["their dry mass in feces", "PROBLEM", 112, 135], ["Methods", "TREATMENT", 150, 157], ["collecting fecal samples", "TEST", 172, 196], ["the study population", "TREATMENT", 271, 291], ["dry", "OBSERVATION_MODIFIER", 118, 121], ["mass", "OBSERVATION", 122, 126], ["feces", "OBSERVATION", 130, 135], ["fecal", "ANATOMY", 183, 188]]], ["Fresh foraging sites were identifiedsystematically by walking the 20 transects.", [["sites", "ANATOMY", 15, 20], ["Fresh foraging sites", "PROBLEM", 0, 20], ["foraging sites", "OBSERVATION", 6, 20]]], ["We also searched for fresh foraging sites usingradiotracking data collected as part of a concurrent study of civet behavior and by lookingfor civet paw prints and the fresh remains of prey whenever we walked through the studysite.", [["a concurrent study", "TEST", 87, 105]]], ["At the beginning of the study (May and June 2004), identification of paw prints andfresh food remains was achieved by comparison with a reference collection during feedingtrials conducted with 3 civets captured from the study population.", [["paw", "ORGANISM_SUBDIVISION", 69, 72], ["the study", "TEST", 20, 29], ["paw prints andfresh food", "TREATMENT", 69, 93], ["3 civets", "TREATMENT", 193, 201], ["the study population", "TEST", 216, 236], ["paw", "ANATOMY", 69, 72]]], ["However, because civetsusually swallow animals and some fruits whole, the calculation of biomass at fresh foragingsites was difficult.", [["fruits", "ANATOMY", 56, 62], ["fruits", "ORGANISM_SUBDIVISION", 56, 62]]], ["Thus, for these sites, we present only the number of individualsidentified and the frequency of occurrence for the same or taxonomically similar fooditems.Materials and MethodsFor analyses of both fecal samples and foraging sites, dietary composition was expressed asthe frequency of occurrence (FO = [number of the same species or taxonomic group \u00d7 100]/[total number of feces or foraging sites sampled]) and as the percentage of fresh biomassintake (PB = [ingested biomass of the same species or taxonomic group \u00d7 100]/[total biomassconsumed]\u2014Reynolds and Aebischer 1991; Rosalino et al. 2005).Materials and MethodsEstimating food availability.\u2014In order to examine relationships betweendietary variation and food availability, the abundances of the 2 main food items ofcivets\u2014fruit and small mammals\u2014were evaluated (Wang1987; Wang and Fuller 2003).", [["fecal samples", "ANATOMY", 197, 210], ["fecal samples", "MULTI-TISSUE_STRUCTURE", 197, 210], ["feces", "ORGANISM_SUBDIVISION", 372, 377], ["Methods", "TREATMENT", 169, 176], ["analyses", "TEST", 180, 188], ["both fecal samples", "TEST", 192, 210], ["foraging sites", "TREATMENT", 215, 229], ["taxonomic group \u00d7", "TREATMENT", 332, 349], ["taxonomic group \u00d7", "TREATMENT", 498, 515], ["fecal", "ANATOMY", 197, 202], ["small", "OBSERVATION_MODIFIER", 788, 793]]], ["Based on aprevious vegetation survey (Song and Liu 1999) andthe experience of local trappers, 15 species of wild fruit plants used by civets wereidentified and surveyed in 2004; based on our 2004 analyses, an additional 6 species weresurveyed in 2005.", [["fruit", "SPECIES", 113, 118], ["local trappers", "PROBLEM", 78, 92], ["vegetation", "OBSERVATION", 19, 29]]], ["These species contributed >85% of the biomass of wild fruits in thediet of P. larvata.", [["fruits", "ANATOMY", 54, 60], ["fruits", "ORGANISM_SUBDIVISION", 54, 60], ["P. larvata", "ORGANISM", 75, 85], ["P. larvata", "SPECIES", 75, 85], ["P. larvata", "SPECIES", 75, 85], ["These species", "TEST", 0, 13], ["wild fruits", "OBSERVATION", 49, 60]]], ["Availability of cultivated fruits (10 species surveyedin 2004 and 11 surveyed in 2005) also was evaluated.", [["fruits", "ANATOMY", 27, 33], ["fruits", "ORGANISM_SUBDIVISION", 27, 33], ["cultivated fruits", "PROBLEM", 16, 33]]], ["Distribution and fruit production ofall species were surveyed along the 20 transects described above (Fig. 1); during the fruiting season, transects were surveyed every 2weeks, at the same time as fecal samples were collected.", [["fecal samples", "ANATOMY", 197, 210], ["fecal samples", "ORGANISM_SUBSTANCE", 197, 210], ["fruit production ofall species", "PROBLEM", 17, 47], ["fecal samples", "TEST", 197, 210], ["fruit production", "OBSERVATION", 17, 33], ["ofall species", "OBSERVATION", 34, 47]]], ["Using the estimated biomass offruits in each habitat, we calculated the availability (g/m2) of wild fruits,cultivated fruits, and all fruits for every month of the year.Materials and MethodsWang (1987) suggested that once a civet finds a treewith many mature fruits, it will repeatedly visit that foraging site.", [["fruits", "ANATOMY", 100, 106], ["fruits", "ANATOMY", 118, 124], ["fruits", "ANATOMY", 134, 140], ["fruits", "ANATOMY", 259, 265], ["fruits", "ORGANISM_SUBDIVISION", 100, 106], ["fruits", "ORGANISM_SUBDIVISION", 118, 124], ["fruits", "ORGANISM_SUBDIVISION", 134, 140], ["fruits", "ORGANISM_SUBDIVISION", 259, 265], ["the estimated biomass offruits", "TREATMENT", 6, 36], ["biomass", "OBSERVATION_MODIFIER", 20, 27]]], ["Therefore, wemonitored 20 fruiting trees (10 Ilex macrocarpa, 5 Dendrobenthamiacapitata, and 5 D. japonica) to determine the frequency offoraging visits to each tree and the relationship between the number of visits and the totalfruit biomass of the tree.", [["D. japonica", "ORGANISM", 95, 106], ["Ilex macrocarpa", "SPECIES", 45, 60], ["D. japonica", "SPECIES", 95, 106], ["Ilex macrocarpa", "SPECIES", 45, 60], ["D. japonica", "SPECIES", 95, 106], ["Ilex macrocarpa", "TREATMENT", 45, 60], ["5 Dendrobenthamiacapitata", "TREATMENT", 62, 87], ["tree", "ANATOMY_MODIFIER", 250, 254]]], ["When a focal tree produced mature fruits, the total number offruits on the tree and the number eaten (estimated from pericarp remains on the ground) werecounted.", [["fruits", "ANATOMY", 34, 40], ["pericarp", "ANATOMY", 117, 125], ["fruits", "ORGANISM_SUBDIVISION", 34, 40], ["tree", "ORGANISM_SUBDIVISION", 75, 79], ["pericarp", "ORGANISM_SUBDIVISION", 117, 125], ["focal", "OBSERVATION_MODIFIER", 7, 12], ["tree", "OBSERVATION_MODIFIER", 13, 17], ["mature", "OBSERVATION_MODIFIER", 27, 33], ["fruits", "OBSERVATION_MODIFIER", 34, 40]]], ["Pericarp remains were identified by comparison with a reference collection madefrom feeding trials involving captive civets.", [["a reference collection madefrom feeding trials", "TREATMENT", 52, 98], ["captive civets", "TREATMENT", 109, 123]]], ["If P. larvata had eatenfruits from a given tree, we removed all pericarp remains on the ground near that tree toensure that only fresh pericarp remains were counted on the next survey.", [["pericarp", "ANATOMY", 64, 72], ["pericarp", "ANATOMY", 135, 143], ["P. larvata", "ORGANISM", 3, 13], ["pericarp", "TISSUE", 64, 72], ["pericarp", "ORGANISM_SUBDIVISION", 135, 143], ["P. larvata", "SPECIES", 3, 13], ["P. larvata", "SPECIES", 3, 13], ["all pericarp", "TREATMENT", 60, 72], ["fresh pericarp", "PROBLEM", 129, 143], ["fresh pericarp", "OBSERVATION", 129, 143]]], ["Trees wereresurveyed every day until no fruits remained on the tree.", [["fruits", "ANATOMY", 40, 46], ["fruits", "ORGANISM_SUBDIVISION", 40, 46]]], ["When no fresh pericarp remainswere found on the ground, we assumed that civets had stopped foraging at that tree.", [["pericarp", "ANATOMY", 14, 22], ["pericarp", "ORGANISM_SUBDIVISION", 14, 22], ["fresh pericarp", "PROBLEM", 8, 22], ["tree", "ANATOMY_MODIFIER", 108, 112]]], ["At thispoint, the final number of fruits remaining on the tree was counted.", [["fruits", "ANATOMY", 34, 40], ["fruits", "ORGANISM_SUBDIVISION", 34, 40], ["final", "OBSERVATION_MODIFIER", 18, 23], ["number", "OBSERVATION_MODIFIER", 24, 30], ["fruits", "OBSERVATION_MODIFIER", 34, 40], ["remaining", "OBSERVATION_MODIFIER", 41, 50], ["tree", "ANATOMY_MODIFIER", 58, 62]]], ["The total and finalfruit biomass for each tree was calculated based on the mean mass of fruits of thatspecies.Materials and MethodsSmall mammal populations in each habitat type were monitored by livetrapping following theprotocol of Sun (2001).", [["fruits", "ANATOMY", 88, 94], ["fruits", "ORGANISM_SUBDIVISION", 88, 94], ["The total and finalfruit biomass", "TREATMENT", 0, 32], ["the mean mass of fruits of thatspecies", "PROBLEM", 71, 109], ["Materials", "TREATMENT", 110, 119], ["Methods", "TREATMENT", 124, 131], ["Small mammal populations", "PROBLEM", 131, 155], ["total", "OBSERVATION_MODIFIER", 4, 9], ["mass", "OBSERVATION", 80, 84], ["Small", "OBSERVATION_MODIFIER", 131, 136], ["mammal", "OBSERVATION_MODIFIER", 137, 143], ["populations", "OBSERVATION_MODIFIER", 144, 155]]], ["Ten grids (Fig. 1) were sampled, each consisting of an 8 \u00d7 8 array of trappingstations (n = 64 traps per grid); each row and column of traps wasseparated by 15 m, resulting in a total grid area of 1.4 ha (including a boundary strip of7.5 m).", [["trappingstations", "TEST", 70, 86], ["a total grid area", "TEST", 176, 193], ["a boundary strip", "TEST", 215, 231]]], ["We baited traps with cultivated peanut (Arachis hypogaea) duringthe evening and checked them the following morning.", [["peanut", "ORGANISM_SUBDIVISION", 32, 38], ["Arachis hypogaea", "ORGANISM", 40, 56], ["peanut", "SPECIES", 32, 38], ["Arachis hypogaea", "SPECIES", 40, 56], ["peanut", "SPECIES", 32, 38], ["Arachis hypogaea", "SPECIES", 40, 56]]], ["Each individual captured was marked,identified to species, and its body mass, sex, and reproductive condition were determined.The total biomass (g/m2) of each species in each habitat type was estimated fromthe biomass of individuals captured during each 2-day trapping session.Materials and MethodsStatistical analyses.\u2014Data are presented as means \u00b1 1 SEunless otherwise stated; the specific statistical tests used are indicated in the text.", [["body", "ANATOMY", 67, 71], ["body", "ORGANISM_SUBDIVISION", 67, 71], ["its body mass", "PROBLEM", 63, 76], ["reproductive condition", "PROBLEM", 87, 109], ["The total biomass (g/m2", "TREATMENT", 126, 149], ["each species", "PROBLEM", 154, 166], ["MethodsStatistical analyses", "TEST", 291, 318], ["the specific statistical tests", "TEST", 379, 409], ["marked", "OBSERVATION_MODIFIER", 29, 35], ["body", "OBSERVATION_MODIFIER", 67, 71], ["mass", "OBSERVATION", 72, 76], ["total", "OBSERVATION_MODIFIER", 130, 135], ["biomass", "OBSERVATION_MODIFIER", 136, 143]]], ["SPSS13.0 (SPSS 2003) was used for all statisticalanalyses.", [["all statisticalanalyses", "PROBLEM", 34, 57]]], ["Because the data were not normally distributed, non-parametric tests were used toexamine dietary variation of civets.", [["the data", "TEST", 8, 16], ["non-parametric tests", "TEST", 48, 68]]], ["Variation in the frequency of occurrence of each preytype in the feces of P. larvata was analyzed across months and habitatsusing Kruskal-Wallis tests.", [["feces", "ANATOMY", 65, 70], ["feces", "ORGANISM_SUBDIVISION", 65, 70], ["P. larvata", "ORGANISM", 74, 84], ["P. larvata", "SPECIES", 74, 84], ["P. larvata", "SPECIES", 74, 84], ["P. larvata", "TREATMENT", 74, 84], ["Kruskal-Wallis tests", "TEST", 130, 150]]], ["This index has been shown to be useful as anindicator of short-term dietary diversity (Revilla andPalomares 2002).", [["This index", "TEST", 0, 10]]], ["For each fecal sample, H\u2032 was calculated usingthe proportion of individuals of each species present in the sample.", [["fecal sample", "ANATOMY", 9, 21], ["each fecal sample", "TEST", 4, 21], ["each species", "PROBLEM", 79, 91]]], ["Variation inH\u2032 was analyzed using a general linear model, with H\u2032 asthe dependent variable and month, year, and habitat as independent variables.", [["H\u2032", "DNA", 12, 14]]], ["To assess theinfluence of prey type on diversity, diversity values also were calculated using theproportion of ingested biomass represented by each prey type in each month.", [["diversity values", "TEST", 50, 66]]], ["A multipleregression was performed with H\u2032 as the dependent variable and theproportion of ingested biomass of each prey type (values subjected angular transformation)as independent variables.Materials and MethodsTo explore temporal variation in diet in greater detail, we grouped months of the yearaccording to dietary composition using a hierarchical cluster analysis (using squaredEuclidean distances).", [["A multipleregression", "TEST", 0, 20], ["Methods", "TREATMENT", 205, 212], ["a hierarchical cluster analysis", "TREATMENT", 337, 368], ["ingested biomass", "OBSERVATION", 90, 106], ["angular transformation", "OBSERVATION", 143, 165], ["temporal", "OBSERVATION_MODIFIER", 223, 231], ["variation", "OBSERVATION_MODIFIER", 232, 241]]], ["Multivariate analyses of variance (MANOVAs) were then performed usingthe grouping classifications obtained from the cluster analyses as an independent variableand the angular-transformed biomass values for each prey type as dependent variables.", [["grouping classifications", "TEST", 73, 97], ["angular", "OBSERVATION_MODIFIER", 167, 174]]], ["Todetermine the most important trophic resources, the significance of the contribution of eachprey type to the final multivariate model was analyzed, after which the relationship betweenabundances of different prey types was examined using Spearman correlation coefficients.Materials and MethodsPatterns of temporal and spatial variability in the abundance of fruits and small mammalswere analyzed with Kruskal-Wallis tests.", [["fruits", "ANATOMY", 360, 366], ["fruits", "ORGANISM_SUBDIVISION", 360, 366], ["Todetermine", "TREATMENT", 0, 11], ["temporal and spatial variability", "PROBLEM", 307, 339], ["Kruskal-Wallis tests", "TEST", 403, 423], ["temporal", "OBSERVATION_MODIFIER", 307, 315], ["spatial", "OBSERVATION_MODIFIER", 320, 327], ["variability", "OBSERVATION_MODIFIER", 328, 339], ["abundance", "OBSERVATION_MODIFIER", 347, 356], ["fruits", "OBSERVATION", 360, 366], ["small", "OBSERVATION_MODIFIER", 371, 376]]], ["A general linear model, with the total fruit biomass as thedependent variable and tree species and foraging by civets as independent variables, wasused to analyze differences in the total fruit biomass of trees at which civets fed versustrees at which no feeding occurred.", [["A general linear model", "PROBLEM", 0, 22], ["the total fruit biomass", "PROBLEM", 29, 52], ["tree species", "PROBLEM", 82, 94], ["linear model", "OBSERVATION_MODIFIER", 10, 22], ["total", "OBSERVATION_MODIFIER", 33, 38], ["fruit biomass", "OBSERVATION", 39, 52], ["tree species", "OBSERVATION", 82, 94]]], ["The frequency of foraging at each fruiting tree and itsrelationship to total and final fruit biomass were analyzed using regression analyses.Variation in the number of fecal samples collected in different months and habitats wereanalyzed using a general linear model, with the number of fecal samples as the dependentvariable and month and habitat as independent variables.", [["fecal samples", "ANATOMY", 168, 181], ["fecal samples", "ANATOMY", 287, 300], ["fruiting tree", "MULTI-TISSUE_STRUCTURE", 34, 47], ["fecal samples", "ORGANISM_SUBSTANCE", 168, 181], ["regression analyses", "TEST", 121, 140], ["fecal samples", "TEST", 168, 181], ["a general linear model", "TREATMENT", 244, 266], ["foraging", "OBSERVATION_MODIFIER", 17, 25], ["fruiting tree", "OBSERVATION", 34, 47], ["fruit biomass", "OBSERVATION", 87, 100], ["number", "OBSERVATION_MODIFIER", 158, 164], ["fecal samples", "OBSERVATION", 168, 181]]], ["To determine whether habitatswitching occurred, Spearman correlation analyses were used to assess the relationshipbetween the proportion of each food item ingested by civets and the habitats in whichforaging occurred.ResultsDiet composition and variation.\u2014A total of 1,023 fecal samples wascollected and 786 fresh foraging sites were detected.", [["fecal samples", "ANATOMY", 273, 286], ["fecal samples", "CANCER", 273, 286], ["Spearman correlation analyses", "TEST", 48, 77], ["fecal samples", "TEST", 273, 286], ["fresh foraging sites", "PROBLEM", 308, 328], ["total", "OBSERVATION_MODIFIER", 258, 263]]], ["Of these, 203 fecal samples and 218foraging sites were sampled between July and November 2004, whereas 820 fecal samples and568 foraging sites were detected between April 2005 and May 2006.", [["fecal samples", "ANATOMY", 14, 27], ["sites", "ANATOMY", 44, 49], ["fecal samples", "ANATOMY", 107, 120], ["sites", "ANATOMY", 137, 142], ["fecal samples", "CANCER", 14, 27], ["fecal samples", "CANCER", 107, 120], ["fecal samples", "TEST", 14, 27], ["foraging sites", "TEST", 35, 49], ["fecal samples", "TEST", 107, 120], ["foraging sites", "TEST", 128, 142]]], ["No civet feces andforaging sites were found in the coniferous plantation forest and so this habitat type wasnot included in subsequent analyses.", [["civet feces andforaging sites", "PROBLEM", 3, 32], ["the coniferous plantation forest", "TREATMENT", 47, 79], ["coniferous", "OBSERVATION_MODIFIER", 51, 61], ["plantation forest", "OBSERVATION", 62, 79]]], ["The distribution of fecal samples and foraging sitesdiffered among habitat types (\u03c72 = 110.53, d.f.= 4,P < 0.001), with the highest percentage in LF and the lowestpercentage in BFP (Fig. 2).ResultsA total of 2,235 food items was detected in feces; the mean \u00b1 1 SD numberof food items per fecal sample was 2.2 \u00b1 1.3 (range 1\u201310).", [["fecal samples", "ANATOMY", 20, 33], ["fecal sample", "ANATOMY", 288, 300], ["fecal samples", "ORGANISM_SUBSTANCE", 20, 33], ["feces", "ORGANISM_SUBDIVISION", 241, 246], ["BFP", "PROTEIN", 177, 180], ["fecal samples", "TEST", 20, 33], ["P", "TEST", 103, 104], ["the mean", "TEST", 248, 256], ["fecal sample", "TEST", 288, 300], ["distribution", "OBSERVATION_MODIFIER", 4, 16], ["fecal samples", "OBSERVATION", 20, 33], ["LF", "ANATOMY", 146, 148], ["fecal", "ANATOMY", 288, 293]]], ["Sixty-seven species of wildfruits, 9 species of cultivated fruits, at least 50 species of vertebrates, and multipleinvertebrates were found in civet scats (Appendix I).", [["fruits", "ANATOMY", 59, 65], ["fruits", "ORGANISM_SUBDIVISION", 59, 65], ["fruits", "SPECIES", 59, 65], ["cultivated fruits", "PROBLEM", 48, 65], ["multipleinvertebrates", "PROBLEM", 107, 128], ["Appendix", "ANATOMY", 156, 164]]], ["Animal prey included ferret-badgers(M. moschata), squirrels, rodents, shrews, birds, reptiles, amphibians,snails, crabs, and at least 4 different orders of insects.", [["crabs", "ANATOMY", 114, 119], ["ferret", "ORGANISM", 21, 27], ["M. moschata", "ORGANISM", 36, 47], ["squirrels", "ORGANISM", 50, 59], ["shrews", "ORGANISM_SUBDIVISION", 70, 76], ["birds", "ORGANISM", 78, 83], ["crabs", "ORGANISM_SUBDIVISION", 114, 119], ["ferret", "SPECIES", 21, 27], ["M. moschata", "SPECIES", 36, 47], ["ferret-badgers", "SPECIES", 21, 35], ["M. moschata", "SPECIES", 36, 47]]], ["Wild fruits were the most commonfood items, accounting for more than 60% of the materials in fecal samples and 47% of theingested biomass.", [["fruits", "ANATOMY", 5, 11], ["fecal samples", "ANATOMY", 93, 106], ["fruits", "ORGAN", 5, 11], ["fecal samples", "ORGANISM_SUBSTANCE", 93, 106], ["fecal samples", "TEST", 93, 106], ["fecal", "ANATOMY", 93, 98]]], ["This was followed by small mammals, which represented 29% and 30% of thematerials in fecal samples and ingested biomass, respectively.", [["fecal samples", "ANATOMY", 85, 98], ["fecal samples", "ORGANISM_SUBSTANCE", 85, 98], ["fecal samples", "TEST", 85, 98], ["small mammals", "OBSERVATION", 21, 34], ["fecal", "ANATOMY", 85, 90], ["ingested biomass", "OBSERVATION", 103, 119]]], ["Invertebrates accounted forabout 26% of the materials in fecal samples and 0.5% of the ingested biomass.ResultsAs determined from fecal samples, the diet of civets was characterized by marked seasonal,annual, and habitat variation that affected all prey types (Fig. 3).", [["fecal samples", "ANATOMY", 57, 70], ["fecal samples", "ANATOMY", 130, 143], ["fecal samples", "ORGANISM_SUBSTANCE", 57, 70], ["fecal samples", "ORGANISM_SUBSTANCE", 130, 143], ["fecal samples", "TEST", 57, 70], ["ResultsAs", "TEST", 104, 113], ["fecal samples", "TEST", 130, 143], ["fecal", "ANATOMY", 57, 62], ["fecal", "ANATOMY", 130, 135], ["marked", "OBSERVATION_MODIFIER", 185, 191], ["habitat variation", "OBSERVATION", 213, 230]]], ["Consumption of wild fruits varied significantly among years, months, andhabitats (Fig. 3; Table1).", [["fruits", "ANATOMY", 20, 26], ["fruits", "ORGANISM_SUBDIVISION", 20, 26]]], ["Consumption of small mammals, birds, and cortexes also varied among years andhabitats; although there was significant monthly variation in the consumption of mammals andcortexes, consumption of birds did not vary significantly among months (Fig. 3; Table 1).ResultsFresh foraging sites were found almost exclusively (99% of 786 sites) in areas withfruiting trees, suggesting that wild and cultivated fruits are an important food source.Wild and cultivated fruits accounted for more than 84% and 15%, respectively, of the fooditems consumed at foraging sites (Appendix I).", [["fruits", "ANATOMY", 400, 406], ["fruits", "ANATOMY", 456, 462], ["fruits", "ORGANISM_SUBDIVISION", 400, 406], ["fruits", "ORGANISM_SUBDIVISION", 456, 462], ["small mammals", "OBSERVATION", 15, 28], ["significant", "OBSERVATION_MODIFIER", 106, 117], ["foraging sites", "OBSERVATION", 271, 285], ["Appendix", "ANATOMY", 559, 567]]], ["Because some wild fruits and animal preyleave no remains after being eaten, some prey types were difficult to detect at freshforaging sites.", [["fruits", "ANATOMY", 18, 24], ["fruits", "ORGANISM_SUBDIVISION", 18, 24], ["freshforaging sites", "MULTI-TISSUE_STRUCTURE", 120, 139], ["some wild fruits", "PROBLEM", 8, 24], ["fruits", "OBSERVATION_MODIFIER", 18, 24]]], ["Only 4 species of animal prey\u2014Edward's Leopoldamys (Leopoldamysedwardsi), Temminck's tragopan (Tragopan temminckii), and 2species of frog\u2014were found to have been eaten, whereas 32 species of wild fruits, and all 9species of cultivated fruits were consumed.", [["fruits", "ANATOMY", 196, 202], ["fruits", "ANATOMY", 235, 241], ["Temminck's tragopan", "ORGANISM", 74, 93], ["Tragopan temminckii", "ORGANISM", 95, 114], ["fruits", "ORGANISM_SUBDIVISION", 196, 202], ["fruits", "ORGANISM_SUBDIVISION", 235, 241], ["Tragopan temminckii", "SPECIES", 95, 114], ["fruits", "SPECIES", 196, 202], ["fruits", "SPECIES", 235, 241], ["Tragopan temminckii", "SPECIES", 95, 114], ["Edward's Leopoldamys (Leopoldamysedwardsi)", "TREATMENT", 30, 72], ["Temminck's tragopan", "TREATMENT", 74, 93], ["Tragopan temminckii", "TREATMENT", 95, 114], ["wild fruits", "PROBLEM", 191, 202], ["4 species", "OBSERVATION_MODIFIER", 5, 14]]], ["Thus, only variability in consumption of wildand cultivated fruits was analyzed.", [["fruits", "ANATOMY", 60, 66], ["fruits", "ORGANISM_SUBDIVISION", 60, 66], ["wildand cultivated fruits", "TREATMENT", 41, 66], ["variability", "OBSERVATION_MODIFIER", 11, 22]]], ["Consumption of wild fruits varied significantly amongyears, months, and habitats (Table 1).", [["fruits", "ANATOMY", 20, 26], ["fruits", "ORGANISM_SUBDIVISION", 20, 26]]], ["Cultivatedfruits only occurred in FL, and the consumption of this food category also varied amongyears and months (Table 1).ResultsDiet diversity and key food resources.\u2014Dietary diversity, measured asH\u2032, differed significantly across years, months, and habitats(F = 2.576, d.f= 73, 949, P < 0.001;Fig. 4).", [["FL", "CHEMICAL", 34, 36], ["Cultivatedfruits", "TEST", 0, 16], ["diversity", "OBSERVATION", 178, 187]]], ["The main effects of year, month, and habitatwere each significant (F= 4.136, d.f. = 2,P = 0.016; F= 4.968, d.f. = 11,P < 0.001; and F= 14.034, d.f.= 4,P < 0.001, respectively), but no significant interaction effects weredetected.", [["d.f.", "TEST", 77, 81], ["P", "TEST", 86, 87], ["d.f.", "TEST", 107, 111], ["F", "TEST", 132, 133], ["d.f.", "TEST", 143, 147], ["P", "TEST", 151, 152], ["significant interaction effects", "PROBLEM", 184, 215], ["main", "OBSERVATION_MODIFIER", 4, 8], ["no", "UNCERTAINTY", 181, 183], ["significant", "OBSERVATION_MODIFIER", 184, 195], ["interaction", "OBSERVATION", 196, 207]]], ["Intra-sample diversity (e.g., H\u2032 within years) was significantlylower in 2006 than in 2004 and 2005 (least square difference [LSD], F=17.569, d.f.= 2, 1,020, P < 0.001; Fig. 4).", [["LSD", "TEST", 126, 129], ["P", "TEST", 158, 159], ["diversity", "OBSERVATION", 13, 22]]], ["In all habitats and years, diversity was higher between July andDecember (average H\u2032 > 0.32 in all months) than between January and May(average H\u2032 < 0.18 in all months), whereas June (H\u2032 \u20140.23) was not significantly different from any other month (LSD, F= 6.372,d.f. = 11, 1,011, P < 0.001).", [["H\u2032", "TEST", 82, 84]]], ["Diet diversity wassignificantly lower in FL than in other habitat types (LSD, F = 8.384,d.f. = 4, 1,018, P < 0.001); the remaining habitatsdid not differ significantly from each other (Fig.4).ResultsTo determine the influence of prey type on monthly diversity, we included all 10 foodcategories in multiple regression analyses of the factors influencing H\u2032.From this initial model, only wild fruits, cultivated fruits, small mammals, birds, andsnakes were retained in the final model, in which H\u2032 = 12.811 arcsine(wildfruits) + 13.049 arcsine(cultivated fruits) + 12.873 arcsine(small mammals) + 11.946arcsine(birds) + 13.678 arcsine(snakes) \u2212 10.748 (adjusted R2 =0.867, F= 13.997, d.f. = 9, 9, P <0.001).ResultsThe simplest classification obtained from the cluster analyses (2 temporal groups) wassignificant (MANOVA Pillai's trace = 0.87, F= 8.38, P <0.001).", [["fruits", "ANATOMY", 392, 398], ["fruits", "ANATOMY", 411, 417], ["fruits", "ANATOMY", 554, 560], ["H\u2032", "GENE_OR_GENE_PRODUCT", 354, 356], ["fruits", "ORGANISM_SUBDIVISION", 392, 398], ["fruits", "ORGANISM_SUBDIVISION", 411, 417], ["birds", "ORGANISM", 434, 439], ["fruits", "ORGANISM_SUBDIVISION", 554, 560], ["H\u2032", "PROTEIN", 354, 356], ["P", "TEST", 105, 106], ["small mammals", "PROBLEM", 419, 432], ["H\u2032", "TEST", 494, 496], ["wildfruits", "TEST", 514, 524], ["cultivated fruits", "TEST", 543, 560], ["arcsine", "TEST", 571, 578], ["arcsine", "TEST", 602, 609], ["arcsine", "TEST", 626, 633], ["snakes", "TEST", 634, 640], ["R2", "TEST", 661, 663], ["F", "TEST", 672, 673], ["d.f.", "TEST", 683, 687], ["P", "TEST", 696, 697], ["the cluster analyses", "TEST", 755, 775], ["MANOVA Pillai's trace", "TEST", 812, 833], ["F", "TEST", 842, 843], ["P", "TEST", 851, 852], ["lower", "OBSERVATION_MODIFIER", 32, 37], ["small", "OBSERVATION_MODIFIER", 419, 424], ["mammals", "OBSERVATION_MODIFIER", 425, 432]]], ["In order ofdecreasing importance, these were wild fruits, cultivated fruits, small mammals, and birds(F = 87.948\u201323.362, d.f. \u2014 1, 17, P< 0.001 in all cases).", [["fruits", "ANATOMY", 50, 56], ["fruits", "ANATOMY", 69, 75], ["fruits", "ORGANISM_SUBDIVISION", 50, 56], ["fruits", "ORGANISM_SUBDIVISION", 69, 75], ["cultivated fruits", "TEST", 58, 75], ["P", "TEST", 135, 136], ["small", "OBSERVATION_MODIFIER", 77, 82]]], ["Among the independent variables considered in our model,significant negative correlations were found between the prevalence of wild fruits and smallmammals (R = \u22120.761, n = 19, P <0.001), the prevalence of wild fruits and birds (R = \u22120.794,n = 19, P< 0.001), the prevalence of cultivatedfruits and small mammals (R= \u22120.635, n= 19,P= 0.003), and the prevalence of cultivated fruits and birds (R =\u22120.669, n= 19, P= 0.002).", [["fruits", "ANATOMY", 132, 138], ["smallmammals", "ANATOMY", 143, 155], ["fruits", "ANATOMY", 211, 217], ["fruits", "ANATOMY", 374, 380], ["fruits", "ORGANISM_SUBDIVISION", 132, 138], ["fruits", "ORGANISM_SUBDIVISION", 211, 217], ["fruits", "ORGANISM_SUBDIVISION", 374, 380], ["smallmammals", "TEST", 143, 155], ["R", "TEST", 157, 158], ["n", "TEST", 169, 170], ["P", "TEST", 177, 178], ["birds", "TEST", 222, 227], ["n", "TEST", 240, 241], ["P", "TEST", 248, 249], ["cultivatedfruits", "TEST", 277, 293], ["small mammals", "PROBLEM", 298, 311], ["cultivated fruits", "TEST", 363, 380], ["birds", "TEST", 385, 390], ["n", "TEST", 403, 404], ["P", "TEST", 410, 411], ["wild fruits", "OBSERVATION", 206, 217], ["small mammals", "OBSERVATION", 298, 311], ["cultivated fruits", "OBSERVATION", 363, 380]]], ["These resultsindicate that fruits characterize the diet of P. larvata between June andOctober, whereas small mammals and birds characterize the diet between November and May(Fig. 3).ResultsFood availability, use, and dietary switching.\u2014Abundance of fruit differedamong months (\u03c72 = 48.72, d.f. = 11, P< 0.001) and habitats (\u03c72= 18.75, d.f. = 4,P = 0.001) but not among years (\u03c72 = 3.19,d.f. = 2, P \u2014 0.074).", [["fruits", "ANATOMY", 27, 33], ["fruits", "ORGANISM_SUBDIVISION", 27, 33], ["P. larvata", "ORGANISM", 59, 69], ["P. larvata", "SPECIES", 59, 69], ["P. larvata", "SPECIES", 59, 69], ["habitats", "TEST", 314, 322], ["P", "TEST", 344, 345], ["P", "TEST", 396, 397], ["fruit differedamong", "OBSERVATION", 249, 268]]], ["Ingested biomass of fruits wascorrelated with availability of fruit (R \u2014 0.633, n= 95,P < 0.001).", [["fruits", "ANATOMY", 20, 26], ["fruits", "ORGANISM_SUBDIVISION", 20, 26], ["fruit", "ORGANISM_SUBDIVISION", 62, 67], ["fruit", "TEST", 62, 67], ["biomass", "OBSERVATION_MODIFIER", 9, 16], ["fruits wascorrelated", "OBSERVATION", 20, 40]]], ["Although no species of wild fruit were found in CFP andFL, similar results were obtained for the remaining habitats when only wild fruits wereconsidered (\u03c72 = 36.33, d.f.= 11, P < 0.001;\u03c72 = 33.85, d.f. = 4, P < 0.001; and x2 =1.92, df = 1, P = 0.166, for months, habitats, and years,respectively).", [["fruits", "ANATOMY", 131, 137], ["fruits", "ORGANISM_SUBDIVISION", 131, 137], ["CFP andFL", "PROTEIN", 48, 57], ["wild fruit", "PROBLEM", 23, 33], ["P", "TEST", 176, 177], ["d.f.", "TEST", 198, 202], ["P", "TEST", 208, 209], ["x2", "TEST", 223, 225], ["df", "TEST", 233, 235], ["P", "TEST", 241, 242], ["habitats", "TEST", 264, 272], ["no", "UNCERTAINTY", 9, 11]]], ["Ingested biomass of wild fruits also was correlated with their availability(R = 0.651, n \u2014 95, P < 0.001).Cultivated fruits were only present and consumed by civets in FL.", [["fruits", "ANATOMY", 25, 31], ["fruits", "ANATOMY", 117, 123], ["fruits", "ORGANISM_SUBDIVISION", 25, 31], ["fruits", "ORGAN", 117, 123], ["R", "TEST", 76, 77], ["P", "TEST", 95, 96], ["biomass", "OBSERVATION_MODIFIER", 9, 16], ["wild fruits", "OBSERVATION", 20, 31]]], ["Their availability wasgreater in 2004 than in 2005 (\u03c72 = 4.28, d.f. = 1,P = 0.039) and differed among months (\u03c72 = 16.62,d.f= 11, P= 0.020).", [["P", "TEST", 72, 73], ["d.f", "TEST", 121, 124], ["P", "TEST", 130, 131]]], ["Ingested biomass and availability ofcultivated fruits also were correlated with each other (R= 0.535,n = 95, P = 0.018).", [["fruits", "ANATOMY", 47, 53], ["fruits", "ORGANISM_SUBDIVISION", 47, 53], ["P", "TEST", 109, 110]]], ["Thirteen of 20 fruiting trees (7 of/. macrocarpa, and 3 each of Dendrobenthamia capitata andD. japonica) were used by P. larvata; the total fruitbiomass of trees at which civets fed was greater than that of the remaining trees, althoughthis difference was not significant (F \u2014 2.739, d.f. = 5,14, P= 0.063).", [["macrocarpa", "ORGANISM", 38, 48], ["Dendrobenthamia capitata", "ORGANISM", 64, 88], ["andD", "ORGANISM", 89, 93], ["japonica", "ORGANISM", 95, 103], ["P. larvata", "ORGANISM", 118, 128], ["Dendrobenthamia capitata", "SPECIES", 64, 88], ["japonica", "SPECIES", 95, 103], ["P. larvata", "SPECIES", 118, 128], ["macrocarpa", "SPECIES", 38, 48], ["Dendrobenthamia capitata", "SPECIES", 64, 88], ["japonica", "SPECIES", 95, 103], ["P. larvata", "SPECIES", 118, 128], ["macrocarpa", "TREATMENT", 38, 48], ["Dendrobenthamia capitata", "PROBLEM", 64, 88], ["the total fruitbiomass of trees", "PROBLEM", 130, 161], ["P", "TEST", 297, 298], ["greater", "OBSERVATION_MODIFIER", 186, 193]]], ["The frequency of foraging at a given fruiting tree waspositively correlated with the total fruit biomass for that tree (R = 0.548, n= 13, P= 0.043).", [["P", "TEST", 138, 139], ["fruit biomass", "OBSERVATION", 91, 104], ["tree", "ANATOMY_MODIFIER", 114, 118]]], ["Regression analyses of foragingfrequency on total fruit biomass indicated that trees should no longer be visited when thefinal fruit biomass drops below 4.5 kg per tree (R2 = 0.", [["Regression analyses", "TEST", 0, 19], ["foragingfrequency", "PROBLEM", 23, 40], ["total fruit biomass", "TREATMENT", 44, 63]]], ["341,F= 5.688, d.f.= 1, 11, P = 0.036).ResultsTwenty-two mammals (including 3 species of squirrels, 13 other rodents, 5 species ofinsectivores, and the ferret-badger) were trapped.", [["squirrels", "ORGANISM", 88, 97], ["ferret", "ORGANISM", 151, 157], ["ferret", "SPECIES", 151, 157], ["ferret-badger", "SPECIES", 151, 164], ["P", "TEST", 27, 28]]], ["The most frequently captured mammal wasEdward's Leopoldamys (L. edwardsi; 22% of captures), followed by thesulfur-bellied rat (Niviventer confucianus; 18% of captures); the leastfrequently captured mammal was the Asian red-cheeked squirrel (Dremomysrufigenis; 0.14% of captures).", [["L. edwardsi", "ORGANISM", 61, 72], ["rat", "ORGANISM", 122, 125], ["Niviventer confucianus", "ORGANISM", 127, 149], ["squirrel", "ORGANISM", 231, 239], ["L. edwardsi", "SPECIES", 61, 72], ["rat", "SPECIES", 122, 125], ["Niviventer confucianus", "SPECIES", 127, 149], ["squirrel", "SPECIES", 231, 239], ["L. edwardsi", "SPECIES", 61, 72], ["thesulfur-bellied rat", "SPECIES", 104, 125], ["Niviventer confucianus", "SPECIES", 127, 149], ["Asian red-cheeked squirrel", "SPECIES", 213, 239], ["Niviventer confucianus", "TREATMENT", 127, 149]]], ["The abundance of small mammals did not differsignificantly among months (\u03c72 = 8.145, d.f. = 11, P =0.700) and years (\u03c72 = 1.960, d.f= 1, P = 0.162), but diddiffer significantly among habitats (\u03c72 = 52.79, d.f. = 4,P < 0.001), with rank based on abundance (highest to lowest) being PF> SLF > LF > FL > BFP.", [["SLF", "PROTEIN", 285, 288], ["LF", "PROTEIN", 291, 293], ["FL", "PROTEIN", 296, 298], ["BFP", "PROTEIN", 301, 304], ["small mammals", "PROBLEM", 17, 30], ["P", "TEST", 96, 97], ["P", "TEST", 137, 138], ["P", "TEST", 214, 215], ["abundance", "TEST", 245, 254], ["PF", "TEST", 281, 283], ["SLF", "TEST", 285, 288], ["small mammals", "OBSERVATION", 17, 30]]], ["The biomass of small mammals ingested by P.larvata was negatively correlated with their abundance and fruit availabilityacross months (R = \u20140.714, n= 14, P=0.004, and R = \u22120.601, n= 19, P = 0.007,respectively) and positively correlated with their abundance across habitat types(R = 0.900, n = 5, P = 0.037).", [["P.larvata", "CHEMICAL", 41, 50], ["P.larvata", "GENE_OR_GENE_PRODUCT", 41, 50], ["R", "TEST", 135, 136], ["n", "TEST", 147, 148], ["P", "TEST", 154, 155], ["R", "TEST", 167, 168], ["\u2212", "TEST", 171, 172], ["n", "TEST", 179, 180], ["P", "TEST", 186, 187], ["R", "TEST", 278, 279], ["P", "TEST", 296, 297], ["biomass", "OBSERVATION_MODIFIER", 4, 11], ["small mammals", "OBSERVATION", 15, 28]]], ["Thehighest consumption of mammals occurred when both small mammals and fruits were at theirlowest abundance (Fig. 3), with abundance of fruitsbeing \u226420 g/m2 (Fig. 5).", [["fruits", "ANATOMY", 71, 77], ["fruits", "ORGANISM_SUBDIVISION", 71, 77], ["small", "OBSERVATION_MODIFIER", 53, 58], ["mammals", "OBSERVATION_MODIFIER", 59, 66]]], ["When fruitconsumption by civets was analyzed as a function of small mammal abundance, no significanteffect was detected (R= 0.199, n = 70, P= 0.099).ResultsIn response to temporal variation in food abundance, P. larvata switchedits dietary habits from fruits to small mammals and birds in May-June and from small mammalsand birds to fruits in November-December (Fig. 6a).With regard to spatial variation in food resources, the number of fecal samples collecteddiffered significantly across months and habitats (F = 77.068,d.f= 48, 974, P < 0.001; Fig. 7), suggesting that the location of foraging varied.", [["fruits", "ANATOMY", 252, 258], ["fruits", "ANATOMY", 333, 339], ["fecal samples", "ANATOMY", 437, 450], ["P. larvata", "ORGANISM", 209, 219], ["fruits", "ORGANISM_SUBDIVISION", 252, 258], ["fruits", "ORGANISM_SUBDIVISION", 333, 339], ["P. larvata", "SPECIES", 209, 219], ["P. larvata", "SPECIES", 209, 219], ["R", "TEST", 121, 122], ["P", "TEST", 139, 140], ["fecal samples", "TEST", 437, 450], ["P", "TEST", 536, 537], ["Fig.", "TEST", 547, 551], ["small", "OBSERVATION_MODIFIER", 62, 67], ["small mammals", "OBSERVATION_MODIFIER", 262, 275], ["spatial variation", "OBSERVATION", 386, 403], ["fecal", "ANATOMY", 437, 442], ["foraging varied", "OBSERVATION", 588, 603]]], ["Significantnegative correlations were found between the proportion of ingested biomass obtained in PFversus LF (R = \u22120.570, n= 19, p = 0.011)and between the proportion of ingested biomass obtained in PF versus FL (R=\u22120.641, n= 19, P= 0.003).", [["ingested biomass", "PROBLEM", 70, 86], ["PFversus LF", "TEST", 99, 110], ["n", "TEST", 124, 125], ["p", "TEST", 131, 132], ["ingested biomass", "PROBLEM", 171, 187], ["FL", "TEST", 210, 212], ["n", "TEST", 224, 225], ["P", "TEST", 231, 232], ["ingested biomass", "OBSERVATION", 70, 86], ["ingested biomass", "OBSERVATION", 171, 187]]], ["These findings suggest thatP. larvata shifts its foraging from PF to LF or FL habitat in spring whensome fruits (F. orientalis, Cerasus, and Berchemia huana)are abundant in LF and cultivated fruits start to mature in FL.", [["fruits", "ANATOMY", 105, 111], ["fruits", "ANATOMY", 191, 197], ["FL", "CHEMICAL", 75, 77], ["fruits", "ORGANISM_SUBDIVISION", 105, 111], ["F. orientalis", "ORGANISM", 113, 126], ["Cerasus", "ORGANISM", 128, 135], ["Berchemia huana", "ORGANISM", 141, 156], ["fruits", "ORGANISM_SUBDIVISION", 191, 197], ["F. orientalis", "SPECIES", 113, 126], ["Berchemia huana", "SPECIES", 141, 156], ["F. orientalis", "SPECIES", 113, 126], ["Berchemia huana", "SPECIES", 141, 156], ["FL habitat", "PROBLEM", 75, 85], ["FL habitat", "OBSERVATION", 75, 85], ["LF", "ANATOMY", 173, 175]]], ["Conversely, the animalsappear to switch foraging sites from LF or FL to PF in the fall, when wild fruits such asDiospyros lotus and H. dulcis are mature (Fig. 6b).DiscussionDiet composition and primary food items.\u2014Although other studies havedocumented the diet of civets (Rabinowitz 1991; Wang and Fuller 2003), this is the 1st study to considerseasonal and habitat differences in the diet of the masked palm civet (P.larvata).", [["fruits", "ANATOMY", 98, 104], ["fruits", "ORGANISM_SUBDIVISION", 98, 104], ["asDiospyros lotus", "ORGANISM", 110, 127], ["H. dulcis", "ORGANISM", 132, 141], ["palm", "ORGANISM_SUBDIVISION", 404, 408], ["asDiospyros lotus", "SPECIES", 110, 127], ["H. dulcis", "SPECIES", 132, 141], ["asDiospyros lotus", "SPECIES", 110, 127], ["H. dulcis", "SPECIES", 132, 141], ["palm civet", "SPECIES", 404, 414], ["H. dulcis", "PROBLEM", 132, 141], ["other studies", "TEST", 223, 236]]], ["Examination of our data showed that P. larvata fromcentral China consumed a wide variety of food items and that the composition of the dietvaried temporally and spatially.", [["P. larvata", "ORGANISM", 36, 46], ["P. larvata", "SPECIES", 36, 46], ["P. larvata", "SPECIES", 36, 46], ["Examination of our data", "TEST", 0, 23]]], ["In particular, thesedata provide one of the few demonstrations of spatial (habitat) dietary switching in a smallcarnivore.DiscussionAlthough no systematic study of the diet of civets has been carried out, fruits typicallyhave been regarded as the principal food resource of these animals (Grassman 1998; Jiang et al. 2003;Lundrigan and Baker 2003; Nowak 1999; Wang 1987).", [["fruits", "ANATOMY", 205, 211], ["fruits", "ORGANISM_SUBDIVISION", 205, 211], ["systematic study", "TEST", 144, 160]]], ["Insubtropical southeastern China, fruits are the most conspicuous food items ingested byP. larvata, with the Chinese abelia (Abelia chinensis)being consumed most frequently (Wang 1999).", [["fruits", "ANATOMY", 34, 40], ["fruits", "ORGANISM_SUBDIVISION", 34, 40], ["byP. larvata", "ORGANISM", 86, 98], ["Chinese abelia", "ORGANISM", 109, 123], ["Abelia chinensis", "ORGANISM", 125, 141], ["byP. larvata", "SPECIES", 86, 98], ["Abelia chinensis", "SPECIES", 125, 141], ["byP. larvata", "SPECIES", 86, 98], ["Chinese abelia", "SPECIES", 109, 123], ["Abelia chinensis", "SPECIES", 125, 141], ["most conspicuous", "OBSERVATION_MODIFIER", 49, 65]]], ["In HongKong, Corlett (1996) found seeds of 15 species offruit in civet scats and Tsang and Corlett (2005)found that the large green fruits of Shaba holly (Ilex chapaensis) wereconsumed only by P. larvata.", [["fruits", "ANATOMY", 132, 138], ["green fruits of Shaba holly (Ilex chapaensis", "CHEMICAL", 126, 170], ["fruits", "ORGANISM_SUBDIVISION", 132, 138], ["Shaba holly", "ORGANISM", 142, 153], ["Ilex chapaensis", "ORGANISM", 155, 170], ["P. larvata", "ORGANISM", 193, 203], ["Ilex chapaensis", "SPECIES", 155, 170], ["P. larvata", "SPECIES", 193, 203], ["Shaba holly", "SPECIES", 142, 153], ["Ilex chapaensis", "SPECIES", 155, 170], ["P. larvata", "SPECIES", 193, 203], ["15 species", "PROBLEM", 43, 53], ["Shaba holly (Ilex chapaensis", "TREATMENT", 142, 170], ["large", "OBSERVATION_MODIFIER", 120, 125], ["green fruits", "OBSERVATION", 126, 138]]], ["In tropical forests in Thailand, where ripefruit is available throughout the year, civets ate fruits of many species (Grassman 1998; Kitamuraet al. 2002; Rabinowitz 1991).", [["fruits", "ANATOMY", 94, 100], ["fruits", "ORGANISM_SUBDIVISION", 94, 100], ["tropical", "OBSERVATION_MODIFIER", 3, 11], ["forests", "OBSERVATION", 12, 19]]], ["Our study,which was conducted where both wild and cultivated fruits are available only seasonally,indicated that fruits were the primary food source for P. larvata duringthe period between June and October.DiscussionIn contrast, outside of the fruiting season (i.e., in spring and winter) the diet ofP. larvata consisted of a large proportion of small mammals, mainlyferret-badgers, squirrels, and rodents.", [["fruits", "ANATOMY", 61, 67], ["fruits", "ANATOMY", 113, 119], ["fruits", "ORGANISM_SUBDIVISION", 61, 67], ["fruits", "ORGANISM_SUBDIVISION", 113, 119], ["P. larvata", "ORGANISM", 153, 163], ["squirrels", "ORGANISM", 383, 392], ["P. larvata", "SPECIES", 153, 163], ["P. larvata", "SPECIES", 153, 163], ["Our study", "TEST", 0, 9], ["large", "OBSERVATION_MODIFIER", 326, 331], ["proportion", "OBSERVATION_MODIFIER", 332, 342], ["small mammals", "OBSERVATION", 346, 359], ["badgers", "OBSERVATION", 374, 381]]], ["These results agree with those of Wang (1999), who also found that small mammals(particularly rodents) were important food items for civets in southeastern China in thespring and winter, when fruits were scarce.", [["fruits", "ANATOMY", 192, 198], ["fruits", "ORGANISM_SUBDIVISION", 192, 198], ["small mammals", "OBSERVATION", 67, 80]]], ["In our study, small mammals were consumed byP. larvata primarily in PF, SLF, and LF, where rodents are relativelyabundant and cultivated fruits are absent.", [["fruits", "ANATOMY", 137, 143], ["byP. larvata", "ORGANISM", 42, 54], ["SLF", "GENE_OR_GENE_PRODUCT", 72, 75], ["fruits", "ORGANISM_SUBDIVISION", 137, 143], ["byP. larvata", "SPECIES", 42, 54], ["our study", "TEST", 3, 12], ["small mammals", "PROBLEM", 14, 27], ["small", "OBSERVATION_MODIFIER", 14, 19], ["mammals", "OBSERVATION", 20, 27], ["LF", "ANATOMY", 81, 83]]], ["The negative correlation between the consumptionof small mammals and their seasonal availability, however, is contrary to our expectationthat P. larvata, as a carnivore, would select small mammals.DiscussionA greater number of fecal samples was collected during the autumn than during the springand summer.", [["fecal samples", "ANATOMY", 227, 240], ["P. larvata", "ORGANISM", 142, 152], ["fecal samples", "ORGANISM_SUBSTANCE", 227, 240], ["P. larvata", "SPECIES", 142, 152], ["P. larvata", "SPECIES", 142, 152], ["fecal samples", "TEST", 227, 240], ["negative", "OBSERVATION", 4, 12], ["small mammals", "OBSERVATION", 183, 196], ["fecal", "ANATOMY", 227, 232]]], ["This may reflect differences in the preservation of samples (feces maydisintegrate more quickly during the spring and summer when rainfall is greater\u2014Juarez and Marinho 2002).", [["samples", "ANATOMY", 52, 59], ["feces", "ANATOMY", 61, 66], ["feces", "ORGANISM_SUBDIVISION", 61, 66], ["may reflect", "UNCERTAINTY", 5, 16]]], ["Agreater number of fecal samples was collected in 2005 and 2006 than during 2004.", [["fecal samples", "ANATOMY", 19, 32], ["fecal samples", "ORGANISM_SUBSTANCE", 19, 32], ["fecal samples", "TEST", 19, 32], ["fecal", "ANATOMY", 19, 24]]], ["This may beexplained by an increase in civet density in 2005 and 2006.", [["an increase in civet density", "PROBLEM", 24, 52], ["increase", "OBSERVATION_MODIFIER", 27, 35], ["civet density", "OBSERVATION", 39, 52]]], ["This increase may reflect a banon hunting (including civets) instituted in 2003 when the severe acute respiratory syndromevirus (SARS-CoV) was believed to have jumped from a wild animal host to humans (Guan et al. 2003).DiscussionFood availability, use, and dietary switching.\u2014Food abundance anddistribution have been shown to affect the behavior (e.g., feeding, social, and spacingbehavior) of a variety of mammals (Isbell et al.1998; Lurz et al. 2000; Wilmshurst et al. 1999), including carnivores (Ferrari and Weber 1995; Joshi et al.1995; Prange et al. 2004; Raymond et al. 1990).", [["acute respiratory syndromevirus", "DISEASE", 96, 127], ["SARS", "DISEASE", 129, 133], ["SARS-CoV", "ORGANISM", 129, 137], ["humans", "ORGANISM", 194, 200], ["humans", "SPECIES", 194, 200], ["SARS-CoV", "SPECIES", 129, 137], ["humans", "SPECIES", 194, 200], ["a banon hunting", "PROBLEM", 26, 41], ["the severe acute respiratory syndromevirus", "PROBLEM", 85, 127], ["may reflect", "UNCERTAINTY", 14, 25], ["banon hunting", "OBSERVATION", 28, 41], ["severe", "OBSERVATION_MODIFIER", 89, 95], ["acute", "OBSERVATION_MODIFIER", 96, 101], ["respiratory syndromevirus", "OBSERVATION", 102, 127]]], ["The dietary choices of smallcarnivores depend primarily on temporal and spatial variation in foraging costs, which areaffected primarily by the availability of critical prey species (Alves-Costa et al. 2004; Erlinge1981; Joshi et al. 1995; Raymond et al. 1990).", [["smallcarnivores depend", "PROBLEM", 23, 45], ["spatial variation", "OBSERVATION", 72, 89], ["foraging costs", "OBSERVATION", 93, 107]]], ["Specifically, as availability of the primary preyspecies decreases, the relative benefits of consuming alternative foods should increase(Agrawal and Klein 2000; Genovesi et al. 1996).", [["the primary preyspecies", "PROBLEM", 33, 56], ["alternative foods", "TREATMENT", 103, 120]]], ["Therefore, a decrease in availability of stapleresources can cause a shift in diet toward alternative food items (e.g., Ferrari and Weber 1995; Prugh 2005; Thompson and Colgan 1990).DiscussionIn our study area, fruits showed significant temporal and spatial variation, being moreabundant in summer and autumn and in primary forests (Songand Liu 1999).", [["fruits", "ANATOMY", 211, 217], ["fruits", "ORGANISM_SUBDIVISION", 211, 217], ["stapleresources", "TREATMENT", 41, 56], ["our study area", "TEST", 195, 209], ["significant temporal and spatial variation", "PROBLEM", 225, 267], ["decrease", "OBSERVATION_MODIFIER", 13, 21], ["significant", "OBSERVATION_MODIFIER", 225, 236], ["temporal", "OBSERVATION_MODIFIER", 237, 245], ["spatial variation", "OBSERVATION", 250, 267]]], ["Correspondingly, the consumption of fruits by civets was highestfrom June to October, and occurred mainly in forested areas.", [["fruits", "ANATOMY", 36, 42], ["fruits", "ORGANISM_SUBDIVISION", 36, 42]]], ["The highest consumption ofsmall mammals occurred when both small mammals and fruits were at their lowest abundance.Birds (mainly pheasants) appeared in the diet in winter and spring, probably because inthese seasons, the loss of leaves on the trees made them easier to capture (Song and Liu 1999; Wanget al. 1997).", [["fruits", "ANATOMY", 77, 83], ["fruits", "ORGANISM_SUBDIVISION", 77, 83], ["pheasants", "ORGANISM", 129, 138], ["the loss of leaves", "PROBLEM", 217, 235], ["highest", "OBSERVATION_MODIFIER", 4, 11], ["consumption", "OBSERVATION_MODIFIER", 12, 23], ["ofsmall mammals", "OBSERVATION", 24, 39], ["small", "OBSERVATION_MODIFIER", 59, 64], ["mammals", "OBSERVATION_MODIFIER", 65, 72]]], ["These results suggest that P. larvata alters itsdiet depending on the availability of fruit resources.DiscussionOptimal foraging theory (Sacks and Neale 2002; Schoener 1971; Stein1977) predicts that the attributes (e.g., vulnerability) of a food resource alsomay influence foraging decisions by predators.", [["P. larvata", "ORGANISM", 27, 37], ["P. larvata", "SPECIES", 27, 37], ["P. larvata", "SPECIES", 27, 37]]], ["Stickney(1991) found that if bird eggs were temporarily abundant and easily obtained, theybecome the primary prey item in the diet of foxes (Vulpes lagopus) insummer in spite of a high abundance of rodents.", [["bird eggs", "ORGANISM", 29, 38], ["foxes", "ORGANISM_SUBDIVISION", 134, 139], ["Vulpes lagopus", "ORGANISM", 141, 155], ["Vulpes lagopus", "SPECIES", 141, 155], ["Vulpes lagopus", "SPECIES", 141, 155], ["bird eggs", "PROBLEM", 29, 38]]], ["The alternative prey hypothesis (Angelstam et al. 1984; H\u00f6rnfeldt 1978; Thompson and Colgan 1990)asserts that predators switch prey types when numbers of their primary prey are low.", [["low", "OBSERVATION_MODIFIER", 177, 180]]], ["Forexample, B\u00eaty et al. (2002) found that predation byfoxes on lemmings and snow goose eggs increased only when rodent populations declined.", [["predation byfoxes", "DISEASE", 42, 59], ["goose", "ORGANISM", 81, 86], ["goose", "SPECIES", 81, 86], ["rodent", "SPECIES", 112, 118], ["goose", "SPECIES", 81, 86], ["lemmings", "TREATMENT", 63, 71]]], ["Inthis case, the alternative prey was relatively difficult to capture and thus the predatorconcentrated its foraging activity on this prey only when the abundance of its primaryrodent prey was low (Norrdahl and Korpim\u00e4ki 2000).Our results are consistent with this scenario.", [["consistent with", "UNCERTAINTY", 243, 258]]], ["The abundance of mature fruits in the summerand autumn meant that fruits became the primary food source in these seasons despite a highabundance of rodents.", [["fruits", "ANATOMY", 24, 30], ["fruits", "ANATOMY", 66, 72], ["fruits", "ORGANISM_SUBDIVISION", 24, 30], ["fruits", "ORGANISM_SUBDIVISION", 66, 72], ["mature fruits", "PROBLEM", 17, 30], ["abundance", "OBSERVATION_MODIFIER", 4, 13], ["mature", "OBSERVATION_MODIFIER", 17, 23], ["fruits", "OBSERVATION", 24, 30]]], ["Accordingly, civets switched their foraging habitat from PF to LF orFL.", [["civets", "TREATMENT", 13, 19], ["LF orFL", "TREATMENT", 63, 70]]], ["These findings suggest that although P. larvata is considered to be ageneralist carnivore, the animals prefer fruits to rodents when the former are available,presumably because of the higher profitability of consuming fruit.DiscussionOur study took place in the subtropical zone, where fruits are abundant in summer andautumn but scarce during other seasons (Song and Liu1999).", [["fruits", "ANATOMY", 110, 116], ["fruit", "ANATOMY", 218, 223], ["fruits", "ANATOMY", 286, 292], ["P. larvata", "DISEASE", 37, 47], ["P. larvata", "ORGANISM", 37, 47], ["fruits", "ORGANISM_SUBDIVISION", 110, 116], ["fruit", "ORGANISM_SUBDIVISION", 218, 223], ["fruits", "ORGANISM_SUBDIVISION", 286, 292], ["P. larvata", "SPECIES", 37, 47], ["P. larvata", "SPECIES", 37, 47], ["DiscussionOur study", "TEST", 224, 243], ["subtropical", "ANATOMY_MODIFIER", 262, 273], ["zone", "ANATOMY_MODIFIER", 274, 278], ["abundant", "OBSERVATION_MODIFIER", 297, 305]]], ["Because of the absence of systematic studies of the diets of civets intropical areas where fruits are available throughout the year, we cannot compare theforaging behavior of civets in areas where fruits are seasonally versus continuallyavailable.", [["fruits", "ANATOMY", 91, 97], ["fruits", "ANATOMY", 197, 203], ["fruits", "ORGANISM_SUBDIVISION", 91, 97], ["fruits", "ORGANISM_SUBDIVISION", 197, 203], ["systematic studies", "TEST", 26, 44]]], ["We predict that in tropical areas where fruits are available throughout the year,dietary switching will not occur and that fruits, with their higher profitability, will bethe main food of P. larvata throughout the year.", [["fruits", "ANATOMY", 40, 46], ["fruits", "ANATOMY", 123, 129], ["fruits", "ORGANISM_SUBDIVISION", 40, 46], ["fruits", "ORGANISM_SUBDIVISION", 123, 129], ["P. larvata", "ORGANISM", 188, 198], ["P. larvata", "SPECIES", 188, 198], ["P. larvata", "SPECIES", 188, 198]]], ["Complementary studies intropical areas are called for in order to gain a more complete understanding of the effectsof spatial and temporal variation in food resources on foraging behavior of civets.", [["temporal variation", "OBSERVATION", 130, 148]]]], "6c806034d4e17f1e43b7415c9c906c8160622694": [["IntroductionEvery year in the United States, influenza (commonly known as flu) is responsible for more than 30,000 deaths and about 200,000 hospitalizations (Thompson et al., 2004) .", [["influenza", "DISEASE", 45, 54], ["deaths", "DISEASE", 115, 121], ["influenza", "PROBLEM", 45, 54]]], ["The total economic burden of influenza epidemics amounted to $87.1 billion/year (Molinari et al., 2007) .", [["influenza", "DISEASE", 29, 38], ["influenza epidemics", "PROBLEM", 29, 48], ["total", "OBSERVATION_MODIFIER", 4, 9], ["economic", "OBSERVATION_MODIFIER", 10, 18], ["burden", "OBSERVATION_MODIFIER", 19, 25], ["influenza", "OBSERVATION", 29, 38]]], ["In recent years, influenza has obtained unprecedented attention due to widespread occurrence of novel influenza viruses, such as the bird flu and H1N1 flu.", [["influenza", "DISEASE", 17, 26], ["influenza viruses", "DISEASE", 102, 119], ["H1N1 flu", "DISEASE", 146, 154], ["bird flu", "ORGANISM", 133, 141], ["H1N1 flu", "ORGANISM", 146, 154], ["H1N1 flu", "SPECIES", 146, 154], ["H1N1 flu", "SPECIES", 146, 154], ["influenza", "PROBLEM", 17, 26], ["novel influenza viruses", "PROBLEM", 96, 119], ["the bird flu", "PROBLEM", 129, 141], ["H1N1 flu", "PROBLEM", 146, 154], ["influenza viruses", "OBSERVATION", 102, 119], ["H1N1 flu", "OBSERVATION", 146, 154]]], ["A major public health concern is the possibility of a pandemic, which could be as severe as the 1918 Spanish flu (Webby & Webster, 2003) .", [["a pandemic", "PROBLEM", 52, 62], ["pandemic", "OBSERVATION", 54, 62]]], ["This great concern has motivated scientists and health policy makers to model influenza epidemics and predict transmission dynamics (Coburn, Wagner, & Blower, 2009) .IntroductionInfluenza is an infectious disease transmitted from individual to individual through physical contacts.", [["influenza", "DISEASE", 78, 87], ["Influenza", "DISEASE", 178, 187], ["model influenza epidemics", "PROBLEM", 72, 97], ["Influenza", "PROBLEM", 178, 187], ["an infectious disease", "PROBLEM", 191, 212], ["infectious", "OBSERVATION", 194, 204]]], ["The dense human contacts in a city form fast and uncontrolled channels for transmission (Meade & Earickson, 2005) .", [["human", "ORGANISM", 10, 15], ["human", "SPECIES", 10, 15], ["human", "SPECIES", 10, 15], ["dense", "OBSERVATION_MODIFIER", 4, 9], ["human contacts", "OBSERVATION", 10, 24]]], ["Although the importance of cities is widely recog-nized, little research has been devoted to modeling and understanding the city-wide influenza transmission.", [["influenza", "DISEASE", 134, 143], ["wide influenza transmission", "PROBLEM", 129, 156]]], ["In recent literature, there has been seen a few efforts to model city-scale disease epidemics, such as the Epi-Sims model by Eubank et al. (2004) , and the BioWar model by Carley et al. (2006) .", [["few", "OBSERVATION_MODIFIER", 44, 47]]], ["These studies have been focused on modeling issues at the city scale, but little attention has been paid to the spatial-temporal transmission of influenza, possible factors contributing to transmission, and resultant urban health risks.IntroductionFor these reasons, the objectives of this article are to understand the spatial-temporal transmission of influenza, and identify its health risks in the urbanized area of Buffalo, New York.", [["influenza", "DISEASE", 145, 154], ["influenza", "DISEASE", 353, 362], ["These studies", "TEST", 0, 13], ["modeling issues", "PROBLEM", 35, 50], ["influenza", "PROBLEM", 145, 154], ["influenza", "PROBLEM", 353, 362], ["influenza", "OBSERVATION", 145, 154], ["influenza", "OBSERVATION", 353, 362]]], ["Based on such network, infection sources are introduced with different patterns and corresponding influenza epidemics are simulated.", [["infection", "DISEASE", 23, 32], ["influenza", "DISEASE", 98, 107], ["infection sources", "PROBLEM", 23, 40], ["corresponding influenza epidemics", "PROBLEM", 84, 117], ["infection", "OBSERVATION", 23, 32], ["influenza epidemics", "OBSERVATION", 98, 117]]], ["The transmission of influenza over time and space is analyzed, and potential places and times of high risk are identified.", [["influenza", "DISEASE", 20, 29], ["influenza", "PROBLEM", 20, 29], ["influenza", "OBSERVATION", 20, 29]]], ["The remainder of this article is organized into the following sections.", [["sections", "ANATOMY", 62, 70], ["remainder", "OBSERVATION_MODIFIER", 4, 13]]], ["The second section introduces the individual-based modeling approach used in this study.", [["The second section", "TREATMENT", 0, 18], ["this study", "TEST", 77, 87]]], ["The third section describes the urbanized area of Buffalo and the simulation model for influenza transmission.", [["influenza transmission", "DISEASE", 87, 109], ["influenza transmission", "PROBLEM", 87, 109], ["urbanized", "OBSERVATION_MODIFIER", 32, 41]]], ["The two sections that follow present and discuss the simulation results, respectively.", [["sections", "ANATOMY", 8, 16]]], ["The last section concludes the article and discusses its implications.An individual-based modeling approach for epidemiologyDuring the past decade, the individual-based approach began to gain momentum in modeling a variety of infectious diseases, such as influenza, smallpox, severe acute respiratory syndrome (SARS), foot and mouth disease (FMD), and others (Eubank et al., 2004; Huang, Sun, Hsieh, & Lin, 2004; Keeling et al., 2001; .", [["infectious diseases", "DISEASE", 226, 245], ["influenza", "DISEASE", 255, 264], ["smallpox", "DISEASE", 266, 274], ["acute respiratory syndrome", "DISEASE", 283, 309], ["SARS", "DISEASE", 311, 315], ["foot and mouth disease", "DISEASE", 318, 340], ["FMD", "DISEASE", 342, 345], ["foot", "ORGANISM_SUBDIVISION", 318, 322], ["mouth", "ORGAN", 327, 332], ["FMD", "SPECIES", 342, 345], ["The last section", "TREATMENT", 0, 16], ["infectious diseases", "PROBLEM", 226, 245], ["influenza", "PROBLEM", 255, 264], ["smallpox", "TREATMENT", 266, 274], ["severe acute respiratory syndrome", "PROBLEM", 276, 309], ["SARS)", "PROBLEM", 311, 316], ["foot and mouth disease", "PROBLEM", 318, 340], ["infectious", "OBSERVATION", 226, 236], ["severe", "OBSERVATION_MODIFIER", 276, 282], ["acute", "OBSERVATION_MODIFIER", 283, 288], ["respiratory syndrome", "OBSERVATION", 289, 309], ["foot", "ANATOMY", 318, 322], ["mouth", "ANATOMY", 327, 332], ["disease", "OBSERVATION", 333, 340]]], ["These individual-based models use a bottom-up approach, which starts with discrete individuals of a population, and tries to understand how the population's properties emerge from interactions among individuals (Grimm & Railsback, 2005) .", [["a bottom-up approach", "TREATMENT", 34, 54]]], ["This approach offers three advantages for modeling disease transmission.", [["modeling disease transmission", "PROBLEM", 42, 71], ["disease", "OBSERVATION", 51, 58]]], ["First, the heterogeneity of both individuals and their interactions can be explicitly represented, as can the subsequent heterogeneity in disease transmission (Keeling, 1999; Koopman & Lynch, 1999) .", [["heterogeneity", "OBSERVATION_MODIFIER", 11, 24], ["both", "OBSERVATION_MODIFIER", 28, 32], ["individuals", "OBSERVATION", 33, 44]]], ["Second, the randomness of disease infection between a pair of individuals can be captured as a stochastic process.", [["infection", "DISEASE", 34, 43], ["disease infection", "PROBLEM", 26, 43], ["disease", "OBSERVATION_MODIFIER", 26, 33], ["infection", "OBSERVATION", 34, 43]]], ["Third, by aggregating individual infections, the outcome of disease transmission can be studied at multiple scales, such as the community, city, national and international scales.", [["infections", "DISEASE", 33, 43], ["aggregating individual infections", "PROBLEM", 10, 43], ["disease transmission", "PROBLEM", 60, 80], ["individual", "OBSERVATION_MODIFIER", 22, 32], ["infections", "OBSERVATION", 33, 43]]], ["However, the increased realism demands more assumptions to be made and more parameters to be estimated, bringing more complexity in modeling (Judson, 1994; Koopman, 2002) .An individual-based modeling approach for epidemiologyIn many individual-based epidemic models, the concept of network is often included to represent contacts among individuals (Bian, 2004; Eubank, 2005) .", [["the increased realism demands", "PROBLEM", 9, 38], ["increased", "OBSERVATION_MODIFIER", 13, 22]]], ["Conceptually, the network is composed of nodes and links, where nodes represent individuals and links represent direct contacts among individuals (Wasserman & Faust, 1994) .", [["nodes", "ANATOMY", 41, 46], ["nodes", "ANATOMY", 64, 69], ["nodes", "OBSERVATION", 41, 46], ["nodes", "OBSERVATION", 64, 69]]], ["Nodes can have attributes, such as a finite number of links and an infection status.", [["infection", "DISEASE", 67, 76], ["Nodes", "PROBLEM", 0, 5], ["an infection status", "PROBLEM", 64, 83], ["infection", "OBSERVATION", 67, 76]]], ["Links also have a set of attributes, including the closeness and duration of the contact, and the likelihood of infection.", [["infection", "DISEASE", 112, 121], ["infection", "PROBLEM", 112, 121], ["infection", "OBSERVATION", 112, 121]]], ["The diseases are transmitted through links over the population (Keeling & Eames, 2005) .An individual-based modeling approach for epidemiologyIn recent years, there has been a rising number of individualbased spatially explicit models for disease epidemics at the national and international scales, including the models for the United States (Germann, Kadau, Longini, & Macken, 2006; Halloran et al., 2008) , for Great Britain (Riley & Ferguson, 2006) , and for South Asia (Ferguson et al., 2005; .", [["The diseases", "PROBLEM", 0, 12], ["disease epidemics", "PROBLEM", 239, 256], ["diseases", "OBSERVATION", 4, 12], ["rising", "OBSERVATION_MODIFIER", 176, 182], ["number", "OBSERVATION_MODIFIER", 183, 189]]], ["In these macro-scale models, the fundamental geographic unit is a community, which can be either a census tract or a pre-defined square area.", [["a census tract", "PROBLEM", 97, 111], ["a pre-defined square area", "PROBLEM", 115, 140], ["fundamental", "OBSERVATION_MODIFIER", 33, 44], ["geographic", "OBSERVATION_MODIFIER", 45, 55], ["square", "OBSERVATION_MODIFIER", 129, 135]]], ["Individuals are assigned to different communities to satisfy a set of real demographic distributions, such as the distributions of age, gender, and household size.", [["size", "OBSERVATION_MODIFIER", 158, 162]]], ["These models successfully replicate wave-like and hierarchical diffusion patterns that occur in geographically extensive areas.", [["wave-like and hierarchical diffusion patterns", "PROBLEM", 36, 81], ["wave", "OBSERVATION_MODIFIER", 36, 40], ["hierarchical", "OBSERVATION_MODIFIER", 50, 62], ["diffusion patterns", "OBSERVATION", 63, 81], ["geographically", "OBSERVATION_MODIFIER", 96, 110], ["extensive", "OBSERVATION_MODIFIER", 111, 120], ["areas", "OBSERVATION_MODIFIER", 121, 126]]], ["However, by covering such larger geographic areas, these models often simplify or neglect the detailed information within a city, such as the specific locations of households and workplaces, the urban transportation network, and the daily activities of individuals.", [["larger", "OBSERVATION_MODIFIER", 26, 32], ["geographic", "OBSERVATION_MODIFIER", 33, 43], ["areas", "OBSERVATION_MODIFIER", 44, 49]]], ["These models, therefore, may be less useful for planning influenza control in individual cities.An individual-based modeling approach for epidemiologyCurrently, quite a few individual-based models have been proposed at the city scale.", [["influenza", "DISEASE", 57, 66], ["planning influenza control", "TREATMENT", 48, 74]]], ["These models include: the EpiSims model (Eubank et al., 2004) for smallpox in Portland, Oregon; the BioWar simulation of an influenza epidemic in Norfolk, Virginia (Lee, Bedford, Roberts, & Carley, 2008) ; and the activity-based model for influenza in Eemnes, Netherlands (Yang, Atkinson, & Ettema, 2008) .", [["smallpox", "DISEASE", 66, 74], ["influenza", "DISEASE", 124, 133], ["influenza", "DISEASE", 239, 248], ["an influenza epidemic", "PROBLEM", 121, 142], ["influenza", "PROBLEM", 239, 248], ["influenza", "OBSERVATION", 124, 133]]], ["These cities are modeled using specific locations of households, workplaces, schools, health facilities, etc. Each individual has a set of demographic, socio-economic, and behavioral charac-teristics that are estimated from census data and behavioral surveys.", [["behavioral surveys", "TEST", 240, 258]]], ["By taking a range of daily activities (such as work, study and shopping), individuals move between several locations, both exposing themselves to infectious diseases within these locations and transporting diseases between locations (Eubank et al., 2004) .An individual-based modeling approach for epidemiologyCompared to the macro-scale models, these city-scale models include such detailed descriptions that every individual can be identified at a specific location and time.", [["infectious diseases", "DISEASE", 146, 165], ["infectious diseases", "PROBLEM", 146, 165], ["infectious", "OBSERVATION", 146, 156]]], ["The information about who infects whom, and where and when the infection happens can be traced and recorded.", [["infection", "DISEASE", 63, 72], ["the infection", "PROBLEM", 59, 72], ["infection", "OBSERVATION", 63, 72]]], ["The increased details, however, introduce more complexity to the model, and thus only a few city-scale models exist so far.", [["increased", "OBSERVATION_MODIFIER", 4, 13]]], ["Another issue is that few of these city-scale models have been used to explore the potential patterns, contributing factors, and health risks of influenza transmission.", [["influenza", "DISEASE", 145, 154], ["influenza transmission", "PROBLEM", 145, 167], ["few", "OBSERVATION_MODIFIER", 22, 25]]], ["The relevant literature mainly reports model establishment and tests control strategies, but influenza transmission itself is under-studied.", [["tests control strategies", "TREATMENT", 63, 87], ["influenza transmission itself", "PROBLEM", 93, 122]]], ["This study aims to fill this knowledge gap using an individual-based city-scale model.Study areaThe urbanized area of Buffalo is located at the western end of New York State, and on the eastern shore of Lake Erie (Fig. 1a) .", [["This study", "TEST", 0, 10], ["Study area", "TEST", 86, 96], ["urbanized", "OBSERVATION_MODIFIER", 100, 109], ["area", "OBSERVATION_MODIFIER", 110, 114], ["New", "OBSERVATION_MODIFIER", 159, 162]]], ["Geographically, the study area is relatively separated from other urbanized areas, because it is surrounded by great lakes and rural areas.", [["the study area", "TEST", 16, 30], ["relatively", "OBSERVATION_MODIFIER", 34, 44], ["separated", "OBSERVATION", 45, 54], ["urbanized", "OBSERVATION_MODIFIER", 66, 75], ["areas", "OBSERVATION", 76, 81], ["great", "OBSERVATION_MODIFIER", 111, 116], ["lakes", "OBSERVATION", 117, 122], ["rural", "OBSERVATION_MODIFIER", 127, 132], ["areas", "OBSERVATION_MODIFIER", 133, 138]]], ["The nearest urbanized area, Rochester, New York, is about 120 km to the east.", [["urbanized", "OBSERVATION_MODIFIER", 12, 21]]], ["According to 2002 travel survey by Greater Buffalo-Niagara Regional Transportation Council (GBNRTC, 2002) , most people living in this area take their daily activities within it.", [["people", "ORGANISM", 113, 119], ["people", "SPECIES", 113, 119]]], ["For these reasons, the study area can be treated as a closed system, where an influenza epidemic may develop with little outside influence.", [["influenza", "DISEASE", 78, 87], ["the study area", "TEST", 19, 33], ["a closed system", "TREATMENT", 52, 67], ["an influenza epidemic", "PROBLEM", 75, 96]]], ["If an epidemic were to reach this area, the most likely situation would be that the epidemic had already started elsewhere, and the virus would be introduced by infected travelers.Study areaAccording to the US Census (2000), the study area encloses a population of 985,001 individuals in 400,870 households (in 967 census block groups and 12,328 census blocks).", [["travelers", "ORGANISM", 170, 179], ["an epidemic", "PROBLEM", 3, 14], ["the epidemic", "PROBLEM", 80, 92], ["the virus", "PROBLEM", 128, 137], ["the study area", "TEST", 225, 239], ["most likely", "UNCERTAINTY", 44, 55], ["infected", "OBSERVATION", 161, 169]]], ["The age structure indicates that approximately 37.5% of the population is at a high risk of influenza infection, including children younger than 18 years (24.1%) and seniors older than 64 years (13.4%) (Heymann, 2004) .", [["influenza infection", "DISEASE", 92, 111], ["children", "ORGANISM", 123, 131], ["children", "SPECIES", 123, 131], ["influenza infection", "PROBLEM", 92, 111], ["approximately", "OBSERVATION_MODIFIER", 33, 46], ["37.5%", "OBSERVATION_MODIFIER", 47, 52], ["influenza", "OBSERVATION_MODIFIER", 92, 101], ["infection", "OBSERVATION", 102, 111]]], ["In addition, the study area contains 36,839 business locations, according to published business databases from Refer-enceUSA, Inc (2009).", [["the study area", "TEST", 13, 27]]], ["Relevant to this study, individuals may have contact with others in these households and business locations, transmitting influenza virus within and between these locations.Study areaThe study area has a clear spatial structure with three zones: a central business district (CBD), a transition zone, and suburbs (Knox & Marston, 2004) .", [["influenza", "DISEASE", 122, 131], ["individuals", "ORGANISM", 24, 35], ["influenza virus", "ORGANISM", 122, 137], ["this study", "TEST", 12, 22], ["transmitting influenza virus", "PROBLEM", 109, 137], ["Study area", "TEST", 173, 183], ["The study", "TEST", 183, 192], ["a transition zone", "PROBLEM", 281, 298], ["influenza virus", "OBSERVATION", 122, 137], ["clear", "OBSERVATION_MODIFIER", 204, 209], ["spatial structure", "OBSERVATION", 210, 227], ["central", "OBSERVATION_MODIFIER", 248, 255], ["CBD", "ANATOMY", 275, 278], ["transition", "OBSERVATION_MODIFIER", 283, 293], ["zone", "OBSERVATION_MODIFIER", 294, 298]]], ["As shown in Fig. 1b , the CBD covers an area of 42.0 km 2 , and consists of downtown areas in the city of Buffalo and the city of Niagara Falls.", [["CBD", "DISEASE", 26, 29], ["CBD", "CHEMICAL", 26, 29], ["CBD", "PATHOLOGICAL_FORMATION", 26, 29], ["CBD", "ANATOMY", 26, 29], ["Niagara Falls", "OBSERVATION", 130, 143]]], ["The CBD is characterized by its significantly higher densities of residents, households, and businesses than the other two zones (Table 1).", [["CBD", "DISEASE", 4, 7], ["CBD", "CHEMICAL", 4, 7], ["CBD", "ANATOMY", 4, 7], ["significantly", "OBSERVATION_MODIFIER", 32, 45], ["higher", "OBSERVATION_MODIFIER", 46, 52], ["densities", "OBSERVATION_MODIFIER", 53, 62]]], ["The transition zone is adjacent to the CBD, and is enclosed within Interstate Highways 290, 190 and 90, and State Route 61.", [["CBD", "CHEMICAL", 39, 42], ["The transition zone", "PROBLEM", 0, 19], ["transition", "OBSERVATION_MODIFIER", 4, 14], ["zone", "OBSERVATION_MODIFIER", 15, 19], ["CBD", "ANATOMY", 39, 42]]], ["With an area of 144.6 km 2 , this zone has the second highest densi-ties of residents, households, and businesses.", [["area", "OBSERVATION_MODIFIER", 8, 12]]], ["The rest of the urbanized area is the suburbs, which covers a large area of 10,538.1 km 2 .", [["rest", "OBSERVATION_MODIFIER", 4, 8], ["urbanized", "OBSERVATION_MODIFIER", 16, 25], ["area", "OBSERVATION_MODIFIER", 26, 30], ["large", "OBSERVATION_MODIFIER", 62, 67], ["area", "OBSERVATION_MODIFIER", 68, 72]]], ["The suburbs are featured by the largest numbers of residents, households, and businesses, but their densities are the lowest.", [["largest", "OBSERVATION_MODIFIER", 32, 39], ["numbers", "OBSERVATION_MODIFIER", 40, 47], ["densities", "OBSERVATION", 100, 109]]], ["This spatial structure is considered later for seeding infection sources and describing disease transmission patterns.Simulating an urban contact networkTo simulate influenza transmission, an urban contact network is modeled first as a basis.", [["infection", "DISEASE", 55, 64], ["influenza", "DISEASE", 165, 174], ["seeding infection sources", "PROBLEM", 47, 72], ["describing disease transmission patterns", "PROBLEM", 77, 117]]], ["These spatial-temporally dependent contacts link individuals into a population-wide network.Simulating an urban contact networkThe urban contact network is established based on the simulation of three populations corresponding to the three time periods: a nighttime population at homes, a daytime population at workplaces, and a pastime population at service places or neighbor households (Fig. 2) .", [["temporally dependent", "OBSERVATION_MODIFIER", 14, 34]]], ["Small circles on an oval represent individuals who interact with one another within a location.", [["Small circles", "PROBLEM", 0, 13], ["circles", "OBSERVATION_MODIFIER", 6, 13], ["oval", "OBSERVATION_MODIFIER", 20, 24]]], ["The solid-line ovals denote close contacts among individuals, while the dash-line ovals denote occasional contacts.", [["dash-line ovals", "DNA", 72, 87], ["solid", "OBSERVATION_MODIFIER", 4, 9], ["-line", "OBSERVATION_MODIFIER", 9, 14]]], ["A straight line between the three time periods represents the travel of an individual, and links an identical individual at different locations.Simulating an urban contact networkThe 2000 census data (primarily Summary File 3) and land parcel data from New York State GIS Clearinghouse (2009) are used for simulating the nighttime population at homes.", [["A straight line", "TREATMENT", 0, 15], ["straight line", "OBSERVATION", 2, 15], ["individual", "OBSERVATION_MODIFIER", 75, 85], ["identical", "OBSERVATION_MODIFIER", 100, 109], ["individual", "OBSERVATION_MODIFIER", 110, 120]]], ["Using algorithms developed by Bian et al. (2008) , table cross-referencing and Monte-Carlo simulation are performed to fit the modeled distributions to real demographic distributions.", [["Carlo simulation", "TEST", 85, 101]]], ["The spatial distribution of households, expressed by (x, y) coordinates, is estimated based on the number of households within a census block, and the centroids of land parcels in that block.Simulating an urban contact networkThree sets of information are used to simulate the daytime population at workplaces: the 2000 census data, published business databases, and attributes associated with previously simulated individuals and households.", [["a census block", "TREATMENT", 127, 141], ["spatial", "OBSERVATION_MODIFIER", 4, 11], ["distribution", "OBSERVATION_MODIFIER", 12, 24]]], ["Unlike ordinary workers, school-aged individuals in each household are assigned to a nearest school as their workplace.", [["individuals", "ORGANISM", 37, 48]]], ["The establishment of the three linked populations forms a spatially explicit and temporally dynamic contact network.", [["contact network", "MULTI-TISSUE_STRUCTURE", 100, 115]]], ["The contacts among individuals within a location cause the local transmission of influenza, while the travel of individuals between the four types of locations leads to spatial dispersion of influenza.Simulating influenza transmissionThe transmission of influenza is simulated by changing infection status of every individual over time.", [["influenza", "DISEASE", 81, 90], ["influenza", "DISEASE", 191, 200], ["influenza transmission", "DISEASE", 212, 234], ["influenza", "DISEASE", 254, 263], ["infection", "DISEASE", 289, 298], ["influenza", "ORGANISM", 254, 263], ["influenza", "PROBLEM", 81, 90], ["influenza", "PROBLEM", 191, 200], ["Simulating influenza transmission", "PROBLEM", 201, 234], ["influenza", "PROBLEM", 254, 263], ["changing infection status", "PROBLEM", 280, 305], ["influenza", "OBSERVATION", 81, 90], ["influenza", "OBSERVATION", 191, 200], ["influenza", "OBSERVATION", 254, 263], ["infection", "OBSERVATION", 289, 298]]], ["An individual can take one of four infection status at a given time, i.e., susceptible, latent, infectious, or recovered (Anderson & May, 1992) .", [["infection", "DISEASE", 35, 44], ["four infection status", "PROBLEM", 30, 51], ["infection", "OBSERVATION", 35, 44], ["latent", "OBSERVATION_MODIFIER", 88, 94], ["infectious", "OBSERVATION_MODIFIER", 96, 106]]], ["The progress of infection status follows a series of discrete events in the natural history of influenza (Fig. 4) .", [["infection", "DISEASE", 16, 25], ["influenza", "DISEASE", 95, 104], ["infection status", "PROBLEM", 16, 32], ["discrete events", "PROBLEM", 53, 68], ["influenza", "PROBLEM", 95, 104], ["infection", "OBSERVATION", 16, 25]]], ["At some point in time, a susceptible individual comes into the latent status after receiving influenza virus.", [["influenza virus", "DISEASE", 93, 108], ["influenza virus", "ORGANISM", 93, 108], ["influenza virus", "PROBLEM", 93, 108], ["latent", "OBSERVATION_MODIFIER", 63, 69]]], ["The receipt of infection starts a 2-day latent period, during which influenza develops internally and cannot be transmitted.", [["infection", "DISEASE", 15, 24], ["influenza", "DISEASE", 68, 77], ["infection", "PROBLEM", 15, 24], ["influenza", "PROBLEM", 68, 77], ["infection", "OBSERVATION", 15, 24]]], ["At the end of the latent period, the individual becomes infectious and can transmit influenza to other susceptible individuals.", [["influenza", "DISEASE", 84, 93], ["infectious", "PROBLEM", 56, 66], ["influenza", "PROBLEM", 84, 93], ["other susceptible individuals", "PROBLEM", 97, 126], ["infectious", "OBSERVATION", 56, 66]]], ["The length of infectious period varies from 4 to 7 days depending on the age or health status of the individual (Heymann, 2004) .", [["length", "OBSERVATION_MODIFIER", 4, 10], ["infectious", "OBSERVATION", 14, 24]]], ["One day after being infectious, this individual may develop symptoms, or otherwise remain asymptomatic.", [["symptoms", "PROBLEM", 60, 68], ["asymptomatic", "PROBLEM", 90, 102], ["infectious", "OBSERVATION", 20, 30]]], ["Finally, this individual recovers from influenza and develops immunity for the remaining period of the epidemic.Simulating influenza transmissionAmong these influenza-related events, the receipt of infection through one contact is simulated base on a probability of infection p = E contact \u00c2 I age .", [["influenza", "DISEASE", 39, 48], ["influenza transmission", "DISEASE", 123, 145], ["influenza", "DISEASE", 157, 166], ["infection", "DISEASE", 198, 207], ["infection", "DISEASE", 266, 275], ["influenza", "PROBLEM", 39, 48], ["the epidemic", "PROBLEM", 99, 111], ["Simulating influenza transmission", "PROBLEM", 112, 145], ["these influenza-related events", "PROBLEM", 151, 181], ["infection", "PROBLEM", 198, 207], ["infection", "PROBLEM", 266, 275], ["influenza", "OBSERVATION", 39, 48], ["influenza", "OBSERVATION", 157, 166], ["infection", "OBSERVATION", 198, 207], ["infection", "OBSERVATION", 266, 275]]], ["Here, E contact is the effectiveness of a contact for infection, which is related to closeness and duration of the contact .", [["infection", "DISEASE", 54, 63], ["infection", "PROBLEM", 54, 63], ["infection", "OBSERVATION", 54, 63]]], ["This study simply standardizes the effectiveness of close contacts E close_contact to one, while the effectiveness of occasional contacts E occasional_contact is a relative number less than one.", [["This study", "TEST", 0, 10]]], ["I age is termed as age-specific infection rate, and expressed by a real number between [0,1].", [["infection", "DISEASE", 32, 41], ["infection", "OBSERVATION", 32, 41]]], ["It can be interpreted as a conditional probability of infection given E contact = 1 and a specific age group of the receiver.", [["infection", "DISEASE", 54, 63], ["infection", "PROBLEM", 54, 63], ["infection", "OBSERVATION", 54, 63]]], ["For given I age and E contact , the probability p can be estimated and the Monte-Carlo method is used to determine whether an infection event will happen or not.Simulating influenza transmissionFor a more realistic simulation, a background immunity is created by immunizing 62.7% of seniors (older than 64 years), 15.6% of adults (between 18 and 64 years), and 17.9% of children (younger than 18 years), according to reported national immunization coverage (Euler et al., 2005; Molinari et al., 2007) .", [["infection", "DISEASE", 126, 135], ["influenza transmission", "DISEASE", 172, 194], ["children", "ORGANISM", 370, 378], ["children", "SPECIES", 370, 378], ["an infection event", "PROBLEM", 123, 141], ["Simulating influenza transmission", "PROBLEM", 161, 194], ["infection", "OBSERVATION", 126, 135]]], ["In addition, the simulation assumes that 50% of infectious individuals will develop symptoms, following the assumption by Ferguson et al. (2005) .", [["individuals", "ORGANISM", 59, 70], ["infectious individuals", "PROBLEM", 48, 70], ["symptoms", "PROBLEM", 84, 92]]], ["Only these symptomatic individuals can be identified as influenza cases.", [["influenza", "DISEASE", 56, 65], ["individuals", "ORGANISM", 23, 34], ["these symptomatic individuals", "PROBLEM", 5, 34], ["influenza cases", "PROBLEM", 56, 71], ["symptomatic", "OBSERVATION_MODIFIER", 11, 22]]], ["A proportion of these symptomatic individuals may also withdraw to home.", [["individuals", "ORGANISM", 34, 45], ["these symptomatic individuals", "PROBLEM", 16, 45], ["symptomatic", "OBSERVATION", 22, 33]]], ["Specifically, all symptomatic children are assumed to withdraw to home, because they are often cared by parents at homes.", [["children", "ORGANISM", 30, 38], ["children", "SPECIES", 30, 38], ["symptomatic", "OBSERVATION_MODIFIER", 18, 29]]], ["Thirty-three percent of symptomatic adults will withdraw to home based on reported percentage in a health behavior survey (Metzger, Hajat, Crawford, & Mostashari, 2004) .", [["adults", "ORGANISM", 36, 42]]], ["All symptomatic seniors will withdraw to home according to related empirical studies (Stoller, Forster, & Portugal, 1993) .Simulating influenza transmissionThe influenza epidemic is simulated for 120 days, roughly a typical influenza season (from November to February).", [["influenza transmission", "DISEASE", 134, 156], ["influenza", "DISEASE", 160, 169], ["empirical studies", "TEST", 67, 84], ["Simulating influenza transmission", "PROBLEM", 123, 156], ["The influenza epidemic", "PROBLEM", 156, 178], ["symptomatic", "OBSERVATION_MODIFIER", 4, 15]]], ["To initialize the epidemic, five infectious individuals, as infection sources, are seeded into the study area on the first day of the simulation.", [["infection", "DISEASE", 60, 69], ["individuals", "ORGANISM", 44, 55], ["the epidemic", "PROBLEM", 14, 26], ["five infectious individuals", "PROBLEM", 28, 55], ["infection sources", "PROBLEM", 60, 77], ["the simulation", "TEST", 130, 144], ["epidemic", "OBSERVATION_MODIFIER", 18, 26], ["infectious", "OBSERVATION_MODIFIER", 33, 43]]], ["For a comprehensive analysis, four seeding scenarios are devised based on the aforementioned three-in-one urban structure.", [["a comprehensive analysis", "TEST", 4, 28], ["four seeding scenarios", "TREATMENT", 30, 52]]], ["Specifically, the five infection sources are randomly distributed: (1) in the entire study area, (2) only in the CBD (e.g., at bus terminals), (3) only in the transition zone (e.g., at local medical centers), and (4) only in the suburbs (e.g., at airports).", [["infection", "DISEASE", 23, 32], ["CBD", "CHEMICAL", 113, 116], ["the five infection sources", "PROBLEM", 14, 40], ["the transition zone", "PROBLEM", 155, 174], ["five", "OBSERVATION_MODIFIER", 18, 22], ["infection", "OBSERVATION", 23, 32], ["CBD", "ANATOMY", 113, 116], ["transition", "OBSERVATION_MODIFIER", 159, 169], ["zone", "OBSERVATION_MODIFIER", 170, 174]]], ["The influenza epidemic is simulated over 50 realizations under each scenario, resulting in a total of 200 (50 \u00c2 4) realizations.Description of spatial-temporal transmission dynamicsFor each of the four seeding scenarios, the temporal sequence of transmission is described by an epidemic curve that depicts the number of daily new cases during the course of the epidemic (Gordis, 2000).", [["influenza", "DISEASE", 4, 13], ["The influenza epidemic", "PROBLEM", 0, 22], ["an epidemic curve", "PROBLEM", 275, 292], ["seeding scenarios", "OBSERVATION", 202, 219]]], ["The peak time and the number of new cases at the peak time are two major characteristics of the curve.", [["the curve", "TEST", 92, 101], ["peak", "OBSERVATION_MODIFIER", 4, 8], ["new", "OBSERVATION_MODIFIER", 32, 35]]], ["To reduce the randomness, the epidemic curve and two associated characteristics are estimated by averaging 50 model realizations.", [["the epidemic curve", "TEST", 26, 44], ["randomness", "OBSERVATION", 14, 24]]], ["To display the spatial spread of influenza, infection intensity maps are created by the following three steps.", [["influenza", "DISEASE", 33, 42], ["infection", "DISEASE", 44, 53], ["influenza", "PROBLEM", 33, 42], ["infection intensity maps", "PROBLEM", 44, 68], ["spatial", "OBSERVATION_MODIFIER", 15, 22], ["spread", "OBSERVATION_MODIFIER", 23, 29], ["influenza", "OBSERVATION", 33, 42]]], ["First, every infection event occurring in a given time interval is plotted as a point at the location of infection, such as the home, workplace, service place, or neighbor household.", [["infection", "DISEASE", 13, 22], ["infection", "DISEASE", 105, 114], ["every infection event", "PROBLEM", 7, 28], ["infection", "PROBLEM", 105, 114], ["infection", "OBSERVATION", 13, 22], ["infection", "OBSERVATION", 105, 114]]], ["Second, the study area is divided into a cell grid for subsequent estimation.", [["cell", "ANATOMY", 41, 45], ["cell", "CELL", 41, 45], ["the study area", "TEST", 8, 22], ["a cell grid", "TREATMENT", 39, 50], ["subsequent estimation", "TEST", 55, 76]]], ["The reason for rasterization is because plotting tens of thousands of points produces unclear spatial patterns, while rasterization helps provide a clear and reasonable representation.", [["rasterization", "TREATMENT", 15, 28], ["spatial patterns", "OBSERVATION", 94, 110]]], ["Third, a kernel density function is used to estimate the magnitude of new infections occurring within every cell during a time interval, i.e., the infection intensity at a cell location.", [["cell", "ANATOMY", 108, 112], ["cell", "ANATOMY", 172, 176], ["infections", "DISEASE", 74, 84], ["infection", "DISEASE", 147, 156], ["cell", "CELL", 108, 112], ["cell", "CELL", 172, 176], ["a kernel density function", "TREATMENT", 7, 32], ["new infections", "PROBLEM", 70, 84], ["the infection intensity", "PROBLEM", 143, 166], ["density", "OBSERVATION", 16, 23], ["magnitude", "OBSERVATION_MODIFIER", 57, 66], ["new", "OBSERVATION_MODIFIER", 70, 73], ["infections", "OBSERVATION", 74, 84], ["infection", "OBSERVATION", 147, 156]]], ["A high-intensity value indicates that the corresponding cell location is undergoing a rapid growth in the number of infections.Description of spatial-temporal transmission dynamicsThe spatial spread of influenza, then, can be displayed by creating a series of infection intensity maps for every 20 days of the total 120-day simulation.", [["cell", "ANATOMY", 56, 60], ["infections", "DISEASE", 116, 126], ["influenza", "DISEASE", 202, 211], ["infection", "DISEASE", 260, 269], ["cell", "CELL", 56, 60], ["A high-intensity value", "PROBLEM", 0, 22], ["a rapid growth", "PROBLEM", 84, 98], ["infections", "PROBLEM", 116, 126], ["influenza", "PROBLEM", 202, 211], ["infection intensity maps", "TREATMENT", 260, 284], ["high", "OBSERVATION_MODIFIER", 2, 6], ["-intensity", "OBSERVATION_MODIFIER", 6, 16], ["cell location", "OBSERVATION", 56, 69], ["rapid", "OBSERVATION_MODIFIER", 86, 91], ["growth", "OBSERVATION_MODIFIER", 92, 98], ["number", "OBSERVATION_MODIFIER", 106, 112], ["infections", "OBSERVATION", 116, 126], ["spatial", "OBSERVATION_MODIFIER", 184, 191], ["spread", "OBSERVATION_MODIFIER", 192, 198], ["influenza", "OBSERVATION", 202, 211]]], ["The cell size is set to 50 m \u00c2 50 m because it approximates the average extent of a land parcel (the estimated extent is 47 m \u00c2 47 m).", [["cell", "ANATOMY", 4, 8], ["cell", "CELL", 4, 8], ["cell", "OBSERVATION_MODIFIER", 4, 8], ["size", "OBSERVATION_MODIFIER", 9, 13], ["average", "OBSERVATION_MODIFIER", 64, 71], ["extent", "OBSERVATION_MODIFIER", 72, 78], ["land", "ANATOMY_MODIFIER", 84, 88], ["parcel", "ANATOMY_MODIFIER", 89, 95], ["extent", "OBSERVATION_MODIFIER", 111, 117]]], ["In this sense, one or more cells can cover the spatial extent of a location and produce sufficient detail for subsequent analysis.", [["cells", "ANATOMY", 27, 32], ["cells", "CELL", 27, 32], ["subsequent analysis", "TEST", 110, 129]]], ["The intensity value at every cell location is estimated by a kernel density function, and is averaged over 50 model realizations.", [["cell", "ANATOMY", 29, 33], ["cell", "CELL", 29, 33], ["The intensity value", "TEST", 0, 19], ["intensity", "OBSERVATION_MODIFIER", 4, 13], ["kernel density", "OBSERVATION", 61, 75]]], ["The bandwidth of the kernel is set to 1500 m to produce an optimal balance between clear patterns and biases introduced by the function.Model calibration and validationThe simulation model is calibrated and partially validated by established literature.", [["Model calibration", "TEST", 136, 153], ["validation", "TEST", 158, 168]]], ["For the urban contact network, the simulated populations in the nighttime, daytime, and pastime are fitted to the observed distributions of household size, workplace size, and household trips, respectively (Fig. 5a-c) .", [["size", "OBSERVATION_MODIFIER", 150, 154], ["size", "OBSERVATION_MODIFIER", 166, 170]]], ["In addition, it has been reported that the average number of daily contacts of an individual is 16.8 in a survey of 92 adults (Edmunds, 1997) , or near the midpoint of range 10-19 in surveys of Chinese society (Fu, 2005) .", [["average", "OBSERVATION_MODIFIER", 43, 50], ["number", "OBSERVATION_MODIFIER", 51, 57]]], ["Based on these two social studies, the maximum contacts of an individual at a service place is calibrated to two, and at this value, the simulated number of daily contacts of an individual is on average 16.9 (Fig. 5d) .Model calibration and validationTo calibrate the age-specific infection rates I age , three indices are estimated and compared to established literature, including a basic reproductive number (R 0 ), an overall attack rate, and proportions of infection by location.", [["infection", "DISEASE", 281, 290], ["infection", "DISEASE", 462, 471], ["these two social studies", "TEST", 9, 33], ["Model calibration", "TEST", 219, 236], ["validation", "TEST", 241, 251], ["infection", "PROBLEM", 462, 471], ["infection", "OBSERVATION", 281, 290], ["reproductive", "OBSERVATION_MODIFIER", 391, 403], ["infection", "OBSERVATION", 462, 471]]], ["First, R 0 is the number of individuals in a susceptible population that are directly infected by the introduction of a single infectious individual (Diekmann, Heesterbeek, & Metz, 1990) .", [["R 0", "GENE_OR_GENE_PRODUCT", 7, 10], ["a susceptible population", "PROBLEM", 43, 67], ["infected", "OBSERVATION", 86, 94]]], ["Recent studies on observed data have reported that the R 0 of influenza ranges from 0.9 to 2.1 with a mean of 1.3 (Chowell, Miller, & Viboud, 2007; Ferguson et al., 2005; Mills, Robins, & Lipsitch, 2004) .", [["influenza", "DISEASE", 62, 71], ["Recent studies", "TEST", 0, 14], ["observed data", "TEST", 18, 31], ["influenza", "PROBLEM", 62, 71]]], ["In this study, R 0 is estimated by tracing the number of infections directly caused by the infection sources.", [["infections", "DISEASE", 57, 67], ["infection", "DISEASE", 91, 100], ["R 0", "GENE_OR_GENE_PRODUCT", 15, 18], ["this study", "TEST", 3, 13], ["infections", "PROBLEM", 57, 67], ["the infection sources", "PROBLEM", 87, 108], ["infections", "OBSERVATION", 57, 67], ["infection", "OBSERVATION", 91, 100]]], ["Second, the overall attack rate is the proportion of total population that is infected during an epidemic.", [["total population", "PROBLEM", 53, 69], ["infected", "OBSERVATION", 78, 86], ["epidemic", "OBSERVATION_MODIFIER", 97, 105]]], ["The observed overall attack rate for influenza epidemics ranges from 10% to 20% of the population (CDC., 2008; Cox & Subbarao, 2000) .", [["influenza", "DISEASE", 37, 46], ["influenza epidemics", "PROBLEM", 37, 56], ["Cox", "TEST", 111, 114]]], ["Third, the proportion of infections at households (including homes and neighbor households), workplaces, and service places are estimated to be in the ranges of 47-51%, 37-42%, 11-12%, respectively (Longini & Halloran, 2005; .", [["infections", "DISEASE", 25, 35], ["infections", "PROBLEM", 25, 35], ["infections", "OBSERVATION", 25, 35]]], ["To match the three indices to established literature (Table 3 ), the infection rates I age for children, adults, and seniors are calibrated to 0.1, 0.08, and 0.09, respectively.", [["infection", "DISEASE", 69, 78], ["children", "ORGANISM", 95, 103], ["children", "SPECIES", 95, 103], ["the infection rates", "PROBLEM", 65, 84], ["infection", "OBSERVATION", 69, 78]]], ["In addition, the effectiveness of occasional contacts for infection E ocassional_contact is calibrated to 0.2.", [["infection", "DISEASE", 58, 67], ["infection E ocassional_contact", "TREATMENT", 58, 88]]], ["To validate the model, weekly reports of laboratory confirmed specimens in the 2004-2005 influenza season are collected from New York State Department of Health (NYSDOH, 2005) .", [["specimens", "ANATOMY", 62, 71], ["influenza", "DISEASE", 89, 98]]], ["As shown in Fig. 6 , the time course of the epidemic is well predicted by the model, although the magnitude of simulated cases is much larger than the laboratory data.", [["larger", "OBSERVATION_MODIFIER", 135, 141]]], ["The first possible reason is that a large number of infected individuals (more than 80%) may choose selfcare and are reluctant to seek health care (McIsaac, Levine, & Goel, 1998; Stoller et al., 1993) .", [["infected individuals", "PROBLEM", 52, 72], ["large", "OBSERVATION_MODIFIER", 36, 41], ["number", "OBSERVATION_MODIFIER", 42, 48], ["infected", "OBSERVATION", 52, 60]]], ["These infected individuals cannot be identified and reported.", [["individuals", "ORGANISM", 15, 26], ["These infected individuals", "PROBLEM", 0, 26], ["infected", "OBSERVATION", 6, 14], ["cannot be identified", "UNCERTAINTY", 27, 47]]], ["Second, for those who seek health care, only a small portion of their specimens are submitted for laboratory testing.", [["specimens", "ANATOMY", 70, 79], ["specimens", "CANCER", 70, 79], ["laboratory testing", "TEST", 98, 116]]], ["Therefore, the number of influenza cases is always highly under-reported, and a complete data is rather difficult to collect.", [["influenza", "DISEASE", 25, 34], ["influenza cases", "PROBLEM", 25, 40], ["a complete data", "TEST", 78, 93]]], ["The laboratory data, so far, may be the best available touchstone for model validation.", [["The laboratory data", "TEST", 0, 19]]], ["The calibration and validation indicate that the established model is a close representation of influenza transmission.", [["influenza", "DISEASE", 96, 105], ["The calibration and validation", "TEST", 0, 30], ["influenza transmission", "PROBLEM", 96, 118], ["influenza", "OBSERVATION", 96, 105]]], ["Based on this model, the information about every infection event can be traced, such as who infects whom, and where and when the infection occurs.", [["infection", "DISEASE", 49, 58], ["infection", "DISEASE", 129, 138], ["every infection event", "PROBLEM", 43, 64], ["the infection", "PROBLEM", 125, 138], ["infection", "OBSERVATION", 129, 138]]], ["This information provides detailed clues for analyzing the spatial-temporal transmission of influenza.Time sequence of influenza transmissionThe epidemic curves in Fig. 7 indicate similar temporal dynamics of influenza transmission under the four seeding scenarios.", [["influenza", "DISEASE", 92, 101], ["influenza transmission", "DISEASE", 119, 141], ["influenza", "DISEASE", 209, 218], ["influenza", "PROBLEM", 92, 101], ["influenza transmission", "PROBLEM", 119, 141], ["The epidemic curves in Fig", "PROBLEM", 141, 167], ["influenza transmission", "PROBLEM", 209, 231], ["influenza", "OBSERVATION", 92, 101], ["epidemic", "OBSERVATION_MODIFIER", 145, 153], ["curves", "OBSERVATION_MODIFIER", 154, 160], ["Fig", "OBSERVATION_MODIFIER", 164, 167], ["similar", "OBSERVATION_MODIFIER", 180, 187], ["temporal", "OBSERVATION_MODIFIER", 188, 196], ["influenza", "OBSERVATION", 209, 218], ["seeding scenarios", "OBSERVATION", 247, 264]]], ["No matter where the infection sources are initially distributed, the influenza epidemic develops similarly with respect to the peak time, peak number of new cases, and total number of cases.", [["infection", "DISEASE", 20, 29], ["influenza", "DISEASE", 69, 78], ["the infection sources", "PROBLEM", 16, 37], ["the influenza epidemic", "PROBLEM", 65, 87], ["matter", "OBSERVATION", 3, 9], ["infection", "OBSERVATION", 20, 29], ["new", "OBSERVATION_MODIFIER", 153, 156]]], ["The epidemic curves start with a very slow increase as time proceeds to Day 40 with a cumulative number of influ-enza cases around 2800 (2.84\u2030 of the population).", [["The epidemic curves", "PROBLEM", 0, 19]]], ["An abrupt rise begins approximately after Day 40, and subsequently the number of daily new cases peaks at around Day 70.", [["An abrupt rise", "PROBLEM", 0, 14], ["abrupt", "OBSERVATION_MODIFIER", 3, 9], ["rise", "OBSERVATION_MODIFIER", 10, 14]]], ["The average peak number is 5450 new cases, about 5.54\u2030 of the population.", [["average", "OBSERVATION_MODIFIER", 4, 11], ["peak", "OBSERVATION_MODIFIER", 12, 16], ["new", "OBSERVATION_MODIFIER", 32, 35]]], ["After the peak, the number of daily new cases drops quickly until the end of the epidemic.", [["peak", "OBSERVATION_MODIFIER", 10, 14]]], ["It is worth mentioning that the number of daily new cases is cyclical over time, increasing during weekdays and decreasing during weekends.", [["cyclical", "OBSERVATION_MODIFIER", 61, 69]]], ["This results in a bumpy curve rather than a smooth one.Spatial spread of influenzaThe spatial spread of influenza is of interest.", [["influenza", "DISEASE", 73, 82], ["influenza", "DISEASE", 104, 113], ["influenza", "ORGANISM", 73, 82], ["influenza", "SPECIES", 73, 82], ["a bumpy curve", "TEST", 16, 29], ["influenza", "PROBLEM", 73, 82], ["influenza", "PROBLEM", 104, 113], ["influenza", "OBSERVATION", 73, 82], ["spatial", "OBSERVATION_MODIFIER", 86, 93], ["spread", "OBSERVATION_MODIFIER", 94, 100], ["influenza", "OBSERVATION", 104, 113]]], ["8 and 9 , the infection intensity at each cell location is categorized into five levels: extremely low (0-10 infections/sq km 2 ), low (10-50), moderate (50-100), high (100-500), and extremely high (500-1000).", [["cell", "ANATOMY", 42, 46], ["infection", "DISEASE", 14, 23], ["infections", "DISEASE", 109, 119], ["cell", "CELL", 42, 46], ["the infection intensity", "PROBLEM", 10, 33], ["extremely low", "PROBLEM", 89, 102], ["infections/sq km", "TEST", 109, 125], ["infection", "OBSERVATION", 14, 23], ["low", "OBSERVATION_MODIFIER", 99, 102], ["moderate", "OBSERVATION_MODIFIER", 144, 152], ["high", "OBSERVATION_MODIFIER", 193, 197]]], ["For the first 40 days, the four seeding scenarios produce different spatial patterns of infection.", [["infection", "DISEASE", 88, 97], ["the four seeding scenarios", "PROBLEM", 23, 49], ["infection", "PROBLEM", 88, 97], ["different", "OBSERVATION_MODIFIER", 58, 67], ["spatial", "OBSERVATION_MODIFIER", 68, 75], ["patterns", "OBSERVATION_MODIFIER", 76, 84], ["infection", "OBSERVATION", 88, 97]]], ["As shown in Fig. 8 , the infections tend to be limited to areas around the seeding locations, producing moderate infection intensity.", [["infections", "DISEASE", 25, 35], ["infection", "DISEASE", 113, 122], ["the infections", "PROBLEM", 21, 35], ["moderate infection intensity", "PROBLEM", 104, 132], ["infections", "OBSERVATION", 25, 35], ["seeding locations", "OBSERVATION", 75, 92], ["moderate", "OBSERVATION_MODIFIER", 104, 112], ["infection", "OBSERVATION", 113, 122], ["intensity", "OBSERVATION_MODIFIER", 123, 132]]], ["In addition, there are a few lowintensity areas distant from the seeding locations, most likely to occur within the downtown Buffalo, the downtown Niagara Falls, the University of Buffalo, and the Niagara University.", [["a few lowintensity areas", "PROBLEM", 23, 47], ["few", "OBSERVATION_MODIFIER", 25, 28], ["lowintensity", "OBSERVATION_MODIFIER", 29, 41], ["areas", "OBSERVATION_MODIFIER", 42, 47], ["distant", "OBSERVATION_MODIFIER", 48, 55], ["seeding locations", "OBSERVATION", 65, 82], ["most likely", "UNCERTAINTY", 84, 95]]], ["After Day 40, as the number of new infections increases exponentially, the spatial spread of influenza tends to be similar for all four seeding scenarios.", [["infections", "DISEASE", 35, 45], ["influenza", "DISEASE", 93, 102], ["new infections", "PROBLEM", 31, 45], ["influenza", "PROBLEM", 93, 102], ["new", "OBSERVATION_MODIFIER", 31, 34], ["infections", "OBSERVATION", 35, 45], ["influenza", "OBSERVATION", 93, 102], ["seeding scenarios", "OBSERVATION", 136, 153]]], ["For this reason, Fig. 9 only displays the spatial spread of influenza under the random seeding scenario, while the other three scenarios are reported in the supplementary document.", [["influenza", "DISEASE", 60, 69], ["influenza", "PROBLEM", 60, 69], ["influenza", "OBSERVATION", 60, 69]]], ["Be- tween Days 41 and 60 (Fig. 9a) , the infections span long distances and the epidemic rapidly transforms from being predominantly local to city-wide.", [["infections", "DISEASE", 41, 51], ["the infections span long distances", "PROBLEM", 37, 71], ["infections", "OBSERVATION", 41, 51], ["epidemic", "OBSERVATION_MODIFIER", 80, 88], ["rapidly", "OBSERVATION_MODIFIER", 89, 96], ["predominantly", "OBSERVATION_MODIFIER", 119, 132], ["local", "OBSERVATION_MODIFIER", 133, 138], ["wide", "OBSERVATION_MODIFIER", 147, 151]]], ["High infection intensity begins to occur in the CBD and transition zone, while low infection intensity covers the entire suburbs.Spatial spread of influenzaFrom Days 61 to 80 (Fig. 9b) , the entire study area is undergoing a fast and heterogeneous growth in infections.", [["infection", "DISEASE", 5, 14], ["infection", "DISEASE", 83, 92], ["influenza", "DISEASE", 147, 156], ["infections", "DISEASE", 258, 268], ["CBD", "CHEMICAL", 48, 51], ["High infection intensity", "PROBLEM", 0, 24], ["transition zone", "PROBLEM", 56, 71], ["low infection intensity", "PROBLEM", 79, 102], ["influenza", "PROBLEM", 147, 156], ["the entire study", "TEST", 187, 203], ["a fast and heterogeneous growth in infections", "PROBLEM", 223, 268], ["infection", "OBSERVATION", 5, 14], ["CBD", "ANATOMY", 48, 51], ["transition", "OBSERVATION_MODIFIER", 56, 66], ["zone", "OBSERVATION_MODIFIER", 67, 71], ["low", "OBSERVATION_MODIFIER", 79, 82], ["infection", "OBSERVATION", 83, 92], ["spread", "OBSERVATION_MODIFIER", 137, 143], ["influenza", "OBSERVATION", 147, 156], ["heterogeneous", "OBSERVATION_MODIFIER", 234, 247], ["growth", "OBSERVATION_MODIFIER", 248, 254], ["infections", "OBSERVATION", 258, 268]]], ["Five areas with extremely high-intensity values are identified, including the downtown Buffalo, the south campus of University of Buffalo, the town center of Kenmore, the industrial area in southern Buffalo, and the downtown Niagara Falls (ordered by the spatial extent from the largest to the smallest).", [["extremely high-intensity values", "PROBLEM", 16, 47], ["the downtown Niagara Falls", "PROBLEM", 212, 238], ["extremely", "OBSERVATION_MODIFIER", 16, 25], ["high", "OBSERVATION", 26, 30], ["intensity values", "OBSERVATION_MODIFIER", 31, 47], ["industrial", "OBSERVATION_MODIFIER", 171, 181], ["area", "OBSERVATION_MODIFIER", 182, 186], ["largest", "OBSERVATION_MODIFIER", 279, 286]]], ["The remaining areas, covering most parts of the transition zone and suburbs, are dominated by high infection intensity.", [["infection", "DISEASE", 99, 108], ["high infection intensity", "PROBLEM", 94, 118], ["remaining", "OBSERVATION_MODIFIER", 4, 13], ["areas", "OBSERVATION_MODIFIER", 14, 19], ["most parts", "OBSERVATION_MODIFIER", 30, 40], ["transition", "OBSERVATION_MODIFIER", 48, 58], ["zone", "OBSERVATION_MODIFIER", 59, 63], ["suburbs", "OBSERVATION_MODIFIER", 68, 75], ["dominated", "OBSERVATION_MODIFIER", 81, 90], ["high", "OBSERVATION_MODIFIER", 94, 98], ["infection", "OBSERVATION", 99, 108], ["intensity", "OBSERVATION_MODIFIER", 109, 118]]], ["From Days 81 to 100 (Fig. 9c) , the spatial extent of high infection intensity gradually recedes to the transition zone, leaving the suburbs with moderate or low infection intensity.", [["infection", "DISEASE", 59, 68], ["infection", "DISEASE", 162, 171], ["high infection intensity", "PROBLEM", 54, 78], ["the transition zone", "PROBLEM", 100, 119], ["moderate or low infection intensity", "PROBLEM", 146, 181], ["high", "OBSERVATION_MODIFIER", 54, 58], ["infection", "OBSERVATION", 59, 68], ["intensity", "OBSERVATION_MODIFIER", 69, 78], ["moderate", "OBSERVATION_MODIFIER", 146, 154], ["low", "OBSERVATION_MODIFIER", 158, 161], ["infection", "OBSERVATION", 162, 171]]], ["In the final 20 days (Days 101-120) , only a small area in the CBD retains high-intensity infection (Fig. 9d) .", [["infection", "DISEASE", 90, 99], ["CBD", "CHEMICAL", 63, 66], ["a small area in the CBD", "PROBLEM", 43, 66], ["high-intensity infection", "PROBLEM", 75, 99], ["small", "OBSERVATION_MODIFIER", 45, 50], ["area", "OBSERVATION_MODIFIER", 51, 55], ["CBD", "ANATOMY", 63, 66], ["high", "OBSERVATION_MODIFIER", 75, 79], ["intensity", "OBSERVATION_MODIFIER", 80, 89], ["infection", "OBSERVATION", 90, 99]]], ["For the remaining areas, the intensity decreases rapidly from the transition zone to the suburbs.DiscussionThe epidemic curves in Fig. 7 imply that the first month of a flu season (before Day 40) would be crucial for influenza control and prevention.", [["flu", "DISEASE", 169, 172], ["influenza control", "TREATMENT", 217, 234], ["remaining", "OBSERVATION_MODIFIER", 8, 17], ["areas", "OBSERVATION_MODIFIER", 18, 23], ["intensity", "OBSERVATION_MODIFIER", 29, 38], ["decreases", "OBSERVATION_MODIFIER", 39, 48], ["rapidly", "OBSERVATION_MODIFIER", 49, 56], ["transition", "OBSERVATION_MODIFIER", 66, 76], ["zone", "OBSERVATION_MODIFIER", 77, 81]]], ["This is because the number of influenza cases increases slowly before Day 40, and the response time is relatively sufficient.", [["influenza", "DISEASE", 30, 39], ["influenza cases", "PROBLEM", 30, 45], ["influenza", "OBSERVATION", 30, 39]]], ["The epidemic can potentially be avoided by applying voluntary control strategies, such as mass vaccination programs, and campaigns that promote preventive behaviors.", [["voluntary control strategies", "TREATMENT", 52, 80], ["mass vaccination programs", "TREATMENT", 90, 115]]], ["If the early control cannot be achieved, the number of cases would increase dramatically.", [["increase", "OBSERVATION_MODIFIER", 67, 75], ["dramatically", "OBSERVATION_MODIFIER", 76, 88]]], ["Under this circumstance, mandatory control strategies, such as case isolation, contact tracing, and household quarantine, should be implemented to mitigate the impacts of the epidemic.", [["mandatory control strategies", "TREATMENT", 25, 53], ["contact tracing", "TEST", 79, 94]]], ["The weekly variation in the epidemic curves also suggests a possible control strategy that extends the weekend period by 1 or 2 days.", [["the epidemic curves", "PROBLEM", 24, 43]]], ["Because most workplaces and schools are closed simultaneously during the weekends, fewer close contacts may occur than those in weekdays, resulting in fewer infections.", [["infections", "DISEASE", 157, 167], ["fewer infections", "PROBLEM", 151, 167], ["fewer", "OBSERVATION_MODIFIER", 151, 156], ["infections", "OBSERVATION", 157, 167]]], ["The effectiveness of this weekend extension strategy is worthy of investigation.DiscussionThe infection intensity maps (Figs.", [["infection", "DISEASE", 94, 103], ["this weekend extension strategy", "TREATMENT", 21, 52], ["The infection intensity maps", "TEST", 90, 118]]], ["8 and 9) indicate that the spatial spread of influenza can be described by five subsequent stages: local growth, expansion, fast city-wide growth, slow citywide growth, and fade-out.", [["influenza", "DISEASE", 45, 54], ["influenza", "ORGANISM", 45, 54], ["influenza", "PROBLEM", 45, 54], ["local growth", "PROBLEM", 99, 111], ["wide growth", "PROBLEM", 134, 145], ["slow citywide growth", "PROBLEM", 147, 167], ["influenza", "OBSERVATION", 45, 54]]], ["The ''growth\", here, means the number of infections increases.", [["infections", "DISEASE", 41, 51], ["infections", "PROBLEM", 41, 51], ["infections", "OBSERVATION", 41, 51]]], ["As described in the Results section, the early influenza infections are focused around the infection sources (local growth).", [["influenza infections", "DISEASE", 47, 67], ["infection", "DISEASE", 91, 100], ["the early influenza infections", "PROBLEM", 37, 67], ["the infection sources", "PROBLEM", 87, 108], ["early", "OBSERVATION_MODIFIER", 41, 46], ["influenza", "OBSERVATION_MODIFIER", 47, 56], ["infections", "OBSERVATION", 57, 67], ["infection", "OBSERVATION", 91, 100]]], ["Next, the new infections rapidly spread over the entire study area (expansion), probably because of the frequent travel of individuals between the CBD, transition zone, and suburbs.", [["infections", "DISEASE", 14, 24], ["CBD", "CHEMICAL", 147, 150], ["the new infections", "PROBLEM", 6, 24], ["new", "OBSERVATION_MODIFIER", 10, 13], ["infections", "OBSERVATION", 14, 24], ["rapidly", "OBSERVATION_MODIFIER", 25, 32], ["spread", "OBSERVATION_MODIFIER", 33, 39], ["frequent", "OBSERVATION_MODIFIER", 104, 112], ["CBD", "ANATOMY", 147, 150], ["transition", "OBSERVATION_MODIFIER", 152, 162], ["zone", "OBSERVATION_MODIFIER", 163, 167]]], ["Subsequently, most locations in the study area experience a rapid and heterogeneous growth in infections (fast city-wide growth).", [["infections", "DISEASE", 94, 104], ["the study", "TEST", 32, 41], ["a rapid and heterogeneous growth in infections", "PROBLEM", 58, 104], ["rapid", "OBSERVATION_MODIFIER", 60, 65], ["heterogeneous", "OBSERVATION_MODIFIER", 70, 83], ["growth", "OBSERVATION_MODIFIER", 84, 90], ["infections", "OBSERVATION", 94, 104]]], ["As time proceeds, the growth of infections remains widespread but starts to slow down (slow city-wide growth).", [["infections", "DISEASE", 32, 42], ["infections", "PROBLEM", 32, 42], ["growth", "OBSERVATION_MODIFIER", 22, 28], ["infections", "OBSERVATION", 32, 42]]], ["Finally, the growth of infections at every location fades out, possibly due to the herd immunity provided by recovered individuals.DiscussionThis five-stage spreading process implies the existence of highrisk times and places in the study area.", [["infections", "DISEASE", 23, 33], ["infections", "PROBLEM", 23, 33], ["stage spreading process", "PROBLEM", 151, 174], ["growth", "OBSERVATION_MODIFIER", 13, 19], ["infections", "OBSERVATION", 23, 33], ["possibly due to", "UNCERTAINTY", 63, 78]]], ["High-risk times occur when the total number of infections rises significantly, or when the spatial extent of affected areas expands rapidly.", [["infections", "DISEASE", 47, 57], ["infections", "PROBLEM", 47, 57], ["affected areas", "PROBLEM", 109, 123], ["risk times", "OBSERVATION_MODIFIER", 5, 15], ["infections", "OBSERVATION", 47, 57], ["affected", "OBSERVATION_MODIFIER", 109, 117], ["areas", "OBSERVATION", 118, 123]]], ["Days 41-60 and Days 61-80 are two high-risk time periods corresponding to the stages of expansion and fast city-wide growth, respectively.", [["expansion", "PROBLEM", 88, 97], ["expansion", "OBSERVATION_MODIFIER", 88, 97], ["wide", "OBSERVATION_MODIFIER", 112, 116], ["growth", "OBSERVATION_MODIFIER", 117, 123]]], ["On the other hand, high-risk places can be identified as areas with extremely high intensity of infection.", [["infection", "DISEASE", 96, 105], ["extremely high intensity of infection", "PROBLEM", 68, 105], ["high intensity", "OBSERVATION_MODIFIER", 78, 92], ["infection", "OBSERVATION", 96, 105]]], ["The downtown areas of both cities are at high risk because they have the highest densities of residents and businesses.", [["downtown", "OBSERVATION_MODIFIER", 4, 12], ["areas", "OBSERVATION_MODIFIER", 13, 18], ["both", "OBSERVATION_MODIFIER", 22, 26], ["cities", "OBSERVATION", 27, 33], ["high risk", "OBSERVATION_MODIFIER", 41, 50], ["highest", "OBSERVATION_MODIFIER", 73, 80], ["densities", "OBSERVATION", 81, 90]]], ["Similarly, the town center of Kenmore is also sug-gested to be a high-risk place because of its intensive land use for residences, commerce and industry.", [["Kenmore", "CHEMICAL", 30, 37]]], ["The university campuses are large groups of individuals with dense within-group contacts, and they thus are at high risk.", [["large", "OBSERVATION_MODIFIER", 28, 33], ["dense", "OBSERVATION_MODIFIER", 61, 66]]], ["Likewise, the industrial park in southern Buffalo is another high-risk place, because it is a cluster of large-scale chemical factories with a large number of workers.", [["high-risk", "OBSERVATION_MODIFIER", 61, 70], ["large", "OBSERVATION_MODIFIER", 105, 110], ["large", "OBSERVATION_MODIFIER", 143, 148]]], ["Once influenza is identified in the study area, these high-risk places should be monitored under close surveillance and be targeted by control efforts with priority.DiscussionIn summary, the spatial-temporal transmission of influenza and the resulting health risks can be attributed to two major and one minor factor.", [["influenza", "DISEASE", 5, 14], ["influenza", "DISEASE", 224, 233], ["influenza", "PROBLEM", 5, 14], ["the study area", "TEST", 32, 46], ["influenza", "PROBLEM", 224, 233], ["influenza", "OBSERVATION", 224, 233]]], ["One of the two major factors is the spatial heterogeneity in the city, in terms of the population distribution and land use patterns (households and businesses).", [["two", "OBSERVATION_MODIFIER", 11, 14], ["major", "OBSERVATION_MODIFIER", 15, 20], ["spatial", "OBSERVATION_MODIFIER", 36, 43], ["heterogeneity", "OBSERVATION", 44, 57], ["population", "OBSERVATION", 87, 97]]], ["This factor directly influences the spatial layout of disease transmission.", [["disease transmission", "PROBLEM", 54, 74], ["spatial", "OBSERVATION_MODIFIER", 36, 43], ["layout", "OBSERVATION_MODIFIER", 44, 50], ["disease", "OBSERVATION", 54, 61]]], ["Areas with dense population or intensive land use patterns always end up with a high intensity of infection, while sparsely populated areas have relatively low intensity.", [["infection", "DISEASE", 98, 107], ["dense population", "PROBLEM", 11, 27], ["a high intensity of infection", "PROBLEM", 78, 107], ["relatively low intensity", "PROBLEM", 145, 169], ["dense", "OBSERVATION_MODIFIER", 11, 16], ["population", "OBSERVATION", 17, 27], ["intensive", "OBSERVATION_MODIFIER", 31, 40], ["high intensity", "OBSERVATION_MODIFIER", 80, 94], ["infection", "OBSERVATION", 98, 107], ["sparsely", "OBSERVATION_MODIFIER", 115, 123], ["populated", "OBSERVATION_MODIFIER", 124, 133], ["relatively", "OBSERVATION_MODIFIER", 145, 155], ["low intensity", "OBSERVATION_MODIFIER", 156, 169]]], ["The other major factor is the travel of individuals in the city, which has a profound effect on the temporal sequence of transmission.", [["major", "OBSERVATION_MODIFIER", 10, 15], ["profound", "OBSERVATION_MODIFIER", 77, 85], ["effect", "OBSERVATION_MODIFIER", 86, 92]]], ["Without frequent travel of individuals between the CBD, transition zone, and suburbs, the infection can only expand locally around the infection sources.", [["infection", "DISEASE", 90, 99], ["infection", "DISEASE", 135, 144], ["CBD", "CHEMICAL", 51, 54], ["transition zone", "PROBLEM", 56, 71], ["the infection", "PROBLEM", 86, 99], ["the infection sources", "PROBLEM", 131, 152], ["CBD", "ANATOMY", 51, 54], ["infection", "OBSERVATION", 90, 99], ["infection", "OBSERVATION", 135, 144]]], ["The city-wide travel of individuals quickly transports influenza viruses to everywhere else, leading to the rapid expansion of affected areas.DiscussionThe one minor factor is the initial distribution of the infection sources.", [["influenza viruses", "DISEASE", 55, 72], ["infection", "DISEASE", 208, 217], ["influenza viruses", "PROBLEM", 55, 72], ["the rapid expansion of affected areas", "PROBLEM", 104, 141], ["the infection sources", "PROBLEM", 204, 225], ["rapid", "OBSERVATION_MODIFIER", 108, 113], ["expansion", "OBSERVATION", 114, 123], ["affected", "OBSERVATION_MODIFIER", 127, 135], ["areas", "OBSERVATION", 136, 141], ["infection", "OBSERVATION", 208, 217]]], ["Regardless of where the infection sources are seeded, both the spatial layout and the temporal sequence of influenza transmission are similar, except for the early stage.", [["infection", "DISEASE", 24, 33], ["influenza", "DISEASE", 107, 116], ["the infection sources", "PROBLEM", 20, 41], ["influenza transmission", "PROBLEM", 107, 129], ["infection", "OBSERVATION", 24, 33], ["influenza", "OBSERVATION", 107, 116]]], ["It is intuitive that the spatial layout of transmission is similar under different seeding scenarios, because it is primarily determined by the inherent population distribution and land use patterns.", [["seeding scenarios", "OBSERVATION", 83, 100], ["inherent", "OBSERVATION_MODIFIER", 144, 152], ["population", "OBSERVATION", 153, 163]]], ["Surprisingly, the temporal sequence of transmission also remains similar, and is insensitive to where infection sources are seeded.", [["infection", "DISEASE", 102, 111], ["infection sources", "PROBLEM", 102, 119]]], ["A possible reason is that individuals commute frequently between the three zones of the city, and can easily reach everywhere in the study area.", [["possible", "UNCERTAINTY", 2, 10]]], ["Once the infection sources infect a sufficient number of surrounding individuals, the influenza viruses can be transported to places of high risks, from where similar spatialtemporal patterns of infection start to occur.", [["infection", "DISEASE", 9, 18], ["influenza viruses", "DISEASE", 86, 103], ["infection", "DISEASE", 195, 204], ["influenza viruses", "ORGANISM", 86, 103], ["the infection sources", "PROBLEM", 5, 26], ["surrounding individuals", "PROBLEM", 57, 80], ["the influenza viruses", "PROBLEM", 82, 103], ["infection", "PROBLEM", 195, 204], ["infection", "OBSERVATION", 9, 18], ["sufficient", "OBSERVATION_MODIFIER", 36, 46], ["number", "OBSERVATION_MODIFIER", 47, 53], ["infection", "OBSERVATION", 195, 204]]], ["This finding implies that wherever the initial infections are found, the control plan does not need a major change, and the control efforts may be only applied at fixed times and places.", [["infections", "DISEASE", 47, 57], ["the initial infections", "PROBLEM", 35, 57], ["infections", "OBSERVATION", 47, 57]]], ["Further investigations of this finding are warranted.DiscussionThere are three limitations of this study due to the complex disease system in a city.", [["Further investigations", "TEST", 0, 22], ["this study", "TEST", 94, 104], ["the complex disease system", "PROBLEM", 112, 138], ["complex", "OBSERVATION_MODIFIER", 116, 123], ["disease", "OBSERVATION", 124, 131]]], ["First, the behaviors of susceptible individuals do not change during the epidemic.", [["susceptible individuals", "PROBLEM", 24, 47]]], ["In reality, these individuals may be influenced by their contacts, and spontaneously take preventive behaviors to protect themselves.", [["individuals", "ORGANISM", 18, 29]]], ["Second, the simulation of population involves the disaggregation of census data, and assumes independence between a few of demographic variables.", [["few", "OBSERVATION_MODIFIER", 116, 119]]], ["Finally, this study assumes that immunity is obtained through early vaccination before the epidemic or through infection during the epidemic.", [["infection", "DISEASE", 111, 120], ["this study", "TEST", 9, 19], ["early vaccination", "TREATMENT", 62, 79], ["infection", "PROBLEM", 111, 120], ["infection", "OBSERVATION", 111, 120]]], ["It is also possible that individuals can gain immunity from previous epidemics, and therefore the immunity rate may be under-estimated.", [["individuals", "ORGANISM", 25, 36], ["previous epidemics", "PROBLEM", 60, 78], ["the immunity rate", "TEST", 94, 111], ["also possible", "UNCERTAINTY", 6, 19]]], ["In this sense, the model results provide valuable knowledge regarding city-wide influenza transmission.Conclusions and implicationsThis study contributes to the knowledge regarding influenza transmission at the city-wide scale, a topic that is under-studied in the current literature.", [["influenza", "DISEASE", 80, 89], ["influenza", "DISEASE", 181, 190], ["wide influenza transmission", "PROBLEM", 75, 102], ["This study", "TEST", 131, 141], ["influenza transmission", "PROBLEM", 181, 203]]], ["An individual-based spatially explicit model has been developed to simulate influenza transmission through an urban contact network.", [["influenza", "DISEASE", 76, 85]]], ["The simulation results indicate a complex pattern of influenza transmission in a five-stage process.", [["influenza", "DISEASE", 53, 62], ["influenza transmission", "PROBLEM", 53, 75], ["complex", "OBSERVATION_MODIFIER", 34, 41], ["influenza", "OBSERVATION", 53, 62], ["five-stage", "OBSERVATION_MODIFIER", 81, 91]]], ["The complexity is attributable to three factors: the spatial heterogeneity in the population, the frequent city-wide travel of individuals, and the distribution of infection sources.", [["infection", "DISEASE", 164, 173], ["the spatial heterogeneity in the population", "PROBLEM", 49, 92], ["infection sources", "PROBLEM", 164, 181], ["spatial", "OBSERVATION_MODIFIER", 53, 60], ["heterogeneity", "OBSERVATION_MODIFIER", 61, 74], ["population", "OBSERVATION_MODIFIER", 82, 92], ["frequent", "OBSERVATION_MODIFIER", 98, 106], ["wide", "OBSERVATION_MODIFIER", 112, 116], ["infection", "OBSERVATION", 164, 173]]], ["The first factor primarily contributes to the spatial layout of disease transmission, while the second has a profound effect on the temporal sequence of transmission.", [["disease transmission", "PROBLEM", 64, 84], ["a profound effect", "PROBLEM", 107, 124], ["spatial", "OBSERVATION_MODIFIER", 46, 53], ["layout", "OBSERVATION_MODIFIER", 54, 60], ["disease", "OBSERVATION", 64, 71], ["profound", "OBSERVATION_MODIFIER", 109, 117], ["effect", "OBSERVATION", 118, 124]]], ["The third factor, the infectionsource distribution, only affects spatial-temporal transmission at the early stage, but its effect is largely weakened later by the city-wide travel of individuals.", [["the infectionsource distribution", "PROBLEM", 18, 50], ["temporal", "OBSERVATION_MODIFIER", 73, 81], ["early stage", "OBSERVATION_MODIFIER", 102, 113], ["largely", "OBSERVATION_MODIFIER", 133, 140], ["weakened", "OBSERVATION", 141, 149]]], ["Therefore, the high risks of infection occur not only at the same locations, but also at almost the same times, regardless of where the infection sources are introduced.", [["infection", "DISEASE", 29, 38], ["infection", "DISEASE", 136, 145], ["infection", "PROBLEM", 29, 38], ["the infection sources", "PROBLEM", 132, 153], ["infection", "OBSERVATION", 29, 38], ["infection", "OBSERVATION", 136, 145]]], ["A number of studies may have reported the spatial similarity in high-risk places, but the temporal similarity has not been revealed before this study.Conclusions and implicationsThese results suggest a feasibility of identifying high-risk areas in advance based on analysis of census and land use data.", [["this study", "TEST", 139, 149], ["high-risk areas", "PROBLEM", 229, 244]]], ["These high-risk places should be set up as control targets during an epidemic wherever the initial infections are found.", [["infections", "DISEASE", 99, 109], ["the initial infections", "PROBLEM", 87, 109], ["infections", "OBSERVATION", 99, 109]]], ["In addition, the results also imply that the incorporation of city-wide individual travel data into health surveillance is critical for designing proper timelines for allocating control efforts.", [["allocating control efforts", "TREATMENT", 167, 193]]], ["These suggestions are particularly significant under the current circumstances in which vaccines and manpower are insufficient to combat the new wave of H1N1 influenza.", [["influenza", "DISEASE", 158, 167], ["H1N1 influenza", "ORGANISM", 153, 167], ["H1N1 influenza", "PROBLEM", 153, 167], ["H1N1 influenza", "OBSERVATION", 153, 167]]]], "042d606830942bb62835c8e7c3bd98615ef8bdad": [["IntroductionThe coronavirus pandemic has generated an understandable concern about the effects of smoking on disease susceptibility and severity.", [["coronavirus pandemic", "DISEASE", 16, 36], ["smoking", "CHEMICAL", 98, 105], ["coronavirus", "ORGANISM", 16, 27], ["disease susceptibility and severity", "PROBLEM", 109, 144], ["coronavirus", "OBSERVATION", 16, 27]]], ["Smoking is an established risk factor respiratory infections.", [["respiratory", "ANATOMY", 38, 49], ["Smoking", "DISEASE", 0, 7], ["respiratory infections", "DISEASE", 38, 60], ["an established risk factor respiratory infections", "PROBLEM", 11, 60], ["respiratory infections", "OBSERVATION", 38, 60]]], ["1 Media reports and opinion pieces have made reasonable suggestions that smoking may be detrimental in case of infection with SARS-CoV-2, assuming that the gender differences in COVID-19 vulnerability and mortality may be due to the increased prevalence of smoking among Chinese men compared with women.", [["smoking", "CHEMICAL", 73, 80], ["infection", "DISEASE", 111, 120], ["SARS", "DISEASE", 126, 130], ["smoking", "CHEMICAL", 257, 264], ["SARS-CoV-2", "ORGANISM", 126, 136], ["men", "ORGANISM", 279, 282], ["women", "ORGANISM", 297, 302], ["men", "SPECIES", 279, 282], ["women", "SPECIES", 297, 302], ["SARS-CoV", "SPECIES", 126, 134], ["infection", "PROBLEM", 111, 120], ["SARS", "PROBLEM", 126, 130], ["COVID", "TEST", 178, 183], ["infection", "OBSERVATION", 111, 120]]], ["2, 3 However, until recently, clinical data were lacking.", [["clinical data", "TEST", 30, 43]]], ["A study of patients found that history of smoking increased the risk for disease progression by more than 14-fold.", [["smoking", "CHEMICAL", 42, 49], ["patients", "ORGANISM", 11, 19], ["patients", "SPECIES", 11, 19], ["A study", "TEST", 0, 7], ["disease progression", "PROBLEM", 73, 92]]], ["4 However, the association was weak and with a wide 95% confidence interval (CI) since only five smoking patients were included, of whom three progressed to severe disease.", [["patients", "ORGANISM", 105, 113], ["patients", "SPECIES", 105, 113], ["severe disease", "PROBLEM", 157, 171], ["severe", "OBSERVATION_MODIFIER", 157, 163], ["disease", "OBSERVATION", 164, 171]]], ["A meta-analysis of five case series from China found that current smokers had a statistically insignificant increase in the odds of progressing to severe COVID-19.", [["COVID", "DISEASE", 154, 159], ["COVID-19", "CHEMICAL", 154, 162], ["severe COVID", "PROBLEM", 147, 159], ["insignificant", "OBSERVATION_MODIFIER", 94, 107], ["increase", "OBSERVATION_MODIFIER", 108, 116]]], ["5 However, another systematic review reported that smokers were more likely to be admitted to an intensive care unit (ICU), need mechanical ventilation, or die compared with non-smokers.", [["smokers", "ORGANISM", 51, 58], ["mechanical ventilation", "TREATMENT", 129, 151], ["mechanical ventilation", "OBSERVATION", 129, 151]]], ["6 Smoking is an established risk factor for a variety of diseases, including cardiovascular disease and chronic obstructive pulmonary disease (COPD), which appear to be risk factors for severe COVID-19 and adverse outcome.", [["cardiovascular", "ANATOMY", 77, 91], ["pulmonary", "ANATOMY", 124, 133], ["cardiovascular disease", "DISEASE", 77, 99], ["chronic obstructive pulmonary disease", "DISEASE", 104, 141], ["COPD", "DISEASE", 143, 147], ["COVID", "DISEASE", 193, 198], ["pulmonary", "ORGAN", 124, 133], ["a variety of diseases", "PROBLEM", 44, 65], ["cardiovascular disease", "PROBLEM", 77, 99], ["chronic obstructive pulmonary disease", "PROBLEM", 104, 141], ["COPD)", "PROBLEM", 143, 148], ["severe COVID", "PROBLEM", 186, 198], ["adverse outcome", "PROBLEM", 206, 221], ["diseases", "OBSERVATION", 57, 65], ["cardiovascular", "ANATOMY", 77, 91], ["chronic", "OBSERVATION_MODIFIER", 104, 111], ["obstructive", "OBSERVATION_MODIFIER", 112, 123], ["pulmonary", "ANATOMY", 124, 133], ["disease", "OBSERVATION", 134, 141], ["COPD", "OBSERVATION", 143, 147]]], ["7 Thus, it would be expected for smokers to be over-represented among COVID-19 patients.", [["patients", "ORGANISM", 79, 87], ["patients", "SPECIES", 79, 87]]], ["Still, in a recent meta-analysis of 13 studies of hospitalized COVID-19 patients in China, an unexpectedly low prevalence of smoking, approximately one-fourth the population smoking prevalence, was found.", [["COVID", "DISEASE", 63, 68], ["smoking", "CHEMICAL", 125, 132], ["smoking", "CHEMICAL", 174, 181], ["patients", "ORGANISM", 72, 80], ["patients", "SPECIES", 72, 80], ["low prevalence", "OBSERVATION_MODIFIER", 107, 121]]], ["8 To further explore this issue, we performed a systematic review of case series presenting data on the smoking status of hospitalized COVID-19 patients in order to:Introduction1.", [["patients", "ORGANISM", 144, 152], ["patients", "SPECIES", 144, 152]]], ["Calculate the pooled prevalence of smoking among hospitalized COVID-19 patients and compare it with the expected prevalence based on population smoking rates.", [["smoking", "CHEMICAL", 35, 42], ["patients", "ORGANISM", 71, 79], ["patients", "SPECIES", 71, 79]]], ["Examine the association between current, compared with non-current and former, smoking and adverse outcome in COVID-19.Studies includedA systematic search of the literature (PubMed) was performed for studies published until 25 April 2020 using the terms \"(SARS-CoV-2 OR COVID-19 OR 2019-nCoV) AND (Clinical OR Mortality OR Outcome)\" in the title or the abstract.", [["smoking", "CHEMICAL", 79, 86], ["studies", "TEST", 200, 207], ["CoV", "TEST", 261, 264], ["COVID", "TEST", 270, 275]]], ["Studies were included in the analysis if they satisfied all of the following criteria:Studies included1.", [["Studies", "TEST", 0, 7], ["the analysis", "TEST", 25, 37], ["Studies", "TEST", 86, 93]]], ["Present hospitalized patients with COVID-19 2.", [["patients", "ORGANISM", 21, 29], ["patients", "SPECIES", 21, 29], ["COVID", "TEST", 35, 40]]], ["Classify patients according to disease severity, irrespective of the severity definition 3.", [["patients", "ORGANISM", 9, 17], ["patients", "SPECIES", 9, 17], ["disease severity", "PROBLEM", 31, 47], ["the severity definition", "PROBLEM", 65, 88], ["disease", "OBSERVATION", 31, 38]]], ["Present data on the smoking status, separately for each severity classification.Studies includedOut of a total of 1398 studies, 19 studies fulfilling the previously mentioned criteria were found.", [["Studies", "TEST", 80, 87], ["19 studies", "TEST", 128, 138]]], ["4, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] One study was excluded because of unreliable data since the sum of current and former smokers did not correspond to the numbers presented in different severity subgroups.", [["4, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20]", "CHEMICAL", 0, 61], ["[9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26]", "SIMPLE_CHEMICAL", 3, 91], ["One study", "TEST", 92, 101], ["unreliable data", "PROBLEM", 126, 141]]], ["26 Thus, 18 studies were analyzed.", [["18 studies", "TEST", 9, 19]]], ["All of the studies were retrospective observational case series.", [["the studies", "TEST", 7, 18]]], ["The PRISMA flow diagram is presented in the Supplemental Figure S1 .", [["The PRISMA flow diagram", "TEST", 0, 23], ["flow diagram", "OBSERVATION", 11, 23], ["Supplemental Figure S1", "OBSERVATION", 44, 66]]], ["Most of the studies were from China (n = 15), while two studies presented patients from the United States (US) and one from South Korea.", [["patients", "ORGANISM", 74, 82], ["patients", "SPECIES", 74, 82], ["the studies", "TEST", 8, 19]]], ["Four of the studies recorded separately current and former smokers and were used to examine the association between current, rather than former, smoking and adverse outcome.", [["the studies", "TEST", 8, 19]]], ["9, 13, 20, 21 The rest of the studies reported the smoking status as \"smoking\" or \"history of smoking\" and may have included former smokers.", [["smoking", "CHEMICAL", 94, 101], ["the studies", "TEST", 26, 37]]], ["Three studies had missing smoking data on 14 of 1099, 44 of 645, and 22 of 476 patients.", [["patients", "ORGANISM", 79, 87], ["patients", "SPECIES", 79, 87], ["Three studies", "TEST", 0, 13]]], ["9, 16, 23 The number of patients with available smoking data (1085, 601 and 454, respectively) were used in the calculations.", [["patients", "ORGANISM", 24, 32], ["patients", "SPECIES", 24, 32]]], ["Another study reported unknown smoking history for 13 out of 487 patients (all with mild disease) 17 ; they were also excluded from the analysis.Studies includedIn addition, we sought to identify pre-publications (not peer-reviewed) on the pre-print server Medrxiv.", [["patients", "ORGANISM", 65, 73], ["patients", "SPECIES", 65, 73], ["Another study", "TEST", 0, 13], ["mild disease)", "PROBLEM", 84, 97], ["the analysis", "TEST", 132, 144], ["Studies", "TEST", 145, 152], ["mild", "OBSERVATION_MODIFIER", 84, 88], ["disease", "OBSERVATION", 89, 96]]], ["A total of 123 pre-publications were found, with 12 fulfilling the previously mentioned criteria.", [["total", "OBSERVATION_MODIFIER", 2, 7]]], ["[27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] All of the studies were retrospective observational case series.", [["[27] [28] [29] [30] [31] [32]", "CHEMICAL", 0, 29], ["[27] [28] [29] [30] [31] [32] [33]", "CHEMICAL", 0, 34], ["[27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38", "SIMPLE_CHEMICAL", 0, 58], ["the studies", "TEST", 67, 78]]], ["Of these, nine were from China, two from the US, and one from Japan.", [["the US", "TEST", 41, 47]]], ["Two of the studies recorded current and former smokers separately.", [["the studies", "TEST", 7, 18]]], ["27, 31 The rest of the studies reported smoking status as \"smoking\" or \"history of smoking\" and may have included former smokers.", [["smoking", "CHEMICAL", 83, 90]]], ["One study from the US reported never smokers or unknown history of smoking as one group, without clarifying how many patients had missing data.", [["smoking", "CHEMICAL", 67, 74], ["patients", "ORGANISM", 117, 125], ["patients", "SPECIES", 117, 125], ["One study", "TEST", 0, 9], ["the US", "TEST", 15, 21]]], ["27 Another study reported the smoking status and outcomes for 170 of 200 patients.", [["patients", "ORGANISM", 73, 81], ["patients", "SPECIES", 73, 81], ["Another study", "TEST", 3, 16]]], ["29 In total, 30 studies (published and pre-publications) were used in the secondary analysis, whereas 6 journals.sagepub.com/home/taj 3 studies were used to examine the association between current versus former smoking and adverse outcome.AnalysisA cross-sectional analysis was performed.", [["smoking", "CHEMICAL", 211, 218], ["30 studies", "TEST", 13, 23], ["the secondary analysis", "TEST", 70, 92], ["AnalysisA cross-sectional analysis", "TEST", 239, 273]]], ["In two studies, both outpatients and hospitalized patients were presented.", [["outpatients", "ORGANISM", 21, 32], ["patients", "ORGANISM", 50, 58], ["outpatients", "SPECIES", 21, 32], ["patients", "SPECIES", 50, 58], ["two studies", "TEST", 3, 14]]], ["20, 27 In one of them, 7162 patients were presented in total, of whom 5143 were ambulatory, 1037 were hospitalized in non-ICU units, 457 were hospitalized in ICU units, and for 525 patients the hospitalization status was unknown.", [["patients", "ORGANISM", 28, 36], ["patients", "ORGANISM", 181, 189], ["patients", "SPECIES", 28, 36], ["patients", "SPECIES", 181, 189]]], ["20 Only hospitalized patients (n = 1494) were included to the analysis.", [["patients", "ORGANISM", 21, 29], ["patients", "SPECIES", 21, 29], ["the analysis", "TEST", 58, 70]]], ["In the other study, 2104 patients were ambulatory and 1999 were hospitalized.", [["patients", "ORGANISM", 25, 33], ["patients", "SPECIES", 25, 33], ["the other study", "TEST", 3, 18]]], ["In studies where former smokers were not separately presented, all patients with a positive smoking history were classified as current smokers.", [["smokers", "ORGANISM", 24, 31], ["patients", "ORGANISM", 67, 75], ["patients", "SPECIES", 67, 75]]], ["When presented separately, former smokers were included in the non-current smoking group.AnalysisThe pooled prevalence of current smoking was calculated using random-effects meta-analysis.AnalysisSmoking prevalence in each study was compared with the expected prevalence based on genderspecific population smoking rates.", [["smoking", "CHEMICAL", 130, 137], ["Analysis", "TEST", 89, 97], ["random-effects meta-analysis", "TREATMENT", 159, 187], ["each study", "TEST", 218, 228]]], ["The expected prevalence of smoking in each study was calculated using the gender distribution of patients in each study and the gender-specific population smoking prevalence.", [["smoking", "CHEMICAL", 27, 34], ["smoking", "CHEMICAL", 155, 162], ["patients", "ORGANISM", 97, 105], ["patients", "SPECIES", 97, 105], ["each study", "TEST", 38, 48], ["each study", "TEST", 109, 119]]], ["The following formula was used:Analysiswhere SP E = expected smoking prevalence; P M = male prevalence among patients; SP P-M = population smoking prevalence in males; P F = female prevalence among patients; and SP P-F = population smoking prevalence in females.AnalysisThe observed smoking prevalence was compared with the expected smoking prevalence by calculating prevalence odds ratio (POR).", [["patients", "ORGANISM", 109, 117], ["patients", "ORGANISM", 198, 206], ["patients", "SPECIES", 109, 117], ["patients", "SPECIES", 198, 206]]], ["39 The population smoking rates used to calculate the gender-adjusted expected number of smokers in each study were (males and females, respectively): 50.5% and 2.1% for China, 40 15.6% and 12.0% in the US, 41 35 .8% and 6.5% in South Korea, 42 and 29.3% and 7.2% in Japan.", [["The population smoking rates", "TREATMENT", 3, 31], ["each study", "TEST", 100, 110], ["China", "TEST", 170, 175], ["the US", "TEST", 199, 205], ["South Korea", "TEST", 229, 240]]], ["43 The studies analyzed did not include data on the patients' age distribution.", [["patients", "ORGANISM", 52, 60], ["patients", "SPECIES", 52, 60], ["The studies", "TEST", 3, 14]]], ["Therefore, age-adjustment in the expected smoking prevalence calculation was performed by assuming that all patients were \u2a7e65 years old.", [["patients", "ORGANISM", 108, 116], ["patients", "SPECIES", 108, 116]]], ["This represents a worst-case scenario considering that people aged \u2a7e65 years have the lowest smoking rates compared with other adult age groups while the mean or median age of hospitalized COVID-19 patients was by far lower than 65 years in the studies examined (Table 1) .", [["people", "ORGANISM", 55, 61], ["patients", "ORGANISM", 198, 206], ["people", "SPECIES", 55, 61], ["patients", "SPECIES", 198, 206], ["the studies", "TEST", 241, 252]]], ["The population smoking rates used to calculate the age and gender-adjusted expected number of smokers in each study were (males and females, respectively): 44.0% and 4.1% for China, 40 10.1% and 7.7% in the US, 44 17.9% and 1.9% in South Korea, 45 and 21.2% and 5.4% in Japan.", [["The population smoking rates", "TREATMENT", 0, 28], ["each study", "TEST", 105, 115], ["China", "TEST", 175, 180], ["the US", "TEST", 203, 209], ["South Korea", "TEST", 232, 243]]], ["46, 47 The formula mentioned previously was applied to calculate the gender and ageadjusted expected smoking prevalence.", [["The formula", "TREATMENT", 7, 18]]], ["We report both gender-adjusted and gender and age-adjusted POR.", [["POR", "PROTEIN", 59, 62]]], ["The association between current (versus non-current) smoking and adverse outcome was performed by calculating the odds ratio (OR).", [["smoking", "CHEMICAL", 53, 60]]], ["In addition, the association between current smoking (versus former smoking) and adverse outcome was calculated using the studies that presented data for former smokers separately; never smokers were excluded from the latter analysis.", [["smoking", "CHEMICAL", 45, 52], ["the studies", "TEST", 118, 129], ["the latter analysis", "TEST", 214, 233]]], ["All analyses were performed with random-effects meta-analyses using MetaXL v5.3, with heterogeneity evaluated through I 2 and publication bias examined by visual assessment of funnel plots.Study characteristicsThe characteristics of the studies included in this analysis are presented in Table 1 .", [["All analyses", "TEST", 0, 12], ["MetaXL", "TEST", 68, 74], ["publication bias", "TEST", 126, 142], ["visual assessment", "TEST", 155, 172], ["funnel plots", "TEST", 176, 188], ["Study characteristics", "TEST", 189, 210], ["the studies", "TEST", 233, 244], ["this analysis", "TEST", 257, 270], ["funnel plots", "OBSERVATION", 176, 188]]], ["Published studies included 6515 hospitalized patients, of whom 440 were current smokers.", [["patients", "ORGANISM", 45, 53], ["patients", "SPECIES", 45, 53]]], ["Together with the prepublications, 10,631 patients, with 961 of them being smokers, were examined.", [["patients", "ORGANISM", 42, 50], ["patients", "SPECIES", 42, 50]]], ["Adverse outcomes ranged from non-specific \"severe\" to specific definitions based on clinical criteria or death.", [["death", "DISEASE", 105, 110], ["Adverse outcomes", "PROBLEM", 0, 16], ["non-specific \"severe\"", "PROBLEM", 29, 50], ["death", "PROBLEM", 105, 110]]], ["No publication bias was obvious from the funnel plot.", [["publication bias", "PROBLEM", 3, 19], ["the funnel plot", "TEST", 37, 52], ["publication bias", "OBSERVATION", 3, 19], ["funnel plot", "OBSERVATION", 41, 52]]], ["Outcome definitions for each study are presented in Supplemental Table S1 .Primary analysis (published studies)In published studies, the random-effects pooled prevalence of current smoking was 6.8% (95% CI 4.8-9.1%).", [["smoking", "CHEMICAL", 181, 188], ["each study", "TEST", 24, 34], ["Primary analysis", "TEST", 75, 91], ["published studies", "TEST", 93, 110], ["CI", "TEST", 203, 205]]], ["The gender-adjusted POR, displayed in Figure 1 , was 0.20 (95% CI: 0.16-0.25, p < 0.001) with substantial heterogeneity being observed (I 2 = 68%).", [["POR", "PROTEIN", 20, 23], ["CI", "TEST", 63, 65], ["substantial heterogeneity", "PROBLEM", 94, 119], ["I", "TEST", 136, 137], ["substantial", "OBSERVATION_MODIFIER", 94, 105], ["heterogeneity", "OBSERVATION", 106, 119]]], ["The gender and age-adjusted POR, displayed in Figure 2 Figure 4 ).Secondary analysis (published studies and pre-publications)From the secondary analysis, which included both published studies and pre-publications, the random-effects pooled prevalence of current 8 journals.sagepub.com/home/taj smoking was 9.0% (95% CI: 6.5-11.8%).", [["smoking", "CHEMICAL", 294, 301], ["POR", "PROTEIN", 28, 31], ["Secondary analysis", "TEST", 66, 84], ["published studies", "TEST", 86, 103], ["pre-publications", "TEST", 108, 124], ["the secondary analysis", "TEST", 130, 152], ["both published studies", "TEST", 169, 191], ["pre-publications", "TREATMENT", 196, 212], ["CI", "TEST", 316, 318]]], ["The gender-adjusted POR, displayed in Supplemental Figure S2 , was 0.27 (95% CI: 0.19-0.38, p < 0.001), with considerable heterogeneity being observed (I 2 = 93%).", [["POR", "PROTEIN", 20, 23], ["CI", "TEST", 77, 79], ["considerable heterogeneity", "PROBLEM", 109, 135], ["considerable", "OBSERVATION_MODIFIER", 109, 121], ["heterogeneity", "OBSERVATION", 122, 135]]], ["The gender and age-adjusted POR, displayed in Supplemental Figure S3 , was 0.34 (95% CI: 0.24-0.48, p < 0.001), with considerable heterogeneity being observed (I 2 = 93%).Secondary analysis (published studies and pre-publications)In Chinese studies only, the gender-adjusted POR was 0.24 (95% CI: 0.17-0.33, p < 0.001) and the gender and age-adjusted POR was 0.27 (95% CI: 0.20-0.38, p < 0.001).Secondary analysis (published studies and pre-publications)Current smokers were more likely than non-current smokers to experience an adverse outcome (OR: 1.59, 95% CI: 1.15-2.21, p = 0.006) with moderate heterogeneity being observed (I 2 = 67%, Supplemental Figure S4 ).", [["smokers", "ORGANISM", 462, 469], ["POR", "PROTEIN", 28, 31], ["CI", "TEST", 85, 87], ["considerable heterogeneity", "PROBLEM", 117, 143], ["Secondary analysis", "TEST", 171, 189], ["published studies", "TEST", 191, 208], ["Chinese studies", "TEST", 233, 248], ["CI", "TEST", 293, 295], ["POR", "TEST", 351, 354], ["CI", "TEST", 369, 371], ["Secondary analysis", "TEST", 395, 413], ["published studies", "TEST", 415, 432], ["pre-publications", "TEST", 437, 453], ["CI", "TEST", 560, 562], ["p", "TEST", 575, 576], ["moderate heterogeneity", "PROBLEM", 591, 613], ["considerable", "OBSERVATION_MODIFIER", 117, 129], ["heterogeneity", "OBSERVATION", 130, 143], ["more likely", "UNCERTAINTY", 475, 486], ["moderate", "OBSERVATION_MODIFIER", 591, 599], ["heterogeneity", "OBSERVATION", 600, 613]]], ["Compared with former smokers, current smokers were less likely to experience an adverse outcome (OR: 0.61, 95% CI: 0.36-1.02, p = 0.056) with moderate heterogeneity being observed (I 2 = 54%, Supplemental Figure S5 ).DiscussionThe main finding of this systematic review was the unusually low prevalence of current smoking among hospitalized COVID-19 patients.", [["smoking", "CHEMICAL", 314, 321], ["smokers", "ORGANISM", 38, 45], ["patients", "ORGANISM", 350, 358], ["patients", "SPECIES", 350, 358], ["CI", "TEST", 111, 113], ["p", "TEST", 126, 127], ["moderate heterogeneity", "PROBLEM", 142, 164], ["moderate", "OBSERVATION_MODIFIER", 142, 150], ["heterogeneity", "OBSERVATION", 151, 164]]], ["Smoking prevalence was less than one-fourth the expected prevalence based on gender-adjusted population smoking rates.", [["Smoking", "DISEASE", 0, 7]]], ["Even when age-adjustment was performed by calculating expected prevalence based on the age group with the lowest population smoking rates (age \u2a7e 65 years), smoking prevalence in hospitalized COVID-19 patients was still approximately one-third the expected prevalence (66% lower).", [["smoking", "CHEMICAL", 156, 163], ["COVID", "DISEASE", 191, 196], ["patients", "ORGANISM", 200, 208], ["patients", "SPECIES", 200, 208]]], ["Current smokers had higher odds for adverse outcome compared with non-current smokers.", [["smokers", "ORGANISM", 8, 15]]], ["In contrast, current smokers were less likely to have an adverse outcome compared with former smokers.DiscussionAn important limitation is that the analysis was unadjusted for confounding factors such as comorbidities that appear to be associated with higher risk for an adverse outcome in COVID-19.", [["smokers", "ORGANISM", 21, 28], ["an adverse outcome", "PROBLEM", 54, 72], ["the analysis", "TEST", 144, 156], ["confounding factors", "PROBLEM", 176, 195], ["comorbidities", "PROBLEM", 204, 217], ["an adverse outcome", "PROBLEM", 268, 286], ["COVID", "TEST", 290, 295]]], ["Older age is usually associated with lower current smoking and higher former smoking prevalence, which could explain the lower odds for adverse outcome in current compared with former smokers.", [["smoking", "CHEMICAL", 51, 58], ["smoking", "CHEMICAL", 77, 84], ["adverse outcome", "PROBLEM", 136, 151]]], ["40, 49 Moreover, we performed age-adjustment by calculating the expected prevalence based on the adult age group with the lowest population smoking prevalence.", [["smoking", "CHEMICAL", 140, 147]]], ["Still, the difference between observed and expected smoking prevalence was substantial.", [["smoking", "CHEMICAL", 52, 59], ["substantial", "OBSERVATION_MODIFIER", 75, 86]]], ["The possibility for inaccurate recording, false-reporting, or inability to report the smoking status due to critical condition of patients admitted to the hospitals, as well as the lack of an objective assessment of the smoking status, should also be considered.", [["patients", "ORGANISM", 130, 138], ["patients", "SPECIES", 130, 138], ["critical condition", "PROBLEM", 108, 126], ["an objective assessment", "TEST", 189, 212], ["possibility for", "UNCERTAINTY", 4, 19]]], ["Still, the findings that smokers are under-represented by approximately 3-to >4-fold compared with population smoking rates could be explained only by unusually extensive under-reporting of the current smoking status.", [["smokers", "ORGANISM", 25, 32]]], ["Finally, many studies reported smoking history instead of current smoking, which might include former smokers and thus overestimate current smoking prevalence among hospitalized COVID-19 patients.DiscussionLow prevalence of current smokers among hospitalized COVID-19 patients has been observed in case series outside China too.", [["smoking", "CHEMICAL", 66, 73], ["smoking", "CHEMICAL", 140, 147], ["patients", "ORGANISM", 187, 195], ["patients", "ORGANISM", 268, 276], ["patients", "SPECIES", 187, 195], ["patients", "SPECIES", 268, 276]]], ["20, 25, 27, 50 While it is highly unlikely for the majority of cigarette smoke compounds to have any potential benefit considering their toxic characteristics and oxidative stress and inflammation-promoting properties, some researchers have hypothesized that these findings might imply a protective effect of nicotine.", [["inflammation", "DISEASE", 184, 196], ["nicotine", "CHEMICAL", 309, 317], ["nicotine", "CHEMICAL", 309, 317], ["cigarette", "ORGANISM", 63, 72], ["nicotine", "SIMPLE_CHEMICAL", 309, 317], ["their toxic characteristics", "PROBLEM", 131, 158], ["oxidative stress and inflammation", "PROBLEM", 163, 196], ["nicotine", "TREATMENT", 309, 317], ["highly unlikely", "UNCERTAINTY", 27, 42]]], ["[50] [51] [52] [53] It was recently reported that many of the clinical manifestations of COVID-19 could be explained by a dysfunction of the nicotinic cholinergic system, and it was hypothesized that nicotine could modulate the immune response by restoring the function of the cholinergic antiinflammatory pathway.", [["COVID-19", "CHEMICAL", 89, 97], ["nicotine", "CHEMICAL", 200, 208], ["COVID-19", "CHEMICAL", 89, 97], ["nicotine", "CHEMICAL", 200, 208], ["COVID-19", "GENE_OR_GENE_PRODUCT", 89, 97], ["nicotine", "SIMPLE_CHEMICAL", 200, 208], ["COVID", "TEST", 89, 94], ["a dysfunction of the nicotinic cholinergic system", "PROBLEM", 120, 169], ["nicotine", "TREATMENT", 200, 208], ["the cholinergic antiinflammatory pathway", "TREATMENT", 273, 313], ["dysfunction", "OBSERVATION", 122, 133], ["nicotinic cholinergic", "ANATOMY", 141, 162]]], ["52 Severe COVID-19 appears to represent a hyper-inflammatory response that could result from dysregulation of the immune system and a failure to return to homeostasis after being activated to combat viral invasion.", [["immune system", "ANATOMY", 114, 127], ["COVID-19", "CHEMICAL", 10, 18], ["Severe COVID", "PROBLEM", 3, 15], ["a hyper-inflammatory response", "PROBLEM", 40, 69], ["dysregulation of the immune system", "PROBLEM", 93, 127], ["a failure", "PROBLEM", 132, 141], ["viral invasion", "PROBLEM", 199, 213], ["appears to represent", "UNCERTAINTY", 19, 39], ["hyper", "OBSERVATION", 42, 47], ["inflammatory response", "OBSERVATION", 48, 69], ["immune system", "OBSERVATION", 114, 127]]], ["SARS-CoV-2 activates the innate immune system, which, if left unregulated, can increase vascular permeability, cause migration of fluid and blood cells into the alveoli, and result in respiratory failure.", [["immune system", "ANATOMY", 32, 45], ["vascular", "ANATOMY", 88, 96], ["fluid", "ANATOMY", 130, 135], ["blood cells", "ANATOMY", 140, 151], ["alveoli", "ANATOMY", 161, 168], ["respiratory", "ANATOMY", 184, 195], ["SARS", "DISEASE", 0, 4], ["respiratory failure", "DISEASE", 184, 203], ["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 0, 10], ["vascular", "MULTI-TISSUE_STRUCTURE", 88, 96], ["fluid", "ORGANISM_SUBSTANCE", 130, 135], ["blood cells", "CELL", 140, 151], ["alveoli", "MULTI-TISSUE_STRUCTURE", 161, 168], ["blood cells", "CELL_TYPE", 140, 151], ["fluid and blood cells", "TEST", 130, 151], ["respiratory failure", "PROBLEM", 184, 203], ["left", "ANATOMY_MODIFIER", 57, 61], ["vascular", "ANATOMY", 88, 96], ["alveoli", "ANATOMY", 161, 168], ["respiratory failure", "OBSERVATION", 184, 203]]], ["54 This is commonly called \"cytokine storm\", and is characterized by the release of several pro-inflammatory cytokines such as tumor necrosis factor (TNF), interleukin journals.sagepub.com/home/taj 9 (IL)-1, and IL-6.", [["tumor necrosis", "DISEASE", 127, 141], ["tumor necrosis factor", "GENE_OR_GENE_PRODUCT", 127, 148], ["TNF", "GENE_OR_GENE_PRODUCT", 150, 153], ["interleukin", "GENE_OR_GENE_PRODUCT", 156, 167], ["home/taj 9 (IL)-1", "GENE_OR_GENE_PRODUCT", 189, 206], ["IL-6", "GENE_OR_GENE_PRODUCT", 212, 216], ["cytokine", "PROTEIN", 28, 36], ["pro-inflammatory cytokines", "PROTEIN", 92, 118], ["tumor necrosis factor", "PROTEIN", 127, 148], ["TNF", "PROTEIN", 150, 153], ["interleukin", "PROTEIN", 156, 167], ["IL-6", "DNA", 212, 216], ["several pro-inflammatory cytokines", "PROBLEM", 84, 118], ["tumor necrosis factor", "PROBLEM", 127, 148], ["sagepub", "TEST", 177, 184], ["tumor", "OBSERVATION_MODIFIER", 127, 132], ["necrosis", "OBSERVATION", 133, 141]]], ["Elevated levels of these cytokines have been associated with poor prognosis in COVID-19 patients.", [["patients", "ORGANISM", 88, 96], ["cytokines", "PROTEIN", 25, 34], ["patients", "SPECIES", 88, 96], ["Elevated levels of these cytokines", "PROBLEM", 0, 34]]], ["11, 55 The importance of this process in severe COVID-19 has been recognized by the scientific community, and clinical trials of immunosuppressants and cytokine inhibitors are already underway based on biological plausibility and despite warnings and precautions against the use of such medication in the presence of active infection.", [["COVID-19", "CHEMICAL", 48, 56], ["infection", "DISEASE", 324, 333], ["COVID-19", "CHEMICAL", 48, 56], ["cytokine", "PROTEIN", 152, 160], ["severe COVID", "PROBLEM", 41, 53], ["immunosuppressants", "TREATMENT", 129, 147], ["cytokine inhibitors", "TREATMENT", 152, 171], ["precautions", "TREATMENT", 251, 262], ["such medication", "TREATMENT", 282, 297], ["active infection", "PROBLEM", 317, 333], ["active", "OBSERVATION_MODIFIER", 317, 323], ["infection", "OBSERVATION", 324, 333]]], ["[56] [57] [58] [59] [60] The cholinergic anti-inflammatory pathway, mediated mainly through the vagus nerve and alpha 7 nicotinic acetylcholine receptors, has well-established immunomodulatory effects that are present in a variety of cells such as macrophages and bronchial epithelial and endothelial cells.", [["vagus nerve", "ANATOMY", 96, 107], ["cells", "ANATOMY", 234, 239], ["macrophages", "ANATOMY", 248, 259], ["bronchial epithelial", "ANATOMY", 264, 284], ["endothelial cells", "ANATOMY", 289, 306], ["acetylcholine", "CHEMICAL", 130, 143], ["[56] [57] [58] [59] [60]", "CHEMICAL", 0, 24], ["acetylcholine", "CHEMICAL", 130, 143], ["[56] [57] [58] [59] [60]", "SIMPLE_CHEMICAL", 0, 24], ["vagus nerve", "MULTI-TISSUE_STRUCTURE", 96, 107], ["alpha 7 nicotinic acetylcholine receptors", "GENE_OR_GENE_PRODUCT", 112, 153], ["cells", "CELL", 234, 239], ["macrophages", "CELL", 248, 259], ["bronchial epithelial", "CELL", 264, 284], ["endothelial cells", "CELL", 289, 306], ["alpha 7 nicotinic acetylcholine receptors", "PROTEIN", 112, 153], ["macrophages", "CELL_TYPE", 248, 259], ["bronchial epithelial and endothelial cells", "CELL_TYPE", 264, 306], ["The cholinergic anti-inflammatory pathway", "TREATMENT", 25, 66], ["alpha 7 nicotinic acetylcholine receptors", "TREATMENT", 112, 153], ["macrophages", "PROBLEM", 248, 259], ["bronchial epithelial and endothelial cells", "PROBLEM", 264, 306], ["vagus nerve", "ANATOMY", 96, 107], ["immunomodulatory effects", "OBSERVATION", 176, 200], ["macrophages", "OBSERVATION", 248, 259], ["bronchial", "ANATOMY", 264, 273], ["epithelial", "ANATOMY_MODIFIER", 274, 284], ["endothelial cells", "OBSERVATION", 289, 306]]], ["[61] [62] [63] [64] It represents a reflex mechanism based on a bi-directional communication between the immune and nervous systems.", [["nervous systems", "ANATOMY", 116, 131], ["[61] [62] [63] [64", "SIMPLE_CHEMICAL", 0, 18], ["nervous systems", "ANATOMICAL_SYSTEM", 116, 131], ["a reflex mechanism", "PROBLEM", 34, 52], ["nervous", "ANATOMY", 116, 123]]], ["Activation of the cholinergic anti-inflammatory pathway through electrical stimulation of the vagus nerve has been shown to reduce levels of pro-inflammatory cytokines and control the acute hyper-inflammatory response in animal models.", [["vagus nerve", "ANATOMY", 94, 105], ["vagus nerve", "MULTI-TISSUE_STRUCTURE", 94, 105], ["pro-inflammatory cytokines", "PROTEIN", 141, 167], ["the cholinergic anti-inflammatory pathway", "TREATMENT", 14, 55], ["electrical stimulation", "TREATMENT", 64, 86], ["pro-inflammatory cytokines", "TREATMENT", 141, 167], ["the acute hyper-inflammatory response", "PROBLEM", 180, 217], ["vagus nerve", "ANATOMY", 94, 105], ["acute", "OBSERVATION_MODIFIER", 184, 189], ["hyper", "OBSERVATION", 190, 195], ["inflammatory response", "OBSERVATION", 196, 217]]], ["65, 66 Therefore, dysregulation of the cholinergic nervous system could explain the clinical manifestations of severe COVID-19 and the inability to suppress and control the inflammatory response.", [["cholinergic nervous system", "ANATOMY", 39, 65], ["COVID-19", "CHEMICAL", 118, 126], ["cholinergic nervous system", "ANATOMICAL_SYSTEM", 39, 65], ["dysregulation of the cholinergic nervous system", "PROBLEM", 18, 65], ["severe COVID", "PROBLEM", 111, 123], ["the inflammatory response", "PROBLEM", 169, 194], ["cholinergic nervous", "ANATOMY", 39, 58], ["severe", "OBSERVATION_MODIFIER", 111, 117], ["inflammatory response", "OBSERVATION", 173, 194]]], ["Notably, risk factors for severe COVID-19 such as diabetes, heart disease, ageing and obesity are characterized by autonomic nervous system imbalance.", [["heart", "ANATOMY", 60, 65], ["autonomic nervous system", "ANATOMY", 115, 139], ["COVID", "DISEASE", 33, 38], ["diabetes", "DISEASE", 50, 58], ["heart disease", "DISEASE", 60, 73], ["obesity", "DISEASE", 86, 93], ["heart", "ORGAN", 60, 65], ["autonomic nervous system", "ANATOMICAL_SYSTEM", 115, 139], ["severe COVID", "PROBLEM", 26, 38], ["diabetes", "PROBLEM", 50, 58], ["heart disease", "PROBLEM", 60, 73], ["obesity", "PROBLEM", 86, 93], ["autonomic nervous system imbalance", "PROBLEM", 115, 149], ["heart", "ANATOMY", 60, 65], ["disease", "OBSERVATION", 66, 73], ["obesity", "OBSERVATION", 86, 93], ["autonomic nervous", "OBSERVATION", 115, 132]]], ["[67] [68] [69] [70] These patients are expected to be more sensitive to further compromise of the cholinergic nervous system due to SARS-CoV-2 infection.DiscussionNicotine is an agonist of the nicotinic cholinergic system and has been shown to prevent acute respiratory distress syndrome, the hallmark of severe COVID-19, in animal models.", [["cholinergic nervous system", "ANATOMY", 98, 124], ["respiratory", "ANATOMY", 258, 269], ["infection", "DISEASE", 143, 152], ["DiscussionNicotine", "CHEMICAL", 153, 171], ["acute respiratory distress syndrome", "DISEASE", 252, 287], ["COVID-19", "CHEMICAL", 312, 320], ["COVID-19", "CHEMICAL", 312, 320], ["patients", "ORGANISM", 26, 34], ["cholinergic nervous system", "ANATOMICAL_SYSTEM", 98, 124], ["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 132, 142], ["DiscussionNicotine", "SIMPLE_CHEMICAL", 153, 171], ["patients", "SPECIES", 26, 34], ["further compromise of the cholinergic nervous system", "PROBLEM", 72, 124], ["SARS", "PROBLEM", 132, 136], ["CoV", "PROBLEM", 137, 140], ["2 infection", "PROBLEM", 141, 152], ["the nicotinic cholinergic system", "TREATMENT", 189, 221], ["acute respiratory distress syndrome", "PROBLEM", 252, 287], ["severe COVID", "PROBLEM", 305, 317], ["cholinergic nervous", "ANATOMY", 98, 117], ["SARS", "OBSERVATION", 132, 136], ["infection", "OBSERVATION", 143, 152], ["acute", "OBSERVATION_MODIFIER", 252, 257], ["respiratory distress", "OBSERVATION", 258, 278], ["severe", "OBSERVATION_MODIFIER", 305, 311]]], ["71 Therefore, we present the hypothesis that nicotine intake could be the reason for the low prevalence of smoking among hospitalized COVID-19 patients.", [["nicotine", "CHEMICAL", 45, 53], ["smoking", "CHEMICAL", 107, 114], ["nicotine", "CHEMICAL", 45, 53], ["nicotine", "SIMPLE_CHEMICAL", 45, 53], ["patients", "ORGANISM", 143, 151], ["patients", "SPECIES", 143, 151], ["nicotine intake", "TREATMENT", 45, 60]]], ["However, it should be emphasized that smokers experience abrupt cessation of nicotine intake after hospital admission and are unlikely to receive pharmaceutical nicotine replacement therapies while hospitalized.", [["nicotine", "CHEMICAL", 77, 85], ["nicotine", "CHEMICAL", 161, 169], ["nicotine", "CHEMICAL", 77, 85], ["nicotine", "CHEMICAL", 161, 169], ["nicotine", "SIMPLE_CHEMICAL", 77, 85], ["nicotine", "SIMPLE_CHEMICAL", 161, 169], ["pharmaceutical nicotine replacement therapies", "TREATMENT", 146, 191], ["nicotine replacement", "OBSERVATION", 161, 181]]], ["As a result, the effects of nicotine will rapidly wean off within hours after admission considering that the plasma half-life of nicotine is 1-2 h.", [["plasma", "ANATOMY", 109, 115], ["nicotine", "CHEMICAL", 28, 36], ["nicotine", "CHEMICAL", 129, 137], ["nicotine", "CHEMICAL", 28, 36], ["nicotine", "CHEMICAL", 129, 137], ["nicotine", "SIMPLE_CHEMICAL", 28, 36], ["plasma", "ORGANISM_SUBSTANCE", 109, 115], ["nicotine", "SIMPLE_CHEMICAL", 129, 137], ["nicotine", "TREATMENT", 28, 36], ["nicotine", "TREATMENT", 129, 137]]], ["Therefore, the higher odds for adverse outcome in current, compared with non-current, smokers are not contradictory to the hypothesis that nicotine may be beneficial for COVID-19.", [["nicotine", "CHEMICAL", 139, 147], ["nicotine", "CHEMICAL", 139, 147], ["COVID-19", "CHEMICAL", 170, 178], ["nicotine", "SIMPLE_CHEMICAL", 139, 147], ["adverse outcome", "PROBLEM", 31, 46], ["nicotine", "TREATMENT", 139, 147], ["COVID", "TEST", 170, 175]]], ["In addition, any hypothesized benefits of nicotine are expected to be masked by the well-established adverse effects of smoking and smoking-related comorbidities, which could also explain the higher odds for adverse outcome in hospitalized smokers.", [["nicotine", "CHEMICAL", 42, 50], ["smoking", "CHEMICAL", 120, 127], ["smoking", "CHEMICAL", 132, 139], ["nicotine", "CHEMICAL", 42, 50], ["nicotine", "SIMPLE_CHEMICAL", 42, 50], ["nicotine", "TREATMENT", 42, 50]]], ["Thus, it is possible that COVID-19 severity and outcome may differ between smokers without and with smoking-related disease.", [["smoking", "CHEMICAL", 100, 107], ["COVID", "TEST", 26, 31], ["related disease", "PROBLEM", 108, 123]]], ["Therefore, smoking cannot be recommended or used as a protective or therapeutic measure.", [["smoking", "CHEMICAL", 11, 18]]], ["However, pharmaceutical nicotine products have been available for years and have been used therapeutically even in nonsmokers for longer periods of time compared with the few days that would be needed for a clinical trial of nicotine in COVID-19 patients.", [["nicotine", "CHEMICAL", 24, 32], ["nicotine", "CHEMICAL", 225, 233], ["nicotine", "CHEMICAL", 24, 32], ["nicotine", "CHEMICAL", 225, 233], ["nicotine", "SIMPLE_CHEMICAL", 225, 233], ["patients", "ORGANISM", 246, 254], ["patients", "SPECIES", 246, 254], ["pharmaceutical nicotine products", "TREATMENT", 9, 41], ["nicotine in COVID", "TREATMENT", 225, 242]]], ["72, 73 The safety profile and lack of dependence potential that has been observed in these studies, with pharmaceutical nicotine being administered to elderly non-smokers at high doses and for several weeks, offers a rationale for future clinical trials of nicotine in COVID-19 patients.", [["nicotine", "CHEMICAL", 120, 128], ["nicotine", "CHEMICAL", 257, 265], ["nicotine", "CHEMICAL", 120, 128], ["nicotine", "CHEMICAL", 257, 265], ["nicotine", "SIMPLE_CHEMICAL", 120, 128], ["nicotine", "SIMPLE_CHEMICAL", 257, 265], ["patients", "ORGANISM", 278, 286], ["patients", "SPECIES", 278, 286], ["these studies", "TEST", 85, 98], ["pharmaceutical nicotine", "TREATMENT", 105, 128], ["nicotine", "TREATMENT", 257, 265]]], ["In addition, such a clinical trial would not need to administer nicotine as a substitute for other standardized therapeutic measures.DiscussionAnother concern in relation to nicotine and COVID-19 refers to its effects on angiotensin converting enzyme 2 (ACE2) expression, since this enzyme is used as a receptor by SARS-CoV-2 for cell entry.", [["cell", "ANATOMY", 330, 334], ["nicotine", "CHEMICAL", 64, 72], ["nicotine", "CHEMICAL", 174, 182], ["COVID-19", "CHEMICAL", 187, 195], ["angiotensin", "CHEMICAL", 221, 232], ["nicotine", "CHEMICAL", 64, 72], ["nicotine", "CHEMICAL", 174, 182], ["COVID-19", "CHEMICAL", 187, 195], ["nicotine", "SIMPLE_CHEMICAL", 64, 72], ["nicotine", "SIMPLE_CHEMICAL", 174, 182], ["COVID-19", "SIMPLE_CHEMICAL", 187, 195], ["angiotensin converting enzyme 2", "GENE_OR_GENE_PRODUCT", 221, 252], ["ACE2", "GENE_OR_GENE_PRODUCT", 254, 258], ["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 315, 325], ["cell", "CELL", 330, 334], ["angiotensin converting enzyme 2", "PROTEIN", 221, 252], ["ACE2", "PROTEIN", 254, 258], ["nicotine", "TREATMENT", 64, 72], ["other standardized therapeutic measures", "TREATMENT", 93, 132], ["nicotine", "TREATMENT", 174, 182], ["COVID", "TREATMENT", 187, 192], ["angiotensin converting enzyme", "TREATMENT", 221, 250], ["this enzyme", "TEST", 278, 289], ["CoV", "TEST", 320, 323], ["cell entry", "PROBLEM", 330, 340]]], ["74 Recent data support that nicotine upregulates ACE2, which is suggested as a potential mechanism to increase susceptibility and severity of COVID-19.", [["nicotine", "CHEMICAL", 28, 36], ["nicotine", "CHEMICAL", 28, 36], ["COVID-19", "CHEMICAL", 142, 150], ["nicotine", "SIMPLE_CHEMICAL", 28, 36], ["ACE2", "GENE_OR_GENE_PRODUCT", 49, 53], ["ACE2", "PROTEIN", 49, 53], ["nicotine upregulates ACE2", "TREATMENT", 28, 53], ["COVID", "TEST", 142, 147]]], ["75, 76 However, this is in contrast with previous data that nicotine and smoking down-regulate ACE2.", [["nicotine", "CHEMICAL", 60, 68], ["smoking", "CHEMICAL", 73, 80], ["nicotine", "CHEMICAL", 60, 68], ["nicotine", "SIMPLE_CHEMICAL", 60, 68], ["ACE2", "GENE_OR_GENE_PRODUCT", 95, 99], ["ACE2", "PROTEIN", 95, 99], ["nicotine", "TREATMENT", 60, 68]]], ["77 Moreover, upregulation of ACE2 does not necessarily imply more fulminant disease.", [["fulminant disease", "DISEASE", 66, 83], ["ACE2", "GENE_OR_GENE_PRODUCT", 29, 33], ["ACE2", "PROTEIN", 29, 33], ["ACE2", "PROBLEM", 29, 33], ["more fulminant disease", "PROBLEM", 61, 83], ["not necessarily imply", "UNCERTAINTY", 39, 60], ["more", "OBSERVATION_MODIFIER", 61, 65], ["fulminant", "OBSERVATION_MODIFIER", 66, 75], ["disease", "OBSERVATION", 76, 83]]], ["Concerns that up-regulation of ACE2 by ACE-inhibitors and angiotensin receptor blockers could be linked to adverse prognosis in hypertensive COVID-19 patients were raised early in the COVID-19 pandemic.", [["angiotensin", "CHEMICAL", 58, 69], ["hypertensive", "DISEASE", 128, 140], ["ACE2", "GENE_OR_GENE_PRODUCT", 31, 35], ["ACE", "GENE_OR_GENE_PRODUCT", 39, 42], ["angiotensin receptor blockers", "SIMPLE_CHEMICAL", 58, 87], ["patients", "ORGANISM", 150, 158], ["ACE2", "PROTEIN", 31, 35], ["ACE", "PROTEIN", 39, 42], ["patients", "SPECIES", 150, 158], ["ACE2", "TREATMENT", 31, 35], ["ACE-inhibitors", "TREATMENT", 39, 53], ["angiotensin receptor blockers", "TREATMENT", 58, 87], ["hypertensive COVID", "TEST", 128, 146], ["the COVID", "TEST", 180, 189], ["pandemic", "PROBLEM", 193, 201]]], ["78 However, recent studies found either no adverse effect or a protective effect associated with the use of these medications.", [["recent studies", "TEST", 12, 26], ["adverse effect", "PROBLEM", 43, 57], ["these medications", "TREATMENT", 108, 125]]], ["79, 80 In fact, down-regulation of ACE2 immediately after viral cell entry is proposed as an important mechanism favoring the progression and severity of disease.", [["cell", "ANATOMY", 64, 68], ["ACE2", "GENE_OR_GENE_PRODUCT", 35, 39], ["cell", "CELL", 64, 68], ["ACE2", "PROTEIN", 35, 39], ["ACE2", "TREATMENT", 35, 39], ["viral cell entry", "TREATMENT", 58, 74], ["disease", "PROBLEM", 154, 161], ["viral cell", "OBSERVATION", 58, 68], ["progression", "OBSERVATION_MODIFIER", 126, 137], ["disease", "OBSERVATION", 154, 161]]], ["81 ACE2 deficiency has been observed with ageing, in diabetes mellitus, and in heart disease, all of which appear to be risk factors for severe COVID-19.", [["heart", "ANATOMY", 79, 84], ["diabetes mellitus", "DISEASE", 53, 70], ["heart disease", "DISEASE", 79, 92], ["COVID", "DISEASE", 144, 149], ["COVID-19", "CHEMICAL", 144, 152], ["ACE2", "GENE_OR_GENE_PRODUCT", 3, 7], ["heart", "ORGAN", 79, 84], ["ACE2", "PROTEIN", 3, 7], ["ACE2 deficiency", "PROBLEM", 3, 18], ["diabetes mellitus", "PROBLEM", 53, 70], ["heart disease", "PROBLEM", 79, 92], ["severe COVID", "PROBLEM", 137, 149], ["deficiency", "OBSERVATION", 8, 18], ["diabetes mellitus", "OBSERVATION", 53, 70], ["heart", "ANATOMY", 79, 84], ["disease", "OBSERVATION", 85, 92]]], ["[82] [83] [84] In addition, children and young women, who usually experience mild COVID-19, were found to have higher levels of ACE2 than older people.", [["children", "ORGANISM", 28, 36], ["women", "ORGANISM", 47, 52], ["ACE2", "GENE_OR_GENE_PRODUCT", 128, 132], ["people", "ORGANISM", 144, 150], ["ACE2", "PROTEIN", 128, 132], ["children", "SPECIES", 28, 36], ["women", "SPECIES", 47, 52], ["people", "SPECIES", 144, 150], ["mild COVID", "PROBLEM", 77, 87]]], ["85 Thus, it is possible that ACE2 upregulation is protective against severe COVID-19, 78, 86 and the contradictory data about the effects of nicotine on ACE2 expression need to be clarified in future experimental studies.DiscussionIn conclusion, this systematic review and metaanalysis of retrospective, observational case series identified a low prevalence of current smoking among hospitalized COVID-19 patients but higher odds of adverse outcome for current compared with non-current smokers.", [["COVID", "DISEASE", 76, 81], ["nicotine", "CHEMICAL", 141, 149], ["smoking", "CHEMICAL", 369, 376], ["COVID-19", "CHEMICAL", 76, 84], ["nicotine", "CHEMICAL", 141, 149], ["ACE2", "GENE_OR_GENE_PRODUCT", 29, 33], ["nicotine", "SIMPLE_CHEMICAL", 141, 149], ["ACE2", "GENE_OR_GENE_PRODUCT", 153, 157], ["patients", "ORGANISM", 405, 413], ["ACE2", "PROTEIN", 29, 33], ["ACE2", "PROTEIN", 153, 157], ["patients", "SPECIES", 405, 413], ["ACE2 upregulation", "PROBLEM", 29, 46], ["severe COVID", "PROBLEM", 69, 81], ["nicotine on ACE2 expression", "TREATMENT", 141, 168], ["experimental studies", "TEST", 200, 220], ["low prevalence", "OBSERVATION_MODIFIER", 343, 357]]], ["Smoking cannot be considered a protective measure against COVID-19 (or any other condition) due to associated risk for cardiovascular, respiratory and cancer morbidity and mortality.", [["cardiovascular", "ANATOMY", 119, 133], ["respiratory", "ANATOMY", 135, 146], ["cancer", "ANATOMY", 151, 157], ["Smoking", "DISEASE", 0, 7], ["cardiovascular, respiratory and cancer", "DISEASE", 119, 157], ["cancer", "CANCER", 151, 157], ["cardiovascular, respiratory and cancer morbidity", "PROBLEM", 119, 167], ["cardiovascular", "ANATOMY", 119, 133], ["respiratory", "ANATOMY", 135, 146], ["cancer", "OBSERVATION", 151, 157]]], ["While limitations are applicable to this analysis and other unknown reasons or confounding factors could, at least partially, explain these findings, the hypothesis that nicotine may be protective against severe COVID-19 is biologically plausible and should be explored through laboratory and, eventually, clinical trials using pharmaceutical nicotine products.", [["nicotine", "CHEMICAL", 170, 178], ["nicotine", "CHEMICAL", 343, 351], ["nicotine", "CHEMICAL", 170, 178], ["COVID-19", "CHEMICAL", 212, 220], ["nicotine", "CHEMICAL", 343, 351], ["nicotine", "SIMPLE_CHEMICAL", 170, 178], ["nicotine products", "SIMPLE_CHEMICAL", 343, 360], ["this analysis", "TEST", 36, 49], ["confounding factors", "PROBLEM", 79, 98], ["nicotine", "TREATMENT", 170, 178], ["severe COVID", "PROBLEM", 205, 217], ["pharmaceutical nicotine products", "TREATMENT", 328, 360]]]], "cf750714decab335f8990db7d0ca100506fa99fa": [["IntroductionWild birds have been recognized as important reservoir hosts harboring and amplifying emerging zoonotic viruses such as avian influenza A viruses [1] and West Nile virus [2] .", [["zoonotic viruses", "DISEASE", 107, 123], ["avian influenza A viruses", "DISEASE", 132, 157], ["avian influenza A viruses", "ORGANISM", 132, 157], ["West Nile virus", "ORGANISM", 166, 181], ["avian influenza A viruses", "SPECIES", 132, 157], ["West Nile virus", "SPECIES", 166, 181], ["avian influenza A viruses", "SPECIES", 132, 157], ["West Nile virus", "SPECIES", 166, 181], ["emerging zoonotic viruses", "PROBLEM", 98, 123], ["avian influenza A viruses", "PROBLEM", 132, 157]]], ["In the northeastern USA, the Delaware Bay area is crucial for the annual migration of shorebird and gull species that feed on the horseshoe crab eggs found in abundance thanks to the coinciding spawning season (for review see [3] ).", [["crab", "ORGANISM", 140, 144], ["horseshoe crab", "SPECIES", 130, 144], ["gull species", "PROBLEM", 100, 112], ["the horseshoe crab eggs", "TREATMENT", 126, 149], ["migration", "OBSERVATION_MODIFIER", 73, 82], ["gull species", "OBSERVATION", 100, 112]]], ["Avian influenza virus isolation rates from shorebirds and gulls during spring migration are significantly higher in this area than in other surveillance sites [3, 4, 5] .", [["Avian influenza virus", "ORGANISM", 0, 21], ["Avian influenza virus", "SPECIES", 0, 21], ["Avian influenza virus", "SPECIES", 0, 21], ["Avian influenza virus isolation rates", "TREATMENT", 0, 37], ["influenza virus", "OBSERVATION", 6, 21], ["migration", "OBSERVATION_MODIFIER", 78, 87], ["significantly", "OBSERVATION_MODIFIER", 92, 105], ["higher", "OBSERVATION_MODIFIER", 106, 112]]], ["This observation prompted us to assess the ability to detect other, novel viruses in shorebirds during the spring migration.Sample CollectionShorebird fecal samples of apparently healthy birds were collected in May 2004 from Reed's beach, Delaware Bay, New Jersey, USA, held at 4uC for shipment (#96 h) and upon arrival at the laboratory stored at 280uC until further processing.", [["fecal samples", "ANATOMY", 151, 164], ["fecal samples", "ORGANISM_SUBSTANCE", 151, 164], ["birds", "ORGANISM", 187, 192], ["This observation", "TEST", 0, 16], ["novel viruses", "PROBLEM", 68, 81], ["the spring migration", "TREATMENT", 103, 123], ["Sample Collection", "TEST", 124, 141], ["viruses", "OBSERVATION", 74, 81]]], ["Permission to enter restricted access beaches and obtain fecal droppings was granted annually by the State of New Jersey, Department of Environmental Protection, Division of Fish and Wildlife, Endan-gered and Nongame Species Program.", [["fecal droppings", "PROBLEM", 57, 72], ["Environmental Protection", "TREATMENT", 136, 160], ["fecal", "ANATOMY", 57, 62], ["droppings", "OBSERVATION", 63, 72]]], ["The surveillance program was also approved by the St. Jude Children's Research Hospital IACUC protocol #546.PyrosequencingNucleic acid was extracted by using QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany), treated with DNaseI (Ambion, Austin, TX, USA) and reverse transcribed using Superscript II kit (Invitrogen, Carlsbad, CA, USA) with random octamer primers linked to an arbitrary specific anchor sequence [6] .", [["Nucleic acid", "SIMPLE_CHEMICAL", 122, 134], ["DNaseI", "PROTEIN", 224, 230], ["Superscript II", "PROTEIN", 287, 301], ["Children", "SPECIES", 59, 67], ["PyrosequencingNucleic acid", "PROBLEM", 108, 134], ["DNaseI (Ambion", "TREATMENT", 224, 238], ["Invitrogen", "TEST", 307, 317], ["random octamer primers", "TREATMENT", 343, 365], ["an arbitrary specific anchor sequence", "TEST", 376, 413]]], ["The cDNA was RNase H-treated prior to random amplification by the polymerase chain reaction (PCR).", [["RNase H", "GENE_OR_GENE_PRODUCT", 13, 20], ["cDNA", "DNA", 4, 8], ["RNase H", "PROTEIN", 13, 20], ["random amplification", "TEST", 38, 58], ["the polymerase chain reaction", "PROBLEM", 62, 91], ["PCR", "TEST", 93, 96]]], ["The resulting products were purified using MinElute (Qiagen, Hilden, Germany), pooled and ligated to linkers for sequencing on a GSL FLX Sequencer (454 Life Sciences, Branford, CT, USA).", [["a GSL FLX Sequencer", "TEST", 127, 146], ["CT", "TEST", 177, 179]]], ["After primer and adaptor trimming, length filtering, masking of low complexity regions and subtraction of ribosomal and host sequences, sequence reads were assembled using Newbler Assembler (v 2.3, 454 Life Sciences) and analyzed at nucleotide (nt) and amino acid (aa) level by using homology search programs Blastn [7] and Fastx [8] against NCBI Refseq and GenBank databases (http://www.ncbi.nlm.nih.gov).Specific PCR and Assessment of Bird SpeciesSequence-specific PCR was conducted with HotStar polymerase (Qiagen) and random hexamer-primed cDNA (Superscript II, Invitrogen).", [["ribosomal", "ANATOMY", 106, 115], ["nucleotide", "CHEMICAL", 233, 243], ["amino acid", "CHEMICAL", 253, 263], ["nucleotide", "CHEMICAL", 233, 243], ["amino acid", "CHEMICAL", 253, 263], ["ribosomal", "CELLULAR_COMPONENT", 106, 115], ["amino acid", "AMINO_ACID", 253, 263], ["HotStar polymerase", "GENE_OR_GENE_PRODUCT", 490, 508], ["ribosomal and host sequences", "DNA", 106, 134], ["NCBI Refseq", "DNA", 342, 353], ["HotStar polymerase", "PROTEIN", 490, 508], ["primed cDNA", "DNA", 537, 548], ["Superscript II", "DNA", 550, 564], ["primer and adaptor trimming", "TREATMENT", 6, 33], ["length filtering", "TREATMENT", 35, 51], ["masking of low complexity regions", "TREATMENT", 53, 86], ["subtraction of ribosomal and host sequences", "TEST", 91, 134], ["nucleotide (nt) and amino acid (aa) level", "TREATMENT", 233, 274], ["Fastx", "TREATMENT", 324, 329], ["Specific PCR", "TEST", 406, 418], ["Bird SpeciesSequence", "TEST", 437, 457], ["specific PCR", "TEST", 458, 470], ["HotStar polymerase", "TREATMENT", 490, 508], ["random hexamer-primed cDNA (Superscript II", "TREATMENT", 522, 564], ["low complexity", "OBSERVATION_MODIFIER", 64, 78]]], ["Amplified products were subjected to direct dideoxy sequencing (Genewiz, South Plainfield, NJ, USA).", [["Amplified products", "TREATMENT", 0, 18]]], ["The bird species from which samples were obtained was identified by the nested PCR method of Cheung et al. that targets the mitochondrial cytochrome oxidase I (COI) gene [9] .Phylogenetic AnalysisAssessment of phylogenetic relationships was performed using programs of the MEGA 5 software package (http://www. megasoftware.net).", [["samples", "ANATOMY", 28, 35], ["mitochondrial", "ANATOMY", 124, 137], ["samples", "CANCER", 28, 35], ["mitochondrial", "CELLULAR_COMPONENT", 124, 137], ["cytochrome oxidase I", "GENE_OR_GENE_PRODUCT", 138, 158], ["COI", "GENE_OR_GENE_PRODUCT", 160, 163], ["mitochondrial cytochrome oxidase I (COI) gene", "DNA", 124, 169], ["MEGA 5 software package", "DNA", 273, 296], ["The bird species", "TEST", 0, 16], ["the mitochondrial cytochrome oxidase I (COI", "TREATMENT", 120, 163], ["bird species", "OBSERVATION", 4, 16]]], ["Multiple sequence alignments were generated with ClustalW, and phylogenetic trees constructed based on the neighbor joining method using a Poisson correction model to calculate distance; bootstrap values were calculated based on 1000 pseudoreplicates.Results and DiscussionWe applied an unbiased pyrosequencing approach for analyzing total RNA extracts of fecal samples collected at Reed's beach, Delaware Bay, New Jersey, USA, from apparently healthy shorebirds to assess potential microbial burden.", [["extracts", "ANATOMY", 344, 352], ["fecal samples", "ANATOMY", 356, 369], ["fecal samples", "ORGANISM_SUBSTANCE", 356, 369], ["Multiple sequence alignments", "TEST", 0, 28], ["ClustalW", "TEST", 49, 57], ["a Poisson correction model", "TREATMENT", 137, 163], ["bootstrap values", "TEST", 187, 203], ["an unbiased pyrosequencing approach", "TREATMENT", 284, 319], ["analyzing total RNA extracts", "TREATMENT", 324, 352], ["potential microbial burden", "PROBLEM", 473, 499], ["fecal", "ANATOMY", 356, 361]]], ["Samples from eight individual birds, that included semipalmated sandpipers, sanderlings and ruddy turnstones, were extracted for total RNA, reverse transcribed and amplified by random PCR before the purified PCR products were pooled and processed for sequencing on the 454 pyrosequencing platform.", [["Samples", "ANATOMY", 0, 7], ["sandpipers", "ANATOMY", 64, 74], ["sanderlings", "ANATOMY", 76, 87], ["birds", "ORGANISM", 30, 35], ["total RNA", "RNA", 129, 138], ["Samples", "TEST", 0, 7], ["semipalmated sandpipers", "TREATMENT", 51, 74], ["ruddy turnstones", "TREATMENT", 92, 108], ["total RNA", "TREATMENT", 129, 138], ["random PCR", "TEST", 177, 187], ["the purified PCR products", "TREATMENT", 195, 220]]], ["Sequencing yielded 182,358 reads with a mean length of 320 nt (NIH Short Read Archive accession number SRP035900).", [["Sequencing", "TEST", 0, 10], ["a mean length", "TEST", 38, 51]]], ["After filtering for ribosomal and host sequences, the remaining 4171 sequences were processed to assemble possible contiguous sequences and then analyzed at nt and deduced aa level.", [["ribosomal", "ANATOMY", 20, 29], ["ribosomal", "CELLULAR_COMPONENT", 20, 29], ["ribosomal and host sequences", "DNA", 20, 48], ["4171 sequences", "DNA", 64, 78], ["ribosomal and host sequences", "TEST", 20, 48], ["contiguous sequences", "TEST", 115, 135]]], ["Three sequences of 357, 468 and 474 nt length showed homology to members of the coronavirus (CoV) family and two sequences of 436 and 445 nt showed homology to avian astroviruses (AstV).", [["coronavirus (CoV", "ORGANISM", 80, 96], ["avian astroviruses", "ORGANISM", 160, 178], ["AstV", "GENE_OR_GENE_PRODUCT", 180, 184], ["coronavirus (CoV) family", "PROTEIN", 80, 104], ["coronavirus", "SPECIES", 80, 91], ["avian", "SPECIES", 160, 165], ["Three sequences", "TEST", 0, 15], ["nt length", "TEST", 36, 45]]], ["In addition we detected reads with distant homology to tetnoviruses (2 reads) and marnavirus (1 read); viruses of insects and algae, respectively, that were in view of the limited sample material not further followed.", [["tetnoviruses", "DNA", 55, 67], ["marnavirus", "TEST", 82, 92], ["the limited sample material", "PROBLEM", 168, 195]]], ["No other sequences with significant homology to viral records in GenBank (release 175) were detected using an e-value cut-off of 0.001 for Blastn and Fastx.Results and DiscussionThe presence of the detected astro-and coronaviral sequences in individual samples that made up the pool of 8 used for pyrosequencing was confirmed by PCR assays using primers specific for the identified sequences ( Table S1 ).", [["samples", "ANATOMY", 253, 260], ["samples", "CANCER", 253, 260], ["astro-and coronaviral sequences", "DNA", 207, 238], ["an e-value cut-", "TEST", 107, 122], ["pyrosequencing", "PROBLEM", 297, 311], ["PCR assays", "TEST", 329, 339], ["primers", "TREATMENT", 346, 353]]], ["Two of the eight samples pooled for pyrosequencing were confirmed to contain either CoV or AstV sequences.", [["samples", "ANATOMY", 17, 24], ["CoV", "GENE_OR_GENE_PRODUCT", 84, 87], ["AstV", "GENE_OR_GENE_PRODUCT", 91, 95], ["CoV or AstV sequences", "DNA", 84, 105], ["pyrosequencing", "TEST", 36, 50], ["CoV or AstV sequences", "TEST", 84, 105]]], ["The CoV-positive fecal sample originated from a ruddy turnstone (Arenaria interpres) and the AstVpositive sample from a sanderling (Calidris alba), as determined by mitochondrial cytochrome oxidase I (COI) sequence analysis.Results and DiscussionThe sanderling derived AstV-related sequences assembled to an approximately 600 nt long continuous sequence that mapped to the middle region of the non-structural polyprotein 1a open reading frame (ORF).", [["fecal sample", "ANATOMY", 17, 29], ["sample", "ANATOMY", 106, 112], ["mitochondrial", "ANATOMY", 165, 178], ["CoV", "GENE_OR_GENE_PRODUCT", 4, 7], ["Calidris alba", "ORGANISM", 132, 145], ["mitochondrial", "CELLULAR_COMPONENT", 165, 178], ["cytochrome oxidase I", "GENE_OR_GENE_PRODUCT", 179, 199], ["AstV", "GENE_OR_GENE_PRODUCT", 269, 273], ["mitochondrial cytochrome oxidase I (COI) sequence", "DNA", 165, 214], ["sanderling derived AstV-related sequences", "DNA", 250, 291], ["600 nt long continuous sequence", "DNA", 322, 353], ["middle region", "DNA", 373, 386], ["non-structural polyprotein 1a open reading frame", "DNA", 394, 442], ["ORF", "DNA", 444, 447], ["Arenaria interpres", "SPECIES", 65, 83], ["Calidris alba", "SPECIES", 132, 145], ["Arenaria interpres", "SPECIES", 65, 83], ["Calidris alba", "SPECIES", 132, 145], ["The CoV", "TEST", 0, 7], ["positive fecal sample", "PROBLEM", 8, 29], ["a ruddy turnstone", "PROBLEM", 46, 63], ["the AstVpositive sample", "TEST", 89, 112], ["a sanderling (Calidris alba", "TREATMENT", 118, 145], ["COI) sequence analysis", "TEST", 201, 223], ["an approximately 600 nt long continuous sequence", "TREATMENT", 305, 353], ["CoV", "OBSERVATION_MODIFIER", 4, 7], ["positive", "OBSERVATION_MODIFIER", 8, 16], ["fecal sample", "OBSERVATION", 17, 29], ["middle", "ANATOMY_MODIFIER", 373, 379], ["non-structural polyprotein", "OBSERVATION", 394, 420]]], ["Analysis of a PCR product obtained with primers matching that sequence (GenBank accession number JX548301) indicated approximately 41% identity at aa level to avian nephritis virus 1 (ANV-1).", [["avian nephritis", "DISEASE", 159, 174], ["avian nephritis virus 1", "ORGANISM", 159, 182], ["ANV-1", "ORGANISM", 184, 189], ["avian nephritis virus 1", "SPECIES", 159, 182], ["avian nephritis virus 1", "SPECIES", 159, 182], ["ANV-1", "SPECIES", 184, 189], ["a PCR product", "TEST", 12, 25], ["nephritis virus", "PROBLEM", 165, 180], ["ANV", "TEST", 184, 187], ["nephritis", "OBSERVATION", 165, 174]]], ["Closer inspection of the recovered AstV sequence indicated similarity to trypsin-like peptidase family pfam13365 and to peptidase S7 superfamily pfam 00949 between aa residues 121-164 with conservation of the potential catalytic triad in the serine protease domain, including Histidine-24, Aspartic acid-61 and Serine-125 [10] .Results and DiscussionAstVs are small non-enveloped viruses with positive-sense, single-stranded RNA genomes.", [["aa residues 121-164", "CHEMICAL", 164, 183], ["Histidine-24, Aspartic acid-61 and Serine-125", "CHEMICAL", 276, 321], ["serine", "CHEMICAL", 242, 248], ["Histidine", "CHEMICAL", 276, 285], ["Aspartic acid-61", "CHEMICAL", 290, 306], ["Serine-125", "CHEMICAL", 311, 321], ["AstV", "GENE_OR_GENE_PRODUCT", 35, 39], ["trypsin-like peptidase", "GENE_OR_GENE_PRODUCT", 73, 95], ["pfam13365", "GENE_OR_GENE_PRODUCT", 103, 112], ["peptidase S7", "GENE_OR_GENE_PRODUCT", 120, 132], ["-164", "AMINO_ACID", 179, 183], ["Histidine-24", "SIMPLE_CHEMICAL", 276, 288], ["Aspartic acid-61", "SIMPLE_CHEMICAL", 290, 306], ["Serine-125", "SIMPLE_CHEMICAL", 311, 321], ["AstV sequence", "DNA", 35, 48], ["trypsin-like peptidase family", "PROTEIN", 73, 102], ["pfam13365", "PROTEIN", 103, 112], ["peptidase S7 superfamily", "PROTEIN", 120, 144], ["pfam 00949", "PROTEIN", 145, 155], ["catalytic triad", "PROTEIN", 219, 234], ["serine protease domain", "PROTEIN", 242, 264], ["positive-sense, single-stranded RNA genomes", "DNA", 393, 436], ["Closer inspection", "TEST", 0, 17], ["trypsin", "TEST", 73, 80], ["aa residues", "TEST", 164, 175], ["the potential catalytic triad", "PROBLEM", 205, 234], ["the serine protease domain", "TREATMENT", 238, 264], ["Histidine", "TEST", 276, 285], ["Aspartic acid", "TEST", 290, 303], ["Serine", "TEST", 311, 317], ["DiscussionAstVs", "TEST", 340, 355], ["small non-enveloped viruses", "PROBLEM", 360, 387], ["small", "OBSERVATION_MODIFIER", 360, 365], ["non-enveloped", "OBSERVATION_MODIFIER", 366, 379], ["viruses", "OBSERVATION", 380, 387], ["RNA genomes", "OBSERVATION", 425, 436]]], ["The family Astroviridae is divided into mammalian and avian AstVs (Figure 1 ) ( [11, 12] , http:// www.iah-virus.org/astroviridae/avastrovirus).", [["avian", "SPECIES", 54, 59], ["The family Astroviridae", "TREATMENT", 0, 23]]], ["In addition to yet unassigned chicken AstVs, a novel wood pigeon AstV and feral pigeon AstVs were recently identified in Norway that appear to be highly divergent from ANV-1, their closest relative [13] .", [["chicken", "ORGANISM", 30, 37], ["AstVs", "GENE_OR_GENE_PRODUCT", 38, 43], ["wood pigeon AstV", "ORGANISM", 53, 69], ["feral pigeon", "ORGANISM", 74, 86], ["AstVs", "GENE_OR_GENE_PRODUCT", 87, 92], ["ANV-1", "CELL", 168, 173], ["chicken AstVs", "PROTEIN", 30, 43], ["chicken", "SPECIES", 30, 37], ["pigeon", "SPECIES", 58, 64], ["pigeon", "SPECIES", 80, 86], ["chicken", "SPECIES", 30, 37], ["wood pigeon", "SPECIES", 53, 64], ["feral pigeon", "SPECIES", 74, 86], ["ANV-1", "SPECIES", 168, 173], ["a novel wood pigeon AstV", "PROBLEM", 45, 69], ["feral pigeon AstVs", "PROBLEM", 74, 92], ["ANV", "TEST", 168, 171]]], ["To gain further insight into the evolutionary relationship to other AstVs, a phylogenetic analysis of sanderling AstV was conducted based on a common 198 aa ORF1a sequence aligned to representative members of the family.", [["AstVs", "GENE_OR_GENE_PRODUCT", 68, 73], ["AstV", "GENE_OR_GENE_PRODUCT", 113, 117], ["AstVs", "DNA", 68, 73], ["sanderling AstV", "PROTEIN", 102, 117], ["common 198 aa ORF1a sequence", "DNA", 143, 171], ["a phylogenetic analysis", "TEST", 75, 98]]], ["The analysis indicated that sanderling AstV formed together with ANV-like AstV a branch distinct from other avian AstVs, namely those of duck, chicken and turkey origin (Figure 1) .", [["AstV", "CHEMICAL", 39, 43], ["AstV", "GENE_OR_GENE_PRODUCT", 39, 43], ["ANV", "GENE_OR_GENE_PRODUCT", 65, 68], ["AstV", "GENE_OR_GENE_PRODUCT", 74, 78], ["avian", "ORGANISM", 108, 113], ["AstVs", "GENE_OR_GENE_PRODUCT", 114, 119], ["duck", "ORGANISM", 137, 141], ["chicken", "ORGANISM", 143, 150], ["sanderling AstV", "PROTEIN", 28, 43], ["ANV", "PROTEIN", 65, 68], ["avian", "SPECIES", 108, 113], ["duck", "SPECIES", 137, 141], ["chicken", "SPECIES", 143, 150], ["turkey", "SPECIES", 155, 161], ["chicken", "SPECIES", 143, 150], ["turkey", "SPECIES", 155, 161], ["The analysis", "TEST", 0, 12], ["ANV", "TEST", 65, 68], ["branch", "ANATOMY_MODIFIER", 81, 87]]], ["Because sequence information of ORF1a is only available for ANV-1 and pigeon ANV but not for the novel pigeon AstVs reported from Norway, we cannot determine whether sanderling AstV groups with the subgroup of pigeon AstVs suggested by Kofstad and Jonassen [13] .", [["ORF1a", "GENE_OR_GENE_PRODUCT", 32, 37], ["ANV-1", "GENE_OR_GENE_PRODUCT", 60, 65], ["pigeon ANV", "ORGANISM", 70, 80], ["pigeon AstVs", "ORGANISM", 103, 115], ["pigeon", "ORGANISM", 210, 216], ["AstVs", "GENE_OR_GENE_PRODUCT", 217, 222], ["ORF1a", "DNA", 32, 37], ["ANV-1", "DNA", 60, 65], ["pigeon ANV", "DNA", 70, 80], ["pigeon AstVs", "PROTEIN", 103, 115], ["pigeon", "SPECIES", 70, 76], ["pigeon", "SPECIES", 103, 109], ["pigeon", "SPECIES", 210, 216], ["ANV-1", "SPECIES", 60, 65], ["pigeon", "SPECIES", 70, 76], ["pigeon", "SPECIES", 103, 109], ["pigeon", "SPECIES", 210, 216], ["ORF1a", "TEST", 32, 37], ["ANV", "TEST", 60, 63]]], ["Attempts to obtain additional sequence flanking the 600 bp region failed.", [["600 bp region", "DNA", 52, 65], ["additional sequence flanking", "TEST", 19, 47]]], ["This may reflect compromised nucleic acid quality in the sample material in addition to possible primer failure due to high sequence divergence.Results and DiscussionAvian AstVs are associated with enteric diseases in poultry [10, 14, 15] , nephritis in chicken and turkeys [16, 17] and fatal hepatitis in ducklings [18] .", [["sample material", "ANATOMY", 57, 72], ["nucleic acid", "CHEMICAL", 29, 41], ["enteric diseases", "DISEASE", 198, 214], ["nephritis", "DISEASE", 241, 250], ["hepatitis", "DISEASE", 293, 302], ["AstVs", "GENE_OR_GENE_PRODUCT", 172, 177], ["chicken", "ORGANISM", 254, 261], ["chicken", "SPECIES", 254, 261], ["turkeys", "SPECIES", 266, 273], ["ducklings", "SPECIES", 306, 315], ["chicken", "SPECIES", 254, 261], ["turkeys", "SPECIES", 266, 273], ["compromised nucleic acid quality in the sample material", "PROBLEM", 17, 72], ["primer failure", "PROBLEM", 97, 111], ["high sequence divergence", "PROBLEM", 119, 143], ["enteric diseases", "PROBLEM", 198, 214], ["nephritis", "PROBLEM", 241, 250], ["fatal hepatitis in ducklings", "PROBLEM", 287, 315], ["may reflect", "UNCERTAINTY", 5, 16], ["compromised", "OBSERVATION_MODIFIER", 17, 28], ["nucleic acid quality", "OBSERVATION", 29, 49], ["failure", "OBSERVATION", 104, 111], ["nephritis", "OBSERVATION", 241, 250], ["fatal", "OBSERVATION_MODIFIER", 287, 292], ["hepatitis", "OBSERVATION", 293, 302]]], ["ANV-like viruses as well as antibodies against them have been detected in both chicken and turkeys [17, 19, 20] , suggesting that these viruses may successfully infect and replicate in different poultry species.", [["ANV-like viruses", "ORGANISM", 0, 16], ["chicken", "ORGANISM", 79, 86], ["ANV", "PROTEIN", 0, 3], ["antibodies", "PROTEIN", 28, 38], ["chicken", "SPECIES", 79, 86], ["turkeys", "SPECIES", 91, 98], ["chicken", "SPECIES", 79, 86], ["turkeys", "SPECIES", 91, 98], ["ANV-like viruses", "PROBLEM", 0, 16], ["antibodies", "PROBLEM", 28, 38], ["these viruses", "PROBLEM", 130, 143], ["viruses", "OBSERVATION", 9, 16], ["viruses", "OBSERVATION", 136, 143], ["poultry species", "OBSERVATION", 195, 210]]], ["The discovery of pigeon ANV that is related to chicken ANV supports the likelihood of cross-infection between pigeons and chicken [21, 22] .", [["pigeon", "ORGANISM", 17, 23], ["ANV", "ORGANISM", 24, 27], ["chicken", "ORGANISM", 47, 54], ["ANV", "CANCER", 55, 58], ["pigeons", "ORGANISM", 110, 117], ["chicken", "ORGANISM", 122, 129], ["pigeon ANV", "PROTEIN", 17, 27], ["chicken ANV", "PROTEIN", 47, 58], ["pigeon", "SPECIES", 17, 23], ["chicken", "SPECIES", 47, 54], ["chicken", "SPECIES", 122, 129], ["pigeon", "SPECIES", 17, 23], ["chicken", "SPECIES", 47, 54], ["chicken", "SPECIES", 122, 129], ["pigeon ANV", "PROBLEM", 17, 27], ["pigeon ANV", "OBSERVATION", 17, 27], ["cross-infection", "OBSERVATION", 86, 101]]], ["Additional evidence for interspecies transmission among avian AstVs was provided by the identification of guinea fowl AstV, that is related to turkey AstV type 2 [23] , and the subsequent experimental infections conducted with both viruses in both avian species [24] .", [["infections", "DISEASE", 201, 211], ["avian", "ORGANISM", 56, 61], ["AstVs", "GENE_OR_GENE_PRODUCT", 62, 67], ["guinea fowl", "ORGANISM", 106, 117], ["AstV", "GENE_OR_GENE_PRODUCT", 118, 122], ["turkey", "ORGANISM", 143, 149], ["AstV type 2", "ORGANISM", 150, 161], ["avian", "SPECIES", 56, 61], ["guinea fowl", "SPECIES", 106, 117], ["turkey", "SPECIES", 143, 149], ["guinea fowl AstV", "SPECIES", 106, 122], ["turkey", "SPECIES", 143, 149], ["the subsequent experimental infections", "PROBLEM", 173, 211], ["both viruses", "PROBLEM", 227, 239], ["infections", "OBSERVATION", 201, 211]]], ["Sanderling AstV may potentially also be capable of infecting other avian species beyond its wild bird reservoir.Results and DiscussionThe sequences recovered from a ruddy turnstone mapped to ORF1ab, spike glycoprotein gene and the 39 end of CoV genomes.", [["AstV", "CHEMICAL", 11, 15], ["AstV", "GENE_OR_GENE_PRODUCT", 11, 15], ["ORF1ab", "GENE_OR_GENE_PRODUCT", 191, 197], ["spike glycoprotein", "GENE_OR_GENE_PRODUCT", 199, 217], ["CoV", "GENE_OR_GENE_PRODUCT", 241, 244], ["ruddy turnstone", "DNA", 165, 180], ["ORF1ab", "DNA", 191, 197], ["spike glycoprotein gene", "DNA", 199, 222], ["39 end", "DNA", 231, 237], ["CoV genomes", "DNA", 241, 252], ["infecting other avian species", "PROBLEM", 51, 80], ["a ruddy turnstone", "PROBLEM", 163, 180], ["spike glycoprotein gene", "TREATMENT", 199, 222], ["may potentially also be", "UNCERTAINTY", 16, 39], ["bird reservoir", "OBSERVATION", 97, 111], ["CoV genomes", "OBSERVATION", 241, 252]]], ["Analysis of the 438 nt PCR-amplified spike glycoprotein gene sequence (GenBank accession number JX548305) suggested homology to the CoV S2 glycoprotein multidomain (pfam 01601).", [["438 nt PCR-amplified spike glycoprotein gene sequence", "DNA", 16, 69], ["CoV S2 glycoprotein multidomain", "PROTEIN", 132, 163], ["pfam 01601", "PROTEIN", 165, 175], ["Analysis", "TEST", 0, 8], ["the 438 nt PCR", "TEST", 12, 26]]], ["Further sequence analysis at aa level revealed 79% identity to magpie-robin CoV HKU18 and sparrow CoV HKU17, both identified in Hong Kong [25] .", [["CoV", "ORGANISM", 76, 79], ["sparrow CoV HKU17", "ORGANISM", 90, 107], ["sparrow CoV HKU17", "DNA", 90, 107], ["sparrow CoV", "SPECIES", 90, 101], ["Further sequence analysis", "TEST", 0, 25], ["aa level", "TEST", 29, 37], ["magpie", "TEST", 63, 69], ["sparrow CoV HKU17", "TEST", 90, 107]]], ["Analysis of the amplified 450 nt ORF1ab fragment (GenBank accession number JX548303) indicated approximately 70% identity at aa level to common-moorhen CoV HKU21, also detected in Hong Kong [25] .", [["CoV", "ORGANISM", 152, 155], ["amplified 450 nt ORF1ab fragment", "DNA", 16, 48], ["common-moorhen CoV", "SPECIES", 137, 155], ["Analysis", "TEST", 0, 8], ["the amplified 450 nt ORF1ab fragment", "TREATMENT", 12, 48]]], ["Analysis of the amplified 312 nt fragment (GenBank accession number JX548302) mapping partly to the 39 untranslated region (UTR) also revealed relatedness to the CoVs recently identified by Woo and others [25] by showing 90% identity with white-eye CoV HKU16 39UTR nt 200-312.", [["HKU16 39UTR nt 200-312", "CHEMICAL", 253, 275], ["CoVs", "GENE_OR_GENE_PRODUCT", 162, 166], ["amplified 312 nt fragment", "DNA", 16, 41], ["39 untranslated region", "DNA", 100, 122], ["UTR", "DNA", 124, 127], ["CoVs", "DNA", 162, 166], ["white-eye CoV HKU16 39UTR nt 200-312", "DNA", 239, 275], ["white-eye CoV", "SPECIES", 239, 252], ["Analysis", "TEST", 0, 8], ["the amplified 312 nt fragment (GenBank accession number JX548302) mapping", "TREATMENT", 12, 85], ["the CoVs", "PROBLEM", 158, 166], ["white-eye CoV", "TEST", 239, 252], ["nt", "TEST", 265, 267], ["fragment", "OBSERVATION_MODIFIER", 33, 41], ["eye", "ANATOMY", 245, 248]]], ["A portion of the 312 nt fragment maps to the region potentially coding for nonstructural accessory proteins Ns7c or Ns7d.Results and DiscussionCoVs are enveloped RNA viruses with large, positive-sense single-stranded genomes.", [["Ns7c", "GENE_OR_GENE_PRODUCT", 108, 112], ["Ns7d", "GENE_OR_GENE_PRODUCT", 116, 120], ["312 nt fragment", "DNA", 17, 32], ["nonstructural accessory proteins", "PROTEIN", 75, 107], ["Ns7c", "PROTEIN", 108, 112], ["Ns7d", "PROTEIN", 116, 120], ["positive-sense single-stranded genomes", "DNA", 186, 224], ["the 312 nt fragment maps", "TREATMENT", 13, 37], ["nonstructural accessory proteins Ns7c", "TREATMENT", 75, 112], ["Ns7d", "TREATMENT", 116, 120], ["RNA viruses", "PROBLEM", 162, 173], ["large", "OBSERVATION_MODIFIER", 179, 184], ["stranded genomes", "OBSERVATION", 208, 224]]], ["Members of the family Coronaviridae cause enteric, respiratory and central nervous system (CNS) diseases in a wide range of animal species [26, 27] .", [["respiratory", "ANATOMY", 51, 62], ["central nervous system", "ANATOMY", 67, 89], ["CNS", "ANATOMY", 91, 94], ["enteric, respiratory and central nervous system (CNS) diseases", "DISEASE", 42, 104], ["central nervous system", "ANATOMICAL_SYSTEM", 67, 89], ["CNS", "ANATOMICAL_SYSTEM", 91, 94], ["enteric, respiratory and central nervous system (CNS) diseases", "PROBLEM", 42, 104], ["respiratory", "ANATOMY", 51, 62], ["central", "ANATOMY_MODIFIER", 67, 74], ["nervous system", "ANATOMY", 75, 89]]], ["The subfamily Coronavirinae has been divided into four groups ( Figure 2 ).", [["The subfamily Coronavirinae", "TREATMENT", 0, 27]]], ["Recent studies have revealed the presence of diverse, novel gamma and delta-CoVs in wild birds from Hong Kong [25, 28] , Cambodia [28] and from the Bering Strait area [29] .", [["gamma", "GENE_OR_GENE_PRODUCT", 60, 65], ["delta-CoVs", "GENE_OR_GENE_PRODUCT", 70, 80], ["gamma and delta-CoVs", "DNA", 60, 80], ["Recent studies", "TEST", 0, 14], ["diverse, novel gamma", "PROBLEM", 45, 65], ["delta-CoVs", "PROBLEM", 70, 80]]], ["Since full-length genomic sequences are not available for all of them, we assessed the relationship between those CoVs and ruddy turnstone CoV by amplifying a fragment of the polymerase (pol) gene with degenerate primers described by Muradrasoli et al. [29] .", [["CoVs", "GENE_OR_GENE_PRODUCT", 114, 118], ["turnstone CoV", "ORGANISM", 129, 142], ["pol", "GENE_OR_GENE_PRODUCT", 187, 190], ["full-length genomic sequences", "DNA", 6, 35], ["CoVs", "DNA", 114, 118], ["ruddy turnstone CoV", "DNA", 123, 142], ["polymerase (pol) gene", "DNA", 175, 196], ["ruddy turnstone CoV", "SPECIES", 123, 142], ["those CoVs and ruddy turnstone CoV", "PROBLEM", 108, 142], ["a fragment of the polymerase (pol", "TREATMENT", 157, 190], ["degenerate primers", "PROBLEM", 202, 220]]], ["Phylogenetic analysis of the amplified 508 nt pol sequence (GenBank accession number JX548304) agreed with that of the partial spike, ORF1ab and 39end (NS7c-like) sequences and showed a relation to the delta-CoV clade (Figure 2) .", [["ORF1ab", "GENE_OR_GENE_PRODUCT", 134, 140], ["39end", "GENE_OR_GENE_PRODUCT", 145, 150], ["NS7c", "GENE_OR_GENE_PRODUCT", 152, 156], ["delta-CoV", "GENE_OR_GENE_PRODUCT", 202, 211], ["508 nt pol sequence", "DNA", 39, 58], ["partial spike, ORF1ab and 39end (NS7c-like) sequences", "DNA", 119, 172], ["delta-CoV clade", "DNA", 202, 217], ["Phylogenetic analysis", "TEST", 0, 21], ["the partial spike", "TEST", 115, 132], ["ORF1ab", "TEST", 134, 140], ["the delta", "TEST", 198, 207]]], ["The pol sequence of ruddy turnstone CoV shares approx.", [["pol", "GENE_OR_GENE_PRODUCT", 4, 7], ["pol sequence", "DNA", 4, 16], ["ruddy turnstone CoV", "SPECIES", 20, 39], ["The pol sequence", "TEST", 0, 16]]], ["86% aa identity with commonmoorhen CoV HKU21 from Hong Kong [25] , and is less related to the IBV-like viruses from the Bering Strait area that fall into the gamma-CoV cluster.", [["IBV-like viruses", "ORGANISM", 94, 110], ["gamma-CoV", "GENE_OR_GENE_PRODUCT", 158, 167], ["gamma-CoV cluster", "DNA", 158, 175], ["commonmoorhen CoV", "SPECIES", 21, 38], ["the IBV", "PROBLEM", 90, 97], ["viruses", "PROBLEM", 103, 110], ["IBV", "OBSERVATION", 94, 97], ["viruses", "OBSERVATION", 103, 110], ["gamma", "ANATOMY", 158, 163], ["CoV cluster", "OBSERVATION", 164, 175]]], ["As with Sanderling AstV, attempts to obtain additional sequences from ruddy turnstone CoV were unsuccessful.Results and DiscussionOur findings indicate the importance of surveying wild bird populations for circulating viruses; the discovery of novel shorebird CoV and AstV sequences in a small sample set demonstrates the potential diversity of novel avian viruses yet to be identified.", [["turnstone CoV", "ORGANISM", 76, 89], ["shorebird CoV", "ORGANISM", 250, 263], ["AstV", "GENE_OR_GENE_PRODUCT", 268, 272], ["avian viruses", "ORGANISM", 351, 364], ["shorebird CoV and AstV sequences", "DNA", 250, 282], ["ruddy turnstone CoV", "SPECIES", 70, 89], ["shorebird CoV", "SPECIES", 250, 263], ["additional sequences", "TEST", 44, 64], ["ruddy turnstone CoV", "TREATMENT", 70, 89], ["circulating viruses", "PROBLEM", 206, 225], ["novel shorebird CoV and AstV sequences", "TEST", 244, 282], ["novel avian viruses", "PROBLEM", 345, 364], ["avian viruses", "OBSERVATION", 351, 364]]], ["The phylogenetic relation of sanderling AstV to ANV-1 may indicate a potential for interspecies transmission between wild birds and poultry also suggested by others [21, 22, 23, 24] .", [["AstV", "GENE_OR_GENE_PRODUCT", 40, 44], ["ANV-1", "GENE_OR_GENE_PRODUCT", 48, 53], ["sanderling AstV", "PROTEIN", 29, 44], ["ANV-1", "DNA", 48, 53], ["ANV-1", "SPECIES", 48, 53]]], ["The CoV sequences reported here along with recent discoveries by others [28, 29] imply a vast diversity among circulating avian CoVs and a high prevalence in wild birds [28] .", [["avian", "ORGANISM", 122, 127], ["CoVs", "CANCER", 128, 132], ["CoV sequences", "DNA", 4, 17], ["avian", "SPECIES", 122, 127], ["The CoV sequences", "TEST", 0, 17], ["a vast diversity", "PROBLEM", 87, 103], ["circulating avian CoVs", "PROBLEM", 110, 132], ["avian CoVs", "OBSERVATION", 122, 132], ["high prevalence", "OBSERVATION_MODIFIER", 139, 154]]], ["Finally, the Delaware Bay area could serve as a useful surveillance site for such novel avian viruses, in addition to influenza viruses.", [["influenza viruses", "DISEASE", 118, 135], ["avian", "ORGANISM", 88, 93], ["influenza viruses", "ORGANISM", 118, 135], ["the Delaware Bay area", "TREATMENT", 9, 30], ["a useful surveillance site", "PROBLEM", 46, 72], ["such novel avian viruses", "PROBLEM", 77, 101], ["influenza viruses", "PROBLEM", 118, 135], ["influenza viruses", "OBSERVATION", 118, 135]]], ["Due to the high volume of birds feeding during migration periods, the area may provide a niche for the emergence and spread of novel virus variants.", [["migration periods", "TREATMENT", 47, 64], ["novel virus variants", "PROBLEM", 127, 147], ["high", "OBSERVATION_MODIFIER", 11, 15], ["volume", "OBSERVATION_MODIFIER", 16, 22]]]]}